Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3000067	fp-pth	ng/l (ng/l)	25111	102560	0.00%
3000067	fp-pth	— (—)	6719	13399	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Heart failure and bmi 25plus

2406

6936

2.57

323.01

5.5

3.6

131.36

86.80

ng/l

57.49

2077

5778

Heart failure and coronary heart disease

2896

9526

2.34

322.70

5.7

3.5

141.70

87.07

ng/l

84.63

2538

7939

Iron deficiency anaemia

2843

13247

2.28

321.32

4.9

3.6

111.37

88.85

ng/l

16.34

2395

11322

Depression medications

1108

1362

4.26

316.98

3.7

2.6

76.65

65.83

ng/l

2.25

1004

1234

Thyrotoxicosis, other and/or unspecified

1444

5038

3.20

316.74

3.2

3.6

67.67

89.34

ng/l

16.57

1276

4322

Osteoporosis with pathological fracture (FG)

843

2155

5.11

316.07

3.0

72.75

86.91

ng/l

5.80

687

1759

Codeine or tramadol medication

6195

19922

1.77

315.09

3.9

91.79

90.94

ng/l

0.24

5409

17211

Cardiac arrhythmias

3023

9185

2.24

314.18

4.5

3.2

99.36

71.93

ng/l

32.35

2660

8095

Atrial fibrillation and flutter

1629

3681

3.06

312.33

5.3

2.2

115.52

63.17

ng/l

51.60

1429

3206

Statin medication

3482

9579

2.13

310.62

5.5

2.8

104.99

72.87

ng/l

46.03

3107

8246

Viral Sepsis

1761

5187

3.92

307.65

7.4

3.2

125.90

82.49

ng/l

35.70

1571

4390

Pain in limb

4951

16084

2.17

307.65

4.3

3.9

92.90

90.13

ng/l

0.99

4334

13909

Cystic kidney disease

733

710

24.24

307.65

12.7

4.0

158.48

81.87

ng/l

31.63

697

640

Osteopathies and chondropathies

4611

16015

2.99

307.65

4.5

3.7

93.69

88.76

ng/l

1.96

3964

13754

Hypertensive heart and/or renal disease

2267

4108

4.75

307.65

7.1

2.3

145.69

69.40

ng/l

112.52

2002

3392

Other disorders of kidney and ureter

1628

3439

6.31

307.65

12.2

3.5

181.21

88.12

ng/l

74.35

1499

2941

L04AD Calcineurin inhibitors

2191

2320

17.27

307.65

14.1

3.4

173.64

78.79

ng/l

108.30

2092

2058

Nephropathy related operations

3068

2742

26.70

307.65

15.2

2.8

206.97

79.08

ng/l

232.71

2915

2381

Heart failure, strict

4229

13004

2.51

307.65

5.6

3.6

133.12

84.72

ng/l

106.91

3687

10966

Acute tubulo-interstitial nephritis

4334

13575

3.00

307.65

5.8

2.3

115.30

66.78

ng/l

108.99

3778

11457

Genitourinary diseases

3207

5105

3.33

307.65

6.1

2.3

107.40

62.34

ng/l

76.09

2916

4397

Dialysis

1224

633

91.27

307.65

16.4

2.6

211.65

61.28

ng/l

133.53

1169

575

Gout

2506

6304

4.05

307.65

7.3

3.7

144.18

97.37

ng/l

49.55

2219

5330

Any reimbursement code in KELA

2759

5055

2.86

307.65

4.8

2.2

87.37

63.51

ng/l

27.85

2487

4429

Diabetic nephropathy

2203

4650

6.68

307.65

10.0

3.6

173.04

93.27

ng/l

91.87

2010

3947

Tramadol

5121

13560

2.47

307.65

4.7

3.7

100.44

88.83

ng/l

9.75

4474

11688

Primary hyperparathyroidism

2939

3085

26.52

307.65

5.5

3.2

101.91

84.67

ng/l

12.38

2563

2582

Oedema, not elsewhere classified

2190

8672

2.71

307.65

5.1

3.4

108.97

87.71

ng/l

15.14

1917

7399

Abnormalities of breathing

5162

14749

2.13

307.65

4.3

3.8

98.36

85.24

ng/l

13.34

4488

12843

Explicit Sepsis

3443

11653

3.06

307.65

7.5

3.2

141.29

81.84

ng/l

84.26

3027

9906

Kidney transplant status

1801

1004

141.44

307.65

16.3

3.2

198.83

68.73

ng/l

149.15

1730

909

Type 2 diabetes, wide definition

5353

15358

2.39

307.65

5.4

3.4

116.33

83.83

ng/l

58.96

4625

13197

Autoimmune diseases excluding thyroid diseases

6125

16587

2.11

307.65

5.5

3.6

106.85

85.71

ng/l

29.23

5458

14391

Type 1 diabetes, wide definition

1547

4952

3.45

307.65

8.1

3.9

146.97

80.55

ng/l

46.58

1383

4362

Hypercalcemia

892

1146

16.20

307.65

5.5

3.6

82.05

88.07

ng/l

0.70

752

983

Acute renal failure

2776

4648

7.89

307.65

7.2

2.1

139.87

70.58

ng/l

103.26

2491

3818

All chronic kidney diseases

9164

9708

10.69

307.65

8.0

2.1

138.30

66.60

ng/l

307.65

8332

8067

Hypocalcemia

492

529

21.31

307.65

7.6

3.8

96.52

83.15

ng/l

0.96

426

469

Certain disorders involving the immune mechanism

1498

5033

3.39

307.65

7.1

3.8

109.32

88.07

ng/l

8.45

1374

4366

Antihypertensive medication - note that there are other indications

3076

5471

3.14

307.65

5.8

2.3

92.41

59.41

ng/l

47.74

2794

4806

Pain in throat and chest

4610

14411

2.00

307.65

4.1

3.8

91.71

86.05

ng/l

3.08

4008

12523

Polycystic kidney disease

663

568

33.11

307.65

12.7

4.2

164.92

80.99

ng/l

32.56

630

520

Malignant neoplasm of thyroid gland, including Hilmo

868

1885

6.00

307.65

3.2

3.5

49.44

85.37

ng/l

43.55

784

1613

Dental caries

2185

5692

4.21

307.65

10.0

3.5

145.82

85.80

ng/l

57.39

2010

4951

Malaise and fatigue

3727

11620

2.80

307.65

4.2

3.5

99.03

86.92

ng/l

7.36

3174

9946

Other diseases of intestines

5784

18147

1.89

307.65

4.5

3.9

94.16

87.05

ng/l

4.73

5093

15778

Diabetes, insulin treatment (Kela reimbursement)

6011

19414

1.96

307.65

5.1

3.5

109.69

83.42

ng/l

49.29

5216

16799

Gout, unspecified

1777

5387

3.87

307.65

7.2

3.7

146.12

94.37

ng/l

41.80

1562

4575

Hypertension

5288

10031

3.21

307.65

6.3

2.4

112.38

65.40

ng/l

124.58

4740

8702

Other septicaemia

3107

10528

3.18

307.65

7.8

3.3

145.41

83.93

ng/l

77.46

2737

8875

Caries of dentine

1953

5005

4.36

307.65

9.8

3.5

148.01

85.81

ng/l

53.19

1791

4353

Complications of procedures, not elsewhere classified

4737

21073

1.95

307.65

5.1

3.5

105.74

86.25

ng/l

19.95

4171

18111

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5664

17465

2.05

307.65

5.2

3.4

109.35

81.45

ng/l

52.77

4921

15126

ILD medications: immunosuppressive drugs

4923

15900

3.16

307.65

8.1

3.1

121.09

79.43

ng/l

76.97

4521

13656

All pneumoniae

6062

20890

2.04

307.65

5.4

3.6

110.28

82.41

ng/l

49.37

5332

18133

Anaemias

1895

1336

10.54

307.65

7.7

2.9

121.02

64.84

ng/l

33.97

1725

1211

Congenital malformations of the urinary system

940

1394

10.17

307.65

11.9

4.1

147.26

79.04

ng/l

35.25

888

1237

Pneumonia, organism unspecified

5469

19603

2.06

307.65

5.4

3.6

110.68

82.38

ng/l

50.26

4783

16973

Autoimmune diseases excluding thyroid diseases, strict definition

5723

15135

2.17

307.65

5.5

3.6

109.65

88.69

ng/l

26.31

5104

13085

Condition for Implicit Sepsis (Organ dysfunction codes)

6266

17602

2.64

307.65

5.3

3.3

110.40

78.52

ng/l

70.19

5478

15214

Implicit bacterial Sepsis

3986

11175

3.50

307.65

6.5

3.2

131.99

83.85

ng/l

79.21

3501

9435

ILD medications: prednisolone, methylprednisolone, prednisone

7380

17742

2.48

307.65

6.2

3.0

109.27

81.21

ng/l

61.72

6609

15165

Insulin, combination of fast acting with intermediate-acting or long-acting

4304

17012

2.50

307.65

6.3

3.6

128.88

87.38

ng/l

69.49

3761

14626

All kidney diseases

10387

15694

5.24

307.65

6.6

2.2

119.80

64.64

ng/l

319.55

9332

13320

Bacterial infection, other or unspecified

4136

13810

2.86

307.65

6.8

3.2

129.81

82.22

ng/l

85.11

3651

11691

Erysipelas

4411

16401

2.17

307.65

5.2

3.2

116.49

81.04

ng/l

64.83

3854

14011

Diseases of oesophagus, stomach and duodenum

6217

20015

1.94

307.65

4.3

3.8

95.63

88.92

ng/l

4.59

5367

17392

Infections, IBD-co-morbidities

1250

1485

6.80

307.65

7.7

3.3

128.01

78.31

ng/l

27.79

1137

1292

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5461

16454

2.12

307.65

5.3

3.4

109.22

81.79

ng/l

44.49

4811

14216

ILD medications: azathioprine

1154

3113

4.23

307.65

9.5

3.0

107.98

79.07

ng/l

9.54

1082

2698

Hypothyroidism, levothyroxine purchases

1656

1308

7.80

307.65

3.9

2.7

71.56

66.29

ng/l

0.79

1485

1181

Inflammatory bowel disease treatment related agents

6791

20023

1.99

307.65

4.7

3.8

93.10

89.35

ng/l

1.91

6014

17257

ILD medications

7423

17915

2.38

307.65

6.0

3.1

107.28

80.94

ng/l

56.73

6658

15324

Nutritional anaemias

3306

15376

2.23

307.65

4.8

3.6

109.98

89.59

ng/l

16.08

2783

13125

Hypertension, essential

5035

9758

3.15

307.65

5.5

2.3

110.22

65.98

ng/l

109.00

4479

8442

Hyperparathyroidism

4093

5219

14.21

307.65

7.5

2.7

135.07

82.17

ng/l

87.10

3573

4340

Other bacterial diseases

6750

19197

2.54

307.65

6.2

3.3

120.05

79.60

ng/l

105.80

5953

16506

Hypothyroidism (congenital or acquired)

1672

1314

7.83

307.65

4.0

2.7

73.56

66.16

ng/l

1.26

1503

1187

Implicit bacterial Sepsis

3713

10457

3.60

307.65

6.6

3.2

134.97

84.33

ng/l

78.28

3263

8808

Type 1 diabetes, wide definition, subgroup 1

1514

4525

3.73

307.65

8.0

3.9

146.02

79.79

ng/l

45.10

1351

4000

Other anaemias

3360

12750

2.78

307.65

5.6

3.4

122.09

89.60

ng/l

34.82

2914

10723

Insulin, fast-acting

2695

9794

3.05

307.65

7.2

3.8

138.46

85.74

ng/l

59.69

2377

8476

Pneumonias (Asthma/COPD co-morbidities)

6037

20787

2.05

307.65

5.4

3.5

110.58

81.71

ng/l

52.49

5309

18032

Sub-endpoint used in defining T1D endpoints

1972

7686

2.74

307.65

8.1

3.9

146.11

87.88

ng/l

48.77

1760

6662

Insulin medication

4297

14722

2.66

307.65

6.3

3.7

128.94

85.74

ng/l

73.95

3757

12675

Insulin, fast-acting or short human

2707

10392

2.87

307.65

7.2

3.8

138.26

87.22

ng/l

56.61

2387

8983

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6336

18758

2.34

307.65

7.0

3.0

122.74

76.79

ng/l

124.77

5568

16342

Disorders of thyroid, IBD co-morbidities

1462

1617

7.16

307.65

3.4

3.1

66.10

77.28

ng/l

4.97

1299

1411

Implicit Sepsis

5919

16640

2.95

307.65

5.7

3.2

116.64

80.10

ng/l

81.88

5161

14269

Implicit viral Sepsis

1758

5177

3.92

307.65

7.4

3.2

125.90

82.55

ng/l

35.51

1569

4381

Heart failure,strict

3928

9704

3.17

307.65

5.7

2.6

133.48

69.96

ng/l

171.44

3441

8124

Glomerulonephritis

1479

2313

9.35

307.65

10.7

4.0

148.42

88.69

ng/l

30.23

1387

2021

Certain infectious and parasitic diseases

5378

14330

1.95

307.65

5.0

3.0

100.92

77.35

ng/l

40.99

4744

12335

Disorders of the thyroid gland

5885

18613

2.18

307.65

3.7

4.0

78.40

94.63

ng/l

29.96

5082

16153

Diseases of arteries, arterioles and capillaries (FINNGEN)

1700

2890

4.54

307.65

7.4

2.2

144.02

63.62

ng/l

73.35

1525

2497

Hypertensive Renal Disease

741

597

22.89

307.65

10.6

2.2

174.85

67.94

ng/l

48.60

687

498

Insulin, intermediate and long-acting

3961

15854

2.65

307.65

6.2

3.7

127.23

87.71

ng/l

61.04

3456

13646

Chronic kidney disease

7040

6730

18.58

307.65

9.4

2.1

157.97

70.69

ng/l

307.65

6409

5493

Hypothyroidism, drug reimbursement

1447

936

12.96

307.65

3.7

2.5

59.52

69.40

ng/l

1.62

1306

828

Gout, strict definition

1687

4709

4.30

307.65

7.4

3.8

149.81

96.49

ng/l

40.94

1490

4009

Condition for Implicit Sepsis (Organ dysfunction codes)

6203

17601

2.69

307.65

5.5

3.2

112.64

79.35

ng/l

75.05

5419

15178

Intestinal infectious diseases

5369

22868

1.86

307.65

5.7

3.6

107.11

86.10

ng/l

28.94

4749

19739

Symptoms and signs involving the urinary system

4560

18910

1.93

307.65

4.8

3.8

101.31

89.83

ng/l

8.56

3950

16237

Disorders of parathyroid gland

4558

5932

13.62

307.65

7.2

2.8

127.19

81.86

ng/l

75.27

3950

4943

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5903

20957

2.02

307.65

5.4

3.6

110.69

82.89

ng/l

47.77

5189

18188

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1287

3831

3.72

307.65

10.2

4.3

128.37

82.95

ng/l

28.24

1202

3396

Hypertensive diseases (excluding secondary)

3627

5630

4.09

307.65

6.9

2.3

112.13

61.88

ng/l

96.53

3300

4989

Polyarthropathies

4613

12332

2.62

307.65

5.8

3.8

115.99

88.46

ng/l

35.34

4080

10689

Other heart diseases, wide

5067

15864

2.04

307.65

5.2

3.6

106.60

77.75

ng/l

51.10

4467

13908

Renal failure

8343

9681

11.31

307.65

8.3

2.1

147.84

69.86

ng/l

307.65

7540

7954

Type 1 diabetes

1866

5772

3.59

307.65

8.4

3.9

147.95

81.10

ng/l

58.40

1683

5077

General symptoms and signs

6133

15471

2.07

307.65

4.6

3.6

96.82

85.01

ng/l

11.33

5370

13412

Disorders of lipoprotein metabolism and other lipidaemias

5218

14280

2.41

307.65

5.2

3.3

108.40

85.68

ng/l

36.64

4569

12228

Hypothyreosis and Thyroxine purchase for inclusion criteria

5805

18775

2.15

307.65

3.6

3.9

76.07

93.63

ng/l

37.77

5012

16267

Complications of surgical and medical care, not elsewhere classified

6123

21603

2.05

307.65

5.3

3.6

107.69

86.28

ng/l

29.78

5388

18593

Heart failure and antihypertensive medication

1959

2630

5.55

307.65

6.6

2.2

141.27

62.94

ng/l

101.49

1728

2220

Other nutritional deficiencies

3851

17988

2.13

307.65

4.5

3.9

101.46

85.66

ng/l

15.46

3349

15773

Diabetes, varying definitions

5968

18099

2.03

307.65

5.1

3.4

106.91

80.89

ng/l

51.37

5201

15709

Renal tubulo-interstitial diseases

9681

16173

5.25

307.65

7.1

2.3

130.06

65.95

ng/l

307.65

8671

13755

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1335

4131

3.56

307.65

10.0

4.2

127.36

83.60

ng/l

27.91

1244

3654

Extracorporeal dialysis

1708

1351

43.91

307.65

17.6

3.5

243.65

84.62

ng/l

164.75

1620

1201

Hypertensive Heart Disease

1609

3870

3.60

307.65

6.0

2.2

135.37

69.83

ng/l

74.36

1388

3187

Complications of medical and surgical care

4413

21731

1.97

307.65

5.4

3.6

107.30

87.72

ng/l

18.56

3900

18650

Bacterial infection, other or unspecified

4410

14513

2.82

307.65

6.6

3.2

127.18

81.85

ng/l

84.78

3890

12312

5461

16454

2.12

307.65

5.3

3.4

109.22

81.79

ng/l

44.49

4811

14216

Malignant neoplasm of thyroid gland

761

1621

6.14

307.65

3.2

3.6

48.32

84.74

ng/l

41.11

683

1392

Anaemia in chronic diseases classified elsewhere

463

529

17.18

307.65

13.7

4.0

195.38

86.74

ng/l

32.42

435

475

Hypoparathyroidism

564

873

10.32

307.65

4.9

2.8

56.03

76.82

ng/l

5.82

457

741

Heart failure, not strict

6861

13595

3.92

307.65

7.3

2.6

136.35

68.58

ng/l

271.02

6109

11580

Implicit Sepsis

6177

17434

2.82

307.65

5.6

3.2

114.05

79.69

ng/l

78.26

5398

14989

Cardiovascular diseases

2949

5792

2.87

307.65

5.9

2.5

94.26

59.69

ng/l

48.17

2687

5174

GASTRO-related operations

4405

9552

2.42

307.65

4.9

2.7

94.06

76.23

ng/l

20.67

3904

8180

Other and unspecified anaemias

3341

12662

2.79

307.65

5.6

3.4

122.28

89.74

ng/l

34.65

2897

10651

Diabetes medication

5921

19224

1.91

307.65

5.0

3.5

106.70

82.73

ng/l

43.09

5154

16681

Congenital malformations of the urinary system

920

1301

10.96

307.65

12.1

4.2

147.82

79.37

ng/l

33.98

870

1159

Glomerular disorders in diseases classified elsewhere

2553

2597

19.33

307.65

11.2

3.3

170.48

87.76

ng/l

92.31

2382

2241

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7585

19953

2.85

307.65

5.7

3.4

111.53

81.81

ng/l

72.66

6672

17229

Preparatory care for dialysis

1409

952

109.65

307.65

17.8

3.3

217.06

87.67

ng/l

111.13

1394

834

Malignant neoplasm of endocrine gland

797

1746

5.91

307.65

3.5

3.7

52.05

84.69

ng/l

29.34

713

1503

Other dialysis

944

642

86.57

307.65

16.6

4.1

218.44

81.62

ng/l

82.08

911

577

Examination and observation for other reasons

3659

8121

2.77

307.65

4.8

3.4

95.03

87.54

ng/l

3.60

3342

6975

Diabetes mellitus

6005

18075

2.04

307.65

5.1

3.4

107.33

80.60

ng/l

53.87

5232

15691

Medical observation and evaluation for suspected diseases and conditions

3904

8210

2.56

307.65

4.7

3.4

92.12

87.83

ng/l

1.58

3411

7042

Other special examinations and investigations of persons without complaint or reported diagnosis

3469

8212

2.23

307.65

4.7

3.4

95.25

87.82

ng/l

3.26

3055

7044

Persons encountering health services for specific procedures and health care

7403

18645

2.54

307.65

6.8

2.7

119.83

73.77

ng/l

145.59

6635

16021

Other soft tissue disorders, not elsewhere classified

5453

16394

2.04

307.65

4.1

4.0

91.75

89.96

ng/l

0.58

4779

14180

Cerebrovascular diseases (FINNGEN)

1677

4013

3.16

307.65

5.4

2.3

107.72

63.72

ng/l

39.59

1483

3506

Type 2 diabetes

5728

17326

2.03

307.65

4.9

3.3

107.27

81.77

ng/l

47.44

4978

14974

Other disorders of fluid, electrolyte and acid-base balance

2534

7992

3.41

307.65

5.6

3.2

120.47

86.85

ng/l

25.19

2164

6721

Continuous positive airway pressure

1304

3117

3.90

307.65

5.7

3.5

110.01

73.21

ng/l

27.57

1166

2732

Transplanted organ and tissue status

2177

2055

21.33

307.65

14.6

3.1

183.32

76.09

ng/l

132.39

2080

1812

First line medication for Crohn's disease

6971

17430

2.28

307.65

5.9

3.1

104.78

81.46

ng/l

43.60

6235

14917

Disorders of calcium metabolism

1456

1398

22.12

307.65

6.0

3.3

86.27

86.25

ng/l

0.00

1251

1180

Other disorders involving the immune mechanism, not elsewhere classified

610

630

18.71

307.65

11.0

4.8

146.85

81.82

ng/l

19.74

573

562

Secondary hypertension

1669

1155

25.30

307.65

12.1

2.4

170.91

63.59

ng/l

103.45

1538

1011

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

595

576

21.09

307.65

11.2

5.1

147.39

83.61

ng/l

18.06

560

516

Bleeding

4903

19295

1.90

307.65

5.5

3.7

114.67

86.41

ng/l

43.33

4250

16604

All-cause Heart Failure

4133

12846

2.48

307.65

5.5

3.5

133.32

84.68

ng/l

104.84

3596

10829

Dyspnoea

5427

21309

1.98

307.65

4.4

3.8

102.24

87.72

ng/l

18.19

4689

18428

Glomerular diseases

3429

4312

13.04

307.65

10.8

3.3

159.97

83.96

ng/l

114.96

3191

3700

Diseases of arteries, arterioles and capillaries

4161

16027

2.04

307.65

6.2

3.5

129.05

87.89

ng/l

66.30

3651

13591

Care involving dialysis

2524

1680

61.84

307.65

16.6

2.9

222.63

78.33

ng/l

232.90

2415

1450

Dialysis, with operation codes

3250

2290

34.24

307.65

14.8

2.3

205.38

66.26

ng/l

304.96

3098

1956

Aplastic and other anaemias

3787

13461

2.93

307.65

6.4

3.4

128.35

89.11

ng/l

53.54

3308

11349

Chronic nephritic syndrome

699

804

15.27

307.65

11.2

3.1

172.04

78.45

ng/l

26.26

650

710

Used for control exclusion in common control thyroid runs

6388

14255

2.39

307.65

4.8

3.6

93.92

88.78

ng/l

2.90

5647

12340

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3974

14114

2.46

307.65

5.0

3.6

114.62

89.97

ng/l

32.01

3416

12030

Gout, FINNGEN

2506

7930

3.63

307.65

7.3

3.5

144.18

94.38

ng/l

58.04

2219

6705

Disorders of mineral metabolism

1626

1817

15.56

307.65

6.1

3.4

87.29

85.81

ng/l

0.16

1403

1547

Endocrine, nutritional and metabolic diseases

4832

7029

3.71

307.65

4.9

2.8

94.40

72.20

ng/l

31.79

4310

6153

Carbimazole or st.post thyroidectomy, condition for graves disease

2168

5578

4.71

307.65

3.2

3.6

52.27

87.83

ng/l

79.88

1967

4781

Gout, idiopatic and unspecified

2118

6757

3.64

307.65

7.1

3.7

145.13

95.21

ng/l

48.10

1865

5745

Other bacterial diseases

6860

19160

2.42

307.65

6.0

3.2

116.08

78.39

ng/l

97.68

6074

16520

Any gastric operation

4405

9552

2.42

307.65

4.9

2.7

94.06

76.23

ng/l

20.67

3904

8180

Disorders resulting from impaired renal tubular function

1031

831

48.93

307.65

15.6

3.8

214.05

83.29

ng/l

73.60

971

742

Pure hypercholesterolaemia

4605

13568

2.36

307.65

4.8

3.3

105.60

86.12

ng/l

26.71

4075

11578

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1391

2746

6.38

307.65

4.2

3.1

55.15

78.79

ng/l

22.34

1225

2358

Fever of other and unknown origin

3629

13373

2.58

307.65

6.1

3.5

109.86

85.74

ng/l

22.01

3228

11538

Hypertensive diseases

5289

10036

3.21

307.65

6.3

2.4

112.36

65.39

ng/l

124.58

4741

8707

Hyperkalaemia

654

1226

6.97

307.65

8.6

3.3

175.02

94.44

ng/l

20.10

582

1020

Hypothyroidism and >3 levothyroxin purchases

1656

1308

7.80

307.65

3.9

2.7

71.56

66.29

ng/l

0.79

1485

1181

Hypothyroidism, other/unspecified

5603

17647

2.21

307.65

3.7

3.9

75.87

94.24

ng/l

40.30

4847

15305

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3158

9638

3.81

307.65

3.6

3.8

63.10

89.22

ng/l

49.11

2825

8301

Other metabolic disorders

1449

2987

6.03

307.65

4.3

3.1

56.08

78.76

ng/l

21.71

1278

2567

Unspecified kidney failure

1646

2041

12.26

307.65

8.3

2.0

161.66

71.85

ng/l

81.30

1506

1676

Osteoporosis

2831

8069

3.98

307.65

3.9

3.2

82.19

89.26

ng/l

3.69

2385

6708

Non-invasive ventilation

1782

3992

4.45

307.65

5.2

3.2

102.94

71.66

ng/l

19.29

1653

3485

Nephrotic syndrome

608

645

18.20

307.65

12.7

4.1

136.99

72.96

ng/l

22.31

582

581

Other disorders of urethra and urinary system

4229

15634

2.06

307.65

4.6

3.6

97.91

86.58

ng/l

7.33

3677

13443

Metabolic disorders

7451

15845

3.14

307.65

5.3

3.3

100.41

83.94

ng/l

23.37

6545

13668

Diarrhoea and gastroenteritis of presumed infectious origin

4078

19216

2.01

307.65

6.0

3.6

109.06

86.27

ng/l

23.87

3597

16582

Septicaemia

3381

11541

3.05

307.65

7.6

3.3

142.73

83.41

ng/l

81.39

2973

9767

IgA nephropathy (IgA glomerulonephritis)

545

448

29.50

307.65

11.9

4.2

151.55

85.11

ng/l

16.97

519

400

Codeine

5084

14184

2.03

307.65

3.9

3.7

91.57

87.61

ng/l

1.63

4460

12264

Ulcer of lower limb, not elsewhere classified

1278

3977

3.79

307.65

8.1

3.5

152.92

93.29

ng/l

30.93

1145

3337

Oral corticosteroids

6282

19636

1.99

307.65

4.0

3.8

91.84

89.84

ng/l

0.70

5512

16893

Other heart diseases

2711

5744

3.29

307.65

6.1

2.5

112.34

61.44

ng/l

74.03

2433

5099

Implicit viral Sepsis

2312

7922

3.28

307.65

6.6

3.2

119.22

82.26

ng/l

37.91

2059

6730

L04AA Selective immunosuppressants

2579

5722

5.65

307.65

11.7

3.2

156.93

80.93

ng/l

100.07

2430

4965

Cystic kidney disease

744

777

20.56

307.65

12.7

3.9

158.38

81.29

ng/l

33.43

708

694

Cardiovascular diseases (excluding rheumatic etc)

3406

6795

3.05

307.65

6.2

2.5

99.63

60.01

ng/l

68.08

3101

6061

Erysipelas

3455

14455

2.25

307.65

5.3

3.2

120.77

83.09

ng/l

52.82

3006

12278

Opioids

5273

14347

1.99

307.65

4.2

3.7

94.86

87.30

ng/l

4.99

4628

12404

Autoimmune diseases

6220

16858

1.95

307.65

5.1

3.5

100.88

85.01

ng/l

20.67

5476

14638

Influenza and pneumonia

6316

20538

2.05

307.65

5.4

3.6

109.07

81.74

ng/l

50.64

5575

17819

Disorders of other endocrine glands

5748

11625

6.12

307.65

6.6

3.2

117.71

80.67

ng/l

67.50

4998

10033

Other disorders of skin and subcutaneous tissue

4460

20058

2.10

307.65

5.7

3.5

115.55

86.89

ng/l

39.08

3930

17135

Parasetamol

3789

8965

2.23

307.65

4.3

3.9

95.29

85.71

ng/l

5.30

3321

7891

Care involving use of rehabilitation procedures

3956

17005

2.27

307.65

5.3

2.7

99.47

74.78

ng/l

32.82

3550

14538

Bacterial Sepsis

4045

11489

3.40

307.65

6.6

3.2

133.31

83.54

ng/l

83.68

3554

9716

Azathioprine

1154

3382

3.87

307.65

9.5

3.9

107.98

86.73

ng/l

5.39

1082

2964

Diabetic nephropathy, excluding more controls

2187

3259

8.02

307.65

10.0

3.3

173.33

86.08

ng/l

103.98

1996

2758

Finngen Rheumatological endpoints

5010

15885

1.86

306.75

4.4

3.8

94.74

88.05

ng/l

3.54

4409

13811

Obesity and other hyperalimentation

3525

17547

2.04

306.52

4.6

3.9

103.29

85.60

ng/l

17.25

3080

15390

Low back pain

4154

15971

1.95

305.39

3.6

4.1

86.47

93.59

ng/l

4.15

3564

13825

Obesity

3506

17476

2.04

305.01

4.6

3.9

103.42

85.62

ng/l

17.32

3066

15332

Diabetic maculopathy, excluding more controls

878

2307

4.42

304.71

8.9

3.6

169.46

86.51

ng/l

33.91

784

1980

Asthma, unspecified (mode), excluding more controls

2808

9814

2.25

303.50

4.0

3.3

94.44

78.11

ng/l

13.80

2481

8456

Diverticular disease of intestine

4207

14454

1.95

299.70

4.4

3.6

98.13

90.45

ng/l

4.19

3643

12367

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2064

5253

2.60

296.43

4.9

2.2

99.07

62.38

ng/l

37.41

1841

4635

Pain in joint

3169

9901

2.14

291.66

3.8

4.0

82.76

91.89

ng/l

5.83

2812

8593

Isolated proteinuria

402

581

10.40

285.43

8.8

4.1

122.93

86.55

ng/l

5.89

381

521

Disorders of choroid and retina

4711

19085

1.84

285.24

5.6

3.6

117.08

88.50

ng/l

40.15

4021

16398

Hyperlipidaemia, other/unspecified

2327

9754

2.36

284.08

5.8

3.2

119.85

88.53

ng/l

26.52

1957

8231

Other CVD (FINNGEN)

791

1470

4.70

283.52

5.3

2.2

114.49

65.48

ng/l

20.52

673

1233

Disorders of lens

3853

12796

1.98

283.06

6.0

3.6

118.40

85.70

ng/l

37.36

3306

11204

Vocal cord dysfunction

835

1927

4.25

282.81

4.0

3.0

76.88

69.40

ng/l

1.62

722

1717

Peripheral artery disease

2862

11182

2.19

282.57

6.5

3.4

139.17

91.18

ng/l

58.20

2493

9369

Other retinal disorders

3893

16505

1.94

280.94

5.9

3.6

122.62

89.66

ng/l

40.45

3319

14109

Symptoms and signs involving cognition, perception, emotional state and behaviour

5294

21266

1.76

280.40

3.7

4.0

88.89

91.06

ng/l

0.85

4542

18514

Covid-19 confirmed case

2357

10943

2.32

279.93

6.2

3.7

119.75

90.79

ng/l

21.66

2056

9370

Oxycodone

2337

9732

2.32

276.19

4.3

3.7

106.00

92.02

ng/l

5.46

2007

8270

Provisional assignment of new diseases of uncertain etiology

3085

15822

2.06

275.65

5.8

3.7

112.97

88.67

ng/l

21.92

2672

13687

Codes for special purposes

3089

15853

2.06

275.48

5.8

3.7

113.21

88.61

ng/l

22.24

2676

13713

Other diseases of urinary system

5386

17800

1.76

275.28

4.5

3.8

98.09

87.88

ng/l

7.68

4716

15424

Acute peritonitis

657

1530

5.41

274.10

13.3

3.9

195.97

90.81

ng/l

29.90

614

1326

Thyrotoxicosis

1780

7431

2.64

273.66

3.4

3.6

69.28

86.50

ng/l

14.16

1563

6350

Headache

3401

14214

1.99

272.83

3.8

3.5

82.91

83.58

ng/l

0.16

2979

12327

Other and unspecified iron deficiency

2231

10241

2.36

272.65

4.7

3.6

109.69

87.58

ng/l

13.01

1888

8756

Obesity due to excess calories

2631

12817

2.18

272.48

4.6

3.9

103.86

85.62

ng/l

13.18

2275

11265

Nausea and vomiting

1844

7646

2.56

271.02

6.3

3.6

111.95

86.89

ng/l

13.95

1611

6548

Asthma, unspecified (mode)

2916

10896

2.11

269.94

3.9

3.4

94.45

82.56

ng/l

7.96

2564

9369

Type 2 diabetes, definitions combined

4975

16940

1.79

269.64

4.1

3.3

97.33

82.01

ng/l

19.24

4288

14620

Type 2 diabetes, strict (exclude DM1)

4990

17047

1.78

267.44

4.1

3.3

97.44

82.28

ng/l

18.87

4301

14711

Intestinal infectious diseases

6204

21838

1.68

266.71

5.0

3.6

101.57

86.48

ng/l

19.32

5489

18803

Unspecified haematuria

2567

10260

2.22

265.81

5.4

3.9

108.22

94.43

ng/l

7.27

2237

8782

Papillary adenocarcinoma of thyroid gland

568

1212

6.13

265.71

3.4

3.5

48.74

83.11

ng/l

26.60

511

1045

Nontoxic multinodular goitre

1493

5863

2.86

263.82

3.3

66.20

90.07

ng/l

21.59

1285

4949

Insulin, fast-acting (human)

967

2958

3.63

263.81

8.7

3.6

147.71

83.54

ng/l

25.85

889

2591

Symptoms and signs involving the circulatory and respiratory systems

5086

14776

1.78

263.78

4.3

3.8

92.96

85.25

ng/l

5.25

4486

12869

Calculus of kidney and ureter

1892

8266

2.48

260.63

3.9

4.2

85.63

97.70

ng/l

5.61

1698

7148

General examination and investigation of persons without complaint and reported diagnosis

3146

8189

2.08

260.53

4.5

3.4

97.00

87.72

ng/l

3.49

2745

7029

Lower back pain or/and sciatica

5626

22455

1.69

257.19

3.6

4.0

84.73

92.29

ng/l

6.81

4873

19434

Other specific joint derangements/joint disorders

3696

12942

1.92

255.21

3.8

83.54

86.38

ng/l

0.98

3287

11299

Atrial fibrillation and flutter with reimbursement

1340

2988

3.05

253.62

4.3

2.2

102.88

63.82

ng/l

37.99

1167

2571

Fall on same level

5911

19838

1.68

253.19

4.3

4.0

94.27

87.77

ng/l

3.96

5084

17456

Gastro-oesophageal reflux disease

3785

18254

1.87

252.75

4.0

3.8

92.49

89.63

ng/l

0.86

3174

15803

Nontoxic goitre/thyroid nodule

2093

9712

2.36

252.55

3.2

3.4

67.18

88.26

ng/l

27.54

1806

8215

Constipation

4988

20648

1.74

252.09

3.8

4.0

91.88

90.08

ng/l

0.53

4238

17919

Other (not insulin) diabetes medications

5135

18189

1.74

251.55

4.2

3.4

99.49

84.16

ng/l

19.05

4420

15698

Renal tubulo-interstitial disorders in diseases classified elsewhere

208

148

33.04

251.00

9.9

1.8

131.20

62.88

ng/l

9.96

192

132

Non-ischemic cardiomyopathy

2025

7330

2.42

250.61

5.0

3.4

119.27

81.44

ng/l

40.47

1726

6121

Urolithiasis

1990

9024

2.38

250.46

4.0

4.2

86.88

98.83

ng/l

5.66

1780

7801

Hernia of abdominal wall, postoperative

1100

3740

3.20

249.42

6.0

2.8

119.06

81.45

ng/l

14.83

978

3183

Autoimmune diseases related-to ILD

4578

23169

1.76

248.97

4.3

3.9

90.89

90.21

ng/l

0.16

4023

20021

Follow-up examination after treatment for conditions other than malignant neoplasms

2311

7107

2.25

245.56

3.9

3.3

86.58

86.26

ng/l

0.05

2044

6093

Neurological diseases, wide definition

1295

2149

3.15

245.43

4.3

3.7

81.87

73.18

ng/l

2.36

1159

1908

Type 2 diabetes, definitions combined, including avohilmo

4881

16843

1.75

244.34

4.0

3.3

96.41

82.35

ng/l

16.78

4211

14549

Diabetic retinopathy, excluding more controls

1812

4250

2.65

243.53

7.6

3.3

141.44

83.61

ng/l

45.06

1607

3618

Gout due to impairment of renal function

241

236

26.30

243.35

13.1

3.7

189.22

83.67

ng/l

16.74

223

207

Persons encountering health services for examination and investigation

3193

8212

2.02

241.96

4.3

3.4

92.76

87.82

ng/l

1.79

2769

7044

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5916

20024

1.66

241.08

5.0

3.7

104.37

86.33

ng/l

23.80

5158

17385

Asthma (only as main-diagnosis), excluding more controls

3376

10239

1.96

241.05

3.8

3.3

90.57

78.11

ng/l

10.04

2985

8846

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3521

19449

1.88

240.66

5.6

3.6

110.81

88.43

ng/l

17.59

3112

16676

Atherosclerosis, excluding cerebral and coronary sclerosis

2624

10488

2.12

239.58

6.3

3.4

139.82

92.10

ng/l

51.50

2286

8758

Asthma, excluding more controls

3628

10239

1.91

238.12

3.8

3.3

91.30

78.11

ng/l

11.29

3240

8846

Hypothyroidism, strict autoimmune

3601

13038

1.88

237.30

3.9

3.3

89.15

88.52

ng/l

0.15

3037

11183

Valvular heart disease excluding rheumatic fever

2645

9599

2.10

236.69

5.2

3.5

114.42

79.46

ng/l

40.68

2277

8227

Benign neoplasm of colon, rectum, anus and anal canal

3731

18452

1.85

236.62

4.6

3.7

102.13

91.44

ng/l

8.36

3269

15674

Non-rheumatic valve diseases

2630

9523

2.11

236.32

5.2

3.4

114.53

79.65

ng/l

40.15

2263

8153

Other functional intestinal disorders

2669

12748

2.05

233.98

4.2

3.7

92.18

86.75

ng/l

1.82

2292

10916

Persons encountering health services in other circumstances, wide

6183

20134

1.63

233.23

4.8

3.7

101.73

86.48

ng/l

19.24

5366

17458

Abnormal findings on examination of urine, without diagnosis

483

1011

6.24

230.96

8.0

4.0

119.89

89.86

ng/l

4.85

450

888

Dorsalgia

5055

16359

1.71

230.28

3.6

4.1

85.03

93.31

ng/l

7.07

4414

14161

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1677

3339

2.61

230.07

4.3

3.3

86.04

77.94

ng/l

2.58

1497

2885

Nerve, nerve root and plexus disorders

5608

21561

1.65

227.49

4.2

3.8

93.36

91.18

ng/l

0.79

4921

18559

COPD/asthma related infections

5351

16454

1.68

225.77

4.5

3.4

97.88

81.79

ng/l

18.50

4677

14216

COPD/asthma/ILD related infections

5351

16454

1.68

225.77

4.5

3.4

97.88

81.79

ng/l

18.50

4677

14216

Amputation

830

2595

3.72

223.30

9.3

3.6

165.04

96.19

ng/l

25.55

725

2189

Thyrotoxicosis with diffuse goitre

967

3285

3.28

222.50

3.1

3.5

62.11

86.97

ng/l

16.39

862

2839

Disorders of gallbladder, biliary tract and pancreas

5283

20762

1.66

222.42

4.3

3.8

98.08

89.60

ng/l

6.34

4593

17912

Chronic tubulo-interstitial nephritis

417

790

6.83

221.85

9.8

2.2

143.71

68.08

ng/l

20.08

383

675

Other cataract

2578

9999

2.07

221.45

5.8

3.6

115.98

86.54

ng/l

22.16

2223

8710

Benign neoplasms

4796

15945

1.71

220.82

4.6

3.8

96.70

88.82

ng/l

4.98

4230

13893

Other pulmonary diagnosis

4013

11467

1.81

220.44

4.3

3.4

94.69

82.45

ng/l

9.75

3519

9890

Obesity, other/unspecified

1887

8782

2.29

220.42

4.4

3.8

101.28

84.74

ng/l

9.02

1703

7719

Gastrointestinal diseases

2769

7012

2.04

217.98

4.7

2.8

87.34

74.45

ng/l

8.85

2455

6087

Mood disorders, excluding more controls

4844

17667

1.69

217.25

3.9

4.0

89.38

91.01

ng/l

0.46

4175

15443

Presence of cardiac and vascular implants and grafts

2596

9976

2.05

216.89

4.7

3.1

124.08

86.46

ng/l

43.50

2241

8475

Excluding asthma or asthma-COPD overlap

3995

11467

1.80

216.13

4.3

3.4

93.03

82.45

ng/l

7.74

3510

9890

Asthma

3821

11370

1.82

215.91

3.8

3.4

91.70

82.46

ng/l

6.14

3401

9805

Diseases of the skin and subcutaneous tissue

5130

15841

1.67

213.84

4.8

3.5

100.68

83.66

ng/l

20.29

4498

13659

Spondylopathies

4200

14854

1.75

213.03

3.6

4.0

88.91

95.29

ng/l

3.57

3626

12778

Congenital malformations, deformations and chromosomal abnormalities

2951

15388

1.90

212.98

6.7

3.7

105.81

84.71

ng/l

17.58

2672

13503

Infections of the skin and subcutaneous tissue

3028

16645

1.88

211.17

5.9

4.0

113.83

87.93

ng/l

21.13

2690

14559

Symptoms and signs involving the digestive system and abdomen

5108

15839

1.66

208.59

4.6

3.8

95.97

88.92

ng/l

4.16

4452

13742

Certain infectious and parasitic diseases

3763

10720

1.82

208.51

4.5

3.0

95.35

78.25

ng/l

18.65

3293

9187

Asthma (only as main-diagnosis)

3492

11370

1.84

208.21

3.8

3.4

90.92

82.46

ng/l

5.07

3077

9805

COPD differential diagnosis

3961

11477

1.79

207.48

4.2

3.4

93.04

82.42

ng/l

7.80

3477

9905

ILD differential diagnosis

3960

11474

1.79

207.41

4.3

3.4

93.06

82.43

ng/l

7.82

3476

9902

Hypokalaemia

866

2888

3.38

206.94

4.7

3.2

99.04

86.14

ng/l

2.31

738

2414

Diabetic retinopathy, strict definition

1324

4848

2.75

206.77

8.9

4.2

160.48

99.27

ng/l

31.40

1169

4160

Benign neoplasm: Colon

3175

17232

1.86

206.51

4.7

3.7

103.41

92.00

ng/l

8.03

2801

14621

Asthma (mode)

3742

11474

1.80

206.31

3.8

3.4

90.63

82.43

ng/l

5.04

3330

9902

Other arrhythmias

3216

13609

1.85

206.01

3.8

3.4

91.65

78.66

ng/l

11.08

2772

11823

Hydronephrosis

744

2261

3.68

205.92

6.7

2.2

133.17

67.43

ng/l

22.88

653

1887

Diseases of peritoneum

819

2669

3.55

205.91

11.5

3.6

175.88

89.03

ng/l

29.54

752

2271

All influenza

1512

6619

2.45

205.89

6.3

3.7

117.01

85.01

ng/l

17.67

1344

5719

Postmenopausal osteoporosis with pathological fracture

698

2125

4.23

204.21

3.0

72.23

87.11

ng/l

5.58

564

1722

Peripheral artery operations in Hilmo

936

3285

3.20

204.14

8.5

3.5

158.27

94.16

ng/l

26.96

813

2752

Neoplasms

3423

10124

1.85

203.78

4.8

4.0

91.11

86.39

ng/l

1.50

3065

8882

Hard cardiovascular diseases

4404

15958

1.71

203.22

5.4

3.6

111.89

81.18

ng/l

49.61

3879

13772

STROKE

2870

10565

1.93

202.54

4.6

3.2

102.57

75.94

ng/l

27.64

2507

9053

Diarrhoea and gastroenteritis of presumed infectious origin

5218

21902

1.62

201.76

5.2

3.6

101.94

86.38

ng/l

16.71

4618

18865

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

363

655

6.91

201.48

10.9

3.7

158.29

79.39

ng/l

13.52

333

605

Other and unspecified polyneuropathies, also in other diseases

1289

5373

2.65

199.83

5.9

3.9

114.53

96.32

ng/l

5.41

1151

4565

Diseases of the digestive system

2674

14514

1.94

199.78

5.1

3.8

108.19

91.80

ng/l

10.23

2302

12400

Senile cataract

3376

11767

1.84

199.70

5.5

3.5

115.58

86.09

ng/l

27.96

2858

10265

Failure and rejection of transplanted organs and tissues

219

236

15.80

199.22

16.0

4.3

205.82

69.09

ng/l

18.46

210

215

Congenital malformations, deformations and chromosomal abnormalities

3187

16818

1.81

196.78

6.4

3.7

104.16

84.98

ng/l

16.44

2875

14714

Charcot foot

242

297

12.14

196.35

10.6

3.1

161.58

77.19

ng/l

13.03

225

264

Percutaneous Coronary Intervention

4237

15818

1.71

195.53

5.4

3.6

116.30

81.83

ng/l

55.19

3725

13589

Other/unspecified cytomegaloviral diseases

268

380

10.79

194.16

14.0

3.8

190.36

73.34

ng/l

21.19

256

345

Dizziness and giddiness

4006

19341

1.71

193.32

3.7

3.9

88.65

91.42

ng/l

1.08

3410

16752

Emergency coronary revascularization (for ACS)

4620

17543

1.66

192.44

5.3

3.7

116.17

83.94

ng/l

54.22

4055

15006

Other dorsopathies, not elsewhere classified

4985

16414

1.64

192.32

3.6

4.1

84.93

93.23

ng/l

6.96

4373

14213

Abdominal and pelvic pain

5007

15835

1.63

190.78

4.4

3.8

93.61

88.93

ng/l

2.26

4362

13738

Haemorrhage from respiratory passages

1975

8866

2.13

189.67

4.8

3.8

112.64

89.48

ng/l

14.05

1703

7520

Syncope and collapse

2377

10754

1.98

188.99

4.1

3.5

100.68

88.50

ng/l

5.55

1998

9179

Exposure to unspecified factor

5097

23684

1.60

188.71

4.3

3.9

96.00

88.64

ng/l

4.15

4334

20648

Cytomegalovirus infection, IBD co-morbidity

291

464

9.09

188.21

13.7

4.1

184.71

79.68

ng/l

19.62

278

419

Amputation of toe

617

1795

4.11

187.80

9.4

3.9

166.86

99.43

ng/l

17.57

545

1534

Coronary revascularization (ANGIO or CABG)

4207

15822

1.69

187.70

5.4

3.6

116.25

81.83

ng/l

54.54

3694

13592

Any mental disorder

5588

18193

1.58

185.85

3.9

4.0

88.92

91.24

ng/l

0.85

4808

15899

Systemic connective tissue disorders

2145

11187

2.05

185.76

4.5

3.5

89.91

88.59

ng/l

0.24

1895

9484

5879

20022

1.56

185.33

4.4

3.6

96.81

86.73

ng/l

9.49

5098

17243

Polyneuropathies and other disorders of the peripheral nervous system

1393

6207

2.45

184.74

5.7

3.9

113.27

95.09

ng/l

5.96

1240

5289

Factors influencing health status and contact with health services

1398

2843

2.56

184.56

4.7

2.5

95.01

75.57

ng/l

10.41

1245

2456

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3629

19654

1.73

184.48

4.2

3.8

95.01

91.96

ng/l

0.90

3176

16798

Neurological diseases

4143

12599

1.70

183.96

3.9

4.1

87.39

88.40

ng/l

0.23

3605

11035

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3176

18632

1.78

183.82

5.5

3.6

110.18

89.01

ng/l

14.39

2794

15995

Pain (limb, back, neck, head abdominally)

3583

10460

1.77

182.55

4.3

4.0

91.63

91.68

ng/l

0.01

3143

9044

Cytomegaloviral disease

294

488

8.57

182.48

13.6

4.3

183.31

80.14

ng/l

19.44

281

440

Soft tissue disorders

5039

16574

1.61

181.56

4.2

4.0

91.52

89.89

ng/l

0.47

4404

14333

Other bacterial intestinal infections

1196

5030

2.60

180.53

6.1

3.4

121.88

88.07

ng/l

14.58

1062

4231

Ischemic heart diseases

4337

16259

1.66

180.44

5.4

3.6

115.11

81.55

ng/l

54.87

3796

13992

Graves disease, strict definition

740

2447

3.43

180.03

2.7

3.5

52.97

80.69

ng/l

18.80

664

2116

L04AX Other immunosuppressants

2985

17324

1.80

179.76

5.3

3.8

84.65

88.70

ng/l

1.27

2681

15040

Disorders of eyelid, lacrimal system and orbit

4504

21790

1.62

179.48

3.8

3.9

87.73

90.80

ng/l

1.25

3881

18814

Sleep apnoea

4799

19958

1.61

178.97

4.0

3.9

95.71

90.31

ng/l

3.00

4091

17422

Second line medication for Crohn's disease

3036

17729

1.79

178.64

5.2

3.8

84.40

88.71

ng/l

1.43

2727

15404

Spinal stenosis

2844

12243

1.85

178.28

3.6

3.9

91.49

96.61

ng/l

2.02

2451

10413

Benzodiazepine use

5098

22925

1.58

177.75

3.4

4.0

86.75

91.73

ng/l

2.76

4288

19973

Use of hypnotics and sedatives

5351

20192

1.57

175.09

4.1

4.0

94.82

90.78

ng/l

1.79

4674

17531

Pain, not elsewhere classified

1491

6920

2.28

174.91

4.1

3.5

92.31

84.51

ng/l

2.21

1294

5995

Other intervertebral disc disorders

4135

15445

1.66

174.91

3.4

4.0

85.09

94.80

ng/l

8.20

3659

13328

Idiopathic gout

679

2180

3.58

174.63

7.4

3.8

153.86

97.81

ng/l

16.72

602

1865

Major coronary heart disease event

4425

16905

1.64

174.10

5.4

3.7

115.28

82.68

ng/l

53.33

3877

14506

Diseases of the eye and adnexa

3629

10766

1.73

173.94

4.9

3.7

95.94

81.33

ng/l

11.27

3245

9580

Mood [affective] disorders

5117

21731

1.57

173.77

3.9

4.0

88.34

89.74

ng/l

0.40

4419

18898

Mood disorders

5127

21754

1.57

173.47

3.9

4.0

88.30

89.80

ng/l

0.44

4426

18916

Other antidepressants

5136

17084

1.58

172.71

3.4

4.2

86.10

94.65

ng/l

6.84

4410

14883

Symptoms and signs involving the skin and subcutaneous tissue

3670

22218

1.68

172.26

4.4

3.8

90.47

89.26

ng/l

0.31

3279

19160

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

559

1031

4.15

172.19

4.4

3.1

100.42

81.33

ng/l

3.04

492

878

Episodal and paroxysmal disorders

5451

18253

1.56

172.15

3.9

4.1

88.81

89.06

ng/l

0.06

4735

15871

Other bacterial intestinal infections

1396

6387

2.35

171.96

5.7

3.4

116.55

87.79

ng/l

13.05

1241

5408

Periodontitis

4932

21586

1.58

170.37

5.5

3.6

106.97

88.28

ng/l

20.89

4287

18657

Volume depletion

677

2198

3.47

169.14

5.4

3.4

122.24

91.00

ng/l

6.64

569

1824

Chronic periodontitis, including avohilmo

4914

21594

1.57

168.40

5.5

3.6

107.16

88.33

ng/l

21.00

4268

18668

Diseases of the musculoskeletal system and connective tissue

2416

6400

1.95

167.75

4.4

4.0

87.49

84.72

ng/l

0.58

2163

5602

Enterocolitis due to Clostridium difficile

814

2979

3.09

165.64

6.6

3.5

135.26

91.71

ng/l

13.63

727

2500

Biguanides

4785

18996

1.58

165.44

3.7

94.35

88.03

ng/l

3.88

4086

16434

Diseases of liver

1928

10086

2.03

164.65

4.5

4.0

94.38

91.91

ng/l

0.48

1692

8734

Sleep apnoea, including avohilmo

4976

20288

1.57

164.61

3.9

4.0

94.01

90.18

ng/l

1.80

4238

17739

Cystitis

4276

16167

1.62

163.14

4.0

3.7

91.27

86.47

ng/l

2.28

3738

13938

Bacterial pneumoniae

2231

10726

1.93

162.77

5.4

3.5

116.92

86.79

ng/l

19.61

2008

9158

Sleep disorders (combined)

5651

19945

1.53

162.66

3.8

4.0

89.82

90.18

ng/l

0.10

4836

17336

Liquid cancers, helper endpoint

2133

10046

1.96

161.33

4.0

3.9

91.26

93.21

ng/l

0.39

1837

8522

Bacterial pneumonia, not elsewhere classified

2139

10191

1.94

160.15

5.4

3.5

117.88

86.85

ng/l

19.70

1939

8696

Osteomyelitis

511

1456

4.12

159.26

8.4

4.2

152.36

93.31

ng/l

12.29

457

1286

Anxiety disorders, excluding more controls

3985

16399

1.63

158.02

3.8

4.0

85.21

89.10

ng/l

1.62

3444

14351

Arthropathies in other diseases classified elsewhere

347

753

5.74

157.38

9.1

3.8

151.39

90.01

ng/l

9.81

317

662

Falls/tendency to fall

5171

17161

1.55

157.14

4.2

4.0

94.08

86.91

ng/l

4.16

4492

15109

Bacterial intestinal infections, IBD co-morbidities

1187

5303

2.44

156.18

6.2

3.6

123.07

90.56

ng/l

13.36

1057

4479

Abnormalities of heart beat

1876

9657

2.00

156.07

3.6

91.98

85.85

ng/l

1.70

1605

8253

Benign neoplasm: Parathyroid gland

201

272

13.94

156.06

6.7

3.2

119.56

74.81

ng/l

3.92

182

241

Cough

2134

11075

1.91

154.00

4.4

3.7

90.15

84.71

ng/l

1.53

1849

9546

Depression

4630

20700

1.56

153.59

3.9

4.0

88.22

89.13

ng/l

0.22

4020

18047

Peripheral arterial reconstruction

1122

4942

2.49

153.59

6.5

3.7

148.55

98.90

ng/l

20.20

976

4140

Malignant neoplasm, wide definition for exclusion

4282

16189

1.60

153.55

4.0

87.15

90.15

ng/l

1.08

3781

14036

Diabetic retinopathy

2219

7606

1.97

152.95

7.3

4.1

140.33

98.96

ng/l

30.90

1951

6509

Implicit fungal Sepsis

538

1629

3.86

152.91

5.9

3.2

119.31

82.29

ng/l

4.30

465

1382

Intracranial trauma

2625

10590

1.80

152.38

3.6

4.1

88.95

86.35

ng/l

0.60

2227

9323

Hypo-osmolality and hyponatraemia

1084

4681

2.50

151.86

4.7

3.1

104.99

86.82

ng/l

5.01

911

3887

Paroxysmal tachycardia

985

3342

2.59

150.87

4.5

2.4

99.06

62.10

ng/l

25.69

869

2920

Hypothyroidism, strict autoimmune, 3 medication purchases required

4053

17615

1.60

150.61

3.7

3.8

88.00

92.55

ng/l

2.36

3396

15225

Abnormal findings on examination of blood, without diagnosis

2435

12941

1.81

146.78

4.8

4.1

100.08

96.45

ng/l

0.88

2174

11107

Other arthritis (FG)

1591

8109

2.07

145.38

4.8

3.7

97.68

87.65

ng/l

3.13

1397

7019

Other disorders of skin and subcutaneous tissue, not elsewhere classified

935

3890

2.64

145.19

6.0

3.5

123.87

87.69

ng/l

10.84

810

3295

Sciatica+with lumbago

2542

13715

1.77

144.90

3.6

4.0

81.32

93.14

ng/l

9.11

2279

11841

Ischaemic heart disease, wide definition

3950

15785

1.61

144.35

5.2

3.5

114.34

84.63

ng/l

42.41

3420

13498

Unspecified nephritic syndrome

255

463

7.46

143.54

10.7

3.2

158.50

76.03

ng/l

10.18

236

410

Isolated proteinuria with specified morphological lesion

181

234

12.94

143.47

8.9

3.2

149.38

72.78

ng/l

7.43

168

207

Asthma-related infections

3031

18339

1.68

142.93

4.1

4.0

96.50

89.15

ng/l

3.25

2669

15761

Asthma, hospital admission 2, infections

3031

18339

1.68

142.93

4.1

4.0

96.50

89.15

ng/l

3.25

2669

15761

Bronchitis

5279

22810

1.49

142.69

4.8

3.7

101.16

87.37

ng/l

14.71

4601

19714

Gingival hyperplasia

348

825

5.33

142.58

13.3

4.2

116.27

78.93

ng/l

7.03

326

743

Psychiatric diseases

4861

16271

1.53

142.38

3.9

4.1

88.22

91.65

ng/l

1.42

4199

14260

Conduction disorders

1591

6548

2.08

142.05

4.4

3.4

108.47

80.92

ng/l

19.99

1335

5565

Symptoms and signs concerning food and fluid intake

686

2469

3.06

141.67

4.4

3.7

80.16

86.37

ng/l

1.02

603

2106

Malignant neoplasm

4135

15949

1.58

141.54

4.0

86.81

90.14

ng/l

1.24

3653

13815

Other necrotizing vasculopathies (FG)

488

1461

3.92

141.45

7.2

3.5

112.97

90.00

ng/l

3.43

459

1224

Coronary atherosclerosis

3360

13286

1.66

141.38

5.4

3.5

120.86

82.96

ng/l

51.63

2922

11286

Depression or dysthymia

3324

11312

1.67

141.37

3.7

4.3

89.55

94.43

ng/l

1.68

2844

9945

Asthma (diagnoses ohter than nonallergic)

4316

23868

1.54

141.35

3.8

4.0

91.73

88.98

ng/l

1.00

3802

20613

Vitreous haemorrhage

707

2623

3.04

140.04

9.1

3.9

162.15

93.95

ng/l

18.85

641

2241

Arthropathies

4112

13466

1.58

139.94

4.3

3.9

92.66

86.59

ng/l

2.81

3637

11736

Other arthrosis

2602

10614

1.76

139.03

3.9

3.6

87.42

90.28

ng/l

0.60

2274

9139

Other systemic involvement of connective tissue (FG)

1436

7092

2.12

138.89

3.2

3.4

79.97

87.72

ng/l

2.60

1244

5994

Other external causes of accidental injury

3925

12647

1.59

136.42

4.0

3.9

92.64

86.30

ng/l

3.11

3375

11117

Dorsopathies

4828

16558

1.52

135.12

3.8

4.2

86.65

92.85

ng/l

4.04

4225

14355

Other necrotizing vasculopathies

576

1967

3.42

134.80

7.8

3.8

117.11

92.67

ng/l

4.33

541

1665

Chronic gastritis

1611

8505

2.02

134.59

4.0

3.5

98.41

91.27

ng/l

1.81

1386

7205

Cutaneous abscess, furuncle and carbuncle

1325

6522

2.15

133.82

6.5

4.0

123.01

88.20

ng/l

13.59

1200

5704

Cerebrovascular diseases

3831

17689

1.58

132.22

4.7

3.7

104.87

90.94

ng/l

12.01

3274

15126

Bipolar affective disorders

913

3885

2.49

131.66

3.2

4.0

80.85

86.27

ng/l

0.98

798

3469

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

429

1248

4.17

131.52

5.2

3.6

105.34

93.36

ng/l

1.51

368

1047

Presence of other functional implants

3041

13166

1.66

130.77

4.6

3.0

111.13

82.13

ng/l

29.64

2397

11262

Other/unspecified dorsalgia

1924

10689

1.86

130.51

3.7

3.9

86.93

92.93

ng/l

1.92

1666

9154

Other disorders of glucose regulation and pancreatic internal secretion

582

2015

3.24

130.42

6.6

4.2

118.00

88.73

ng/l

7.65

519

1753

Bacterial pneumonia (organism specified)

2382

12835

1.76

130.13

5.4

3.8

116.24

91.50

ng/l

14.85

2140

10880

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1445

7427

2.06

129.54

4.4

3.9

97.30

87.81

ng/l

3.02

1246

6530

Glucagon-like peptide-1 (GLP-1) analogues

1445

7427

2.06

129.54

4.4

3.9

97.30

87.81

ng/l

3.02

1246

6530

Other specified/unspecified arthritis

1386

7017

2.08

129.27

4.9

3.7

99.76

87.48

ng/l

3.78

1219

6054

Shoulder lesions

3698

14572

1.58

128.61

3.8

86.99

93.03

ng/l

3.08

3253

12521

Cholelithiasis, broad definition with cholecystitis

4334

19735

1.52

128.03

4.0

3.7

94.98

89.03

ng/l

3.31

3751

16971

Other diseases of the digestive system

1784

9871

1.91

127.88

5.5

3.8

116.74

94.15

ng/l

11.66

1529

8353

Injuries to the abdomen, lower back, lumbar spine and pelvis

2102

12066

1.80

127.05

4.1

3.8

92.72

92.49

ng/l

0.03

1778

10330

Other gastritis (incl. Duodenitis)

1279

6370

2.14

126.27

4.9

3.6

102.94

91.45

ng/l

3.17

1120

5410

Concussion

2209

10477

1.77

126.17

3.4

4.1

85.03

86.48

ng/l

0.27

1861

9226

Other symptoms and signs involving cognitive functions and awareness

2448

13464

1.73

126.04

3.4

3.9

91.22

94.76

ng/l

1.02

2065

11496

Dermatitis

3069

19569

1.62

125.41

4.8

3.8

100.70

88.42

ng/l

6.80

2683

16946

GI-bleeding

1773

9884

1.89

123.88

5.5

3.8

116.83

94.45

ng/l

11.56

1523

8350

Obesity related asthma

1789

10012

1.88

123.12

4.1

4.0

98.09

89.67

ng/l

2.62

1563

8686

Disorder of lipoprotein metabolism, unspecified

776

3197

2.64

122.37

6.1

3.3

127.84

89.66

ng/l

12.16

668

2674

Cholelithiasis

4175

19525

1.52

122.27

3.9

3.7

94.23

88.92

ng/l

2.67

3600

16781

Retention of urine

1748

7907

1.90

122.03

4.4

3.9

114.94

97.32

ng/l

6.03

1508

6722

Asthma-related pneumonia

1999

11583

1.81

121.23

4.5

3.9

105.43

91.10

ng/l

6.36

1773

9814

Accidents

3839

12647

1.56

120.90

4.0

3.9

91.37

86.30

ng/l

2.27

3295

11117

Diaphragmatic hernia

2010

11726

1.81

120.63

3.9

3.6

91.25

90.89

ng/l

0.06

1742

9975

Injuries to the hip and thigh

2550

14252

1.69

120.47

4.1

3.8

99.84

93.20

ng/l

1.75

2165

12135

Any event in cancer register

4287

17147

1.51

120.46

4.0

86.66

90.51

ng/l

1.63

3792

14881

Asthma, hospital admissions 3, pneumonia

2000

11615

1.80

120.29

4.5

3.9

105.44

91.07

ng/l

6.40

1774

9841

Asthma-related pneumonia or sepsis

2000

11615

1.80

120.29

4.5

3.9

105.44

91.07

ng/l

6.40

1774

9841

Viral infections characterized by skin and mucous membrane lesions

2103

12388

1.77

119.93

6.0

3.9

101.47

89.19

ng/l

5.32

1831

10767

Cellulitis

1181

5817

2.16

119.80

6.1

4.0

120.40

88.76

ng/l

12.22

1042

5063

Adjustment and management of implanted device

1060

5033

2.26

119.34

4.5

2.7

118.23

83.32

ng/l

23.27

897

4167

Dermatitis and eczema

5298

23317

1.44

118.75

4.5

3.9

95.21

89.00

ng/l

3.69

4633

20190

Hernia

4561

21195

1.48

118.48

4.5

3.8

96.03

89.74

ng/l

3.52

3968

18270

AV-block

997

4015

2.32

118.09

4.6

3.3

116.72

83.50

ng/l

15.73

834

3358

Fracture of femur

1633

8154

1.93

117.83

4.1

3.6

99.10

95.68

ng/l

0.61

1370

6792

Autoimmune hyperthyroidism

430

1325

3.67

117.39

3.1

3.0

62.97

79.90

ng/l

3.23

394

1140

Other reaction to severe stress, and adjustment disorders

1629

8950

1.89

117.37

4.8

3.9

94.20

85.20

ng/l

2.40

1421

7943

Vitamin D deficiency

204

363

7.44

116.69

4.7

4.1

86.27

77.11

ng/l

0.93

171

329

Missing teeth due to accident, extraction or parodontitis

3047

18673

1.60

115.90

4.3

3.8

92.89

91.97

ng/l

0.19

2520

16107

Injuries to the head

5282

23136

1.43

115.77

3.8

4.0

92.70

89.05

ng/l

1.59

4470

20219

Other acute lower respiratory infections

2623

15683

1.65

115.68

5.3

3.9

105.46

90.56

ng/l

8.18

2262

13504

Anxiety disorders

4178

19972

1.49

115.19

3.9

4.0

84.90

88.19

ng/l

1.29

3625

17456

Neurotic, stress-related and somatoform disorders

4129

19783

1.50

114.91

3.9

4.0

84.94

88.14

ng/l

1.23

3581

17299

Diseases of the respiratory system

3082

9776

1.62

114.91

4.1

3.4

90.61

81.88

ng/l

4.90

2679

8429

Fungal Sepsis

339

918

4.42

114.70

6.8

3.4

131.99

83.92

ng/l

3.44

303

791

Solid cancers, helper endpoint

3954

15776

1.52

114.29

4.0

86.97

90.48

ng/l

1.30

3492

13645

Diabetic maculopathy

861

3644

2.49

113.26

8.9

4.2

168.92

99.57

ng/l

24.65

769

3112

Other joint disorders

3801

13402

1.53

111.89

3.8

85.54

86.77

ng/l

0.29

3331

11673

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4612

20712

1.46

111.77

4.4

3.8

97.23

90.65

ng/l

3.93

4005

17915

Viral pneumonia

732

3061

2.59

111.35

6.4

3.7

118.30

83.87

ng/l

10.04

637

2626

Cardiomyopathy

898

4090

2.34

111.35

5.3

3.6

125.34

82.63

ng/l

20.86

814

3501

Viral infections characterized by skin and mucous membrane lesions

4075

24098

1.48

111.35

4.7

3.9

91.04

89.17

ng/l

0.58

3548

20934

Dysphagia

1343

7101

2.00

111.08

3.7

3.6

83.31

90.68

ng/l

2.00

1145

6100

2161

12985

1.71

110.58

4.3

4.0

92.88

87.31

ng/l

1.57

1901

11245

Implicit fungal Sepsis

317

843

4.53

110.23

6.9

3.3

136.35

82.51

ng/l

3.75

283

727

Major coronary heart disease event excluding revascularizations

3031

13096

1.60

110.17

5.2

3.5

121.79

84.67

ng/l

46.91

2623

11076

Diseases of oral cavity, salivary glands and jaws

3000

9834

1.61

109.92

4.1

3.3

94.73

88.89

ng/l

2.21

2550

8384

Sulfonylureas

1887

8747

1.80

109.50

5.4

3.6

126.73

94.77

ng/l

23.58

1582

7312

Idiopathic hypercalciuria

116

123

20.18

109.45

3.8

3.7

60.46

76.39

ng/l

1.52

104

113

External causes of morbidity and mortality

3050

9759

1.60

109.33

4.1

3.8

88.78

83.42

ng/l

2.07

2649

8545

Chronic apical periodontitis

5298

21679

1.42

109.18

4.4

3.8

98.01

88.43

ng/l

7.45

4525

18884

Myalgia

1170

5930

2.08

108.75

3.5

3.8

76.58

87.63

ng/l

4.67

1009

5143

Venous thromboembolism

2798

17505

1.60

108.69

4.7

3.6

104.85

91.85

ng/l

8.09

2433

14847

Coxarthrosis [arthrosis of hip](FG)

2623

11627

1.64

108.34

3.6

89.01

91.93

ng/l

0.82

2226

9913

Spondylosis

2628

13592

1.63

108.20

3.3

4.0

81.80

95.43

ng/l

13.18

2230

11660

Chronic ulcer of skin, not elsewhere classified

495

1749

3.22

107.93

7.2

3.5

144.75

91.25

ng/l

9.20

446

1481

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

651

2637

2.73

107.62

6.0

3.9

129.95

97.95

ng/l

7.80

576

2225

Gingivitis and periodontal diseases

4957

18173

1.44

106.87

4.7

3.5

96.31

86.79

ng/l

8.32

4317

15643

Gastroduodenal ulcer

1403

7604

1.94

106.40

5.2

3.7

114.03

95.87

ng/l

5.97

1214

6411

Visual disturbances and blindness

2617

16793

1.62

106.17

4.2

3.8

92.37

89.45

ng/l

0.70

2294

14417

Myocardial infarction

2457

10793

1.67

106.10

5.5

3.5

127.54

84.72

ng/l

48.89

2129

9104

Exclusions for E4_PCOS_BROAD

934

4411

2.26

106.09

4.6

4.4

87.00

85.64

ng/l

0.13

804

3884

Arthrosis

3240

11657

1.56

106.07

3.7

87.38

90.07

ng/l

0.66

2813

10061

Anxiety (asthma-related co-morbidities)

2586

12646

1.63

105.90

3.6

4.1

79.36

86.55

ng/l

3.74

2249

11202

Other medical care

2204

12167

1.69

105.76

3.9

2.7

102.41

78.46

ng/l

16.58

1888

10259

Other viral diseases

1330

7072

1.96

105.72

7.9

4.1

112.38

85.19

ng/l

12.35

1207

6280

Gonarthrosis [arthrosis of knee](FG)

3457

13440

1.54

104.77

3.5

3.6

85.42

90.54

ng/l

2.77

3010

11552

Other and unspecified dermatitis

2541

16243

1.62

104.69

4.8

3.8

100.77

87.98

ng/l

5.96

2226

14066

Explicit bacterial Sepsis

608

2408

2.75

104.04

7.2

3.3

132.90

83.44

ng/l

13.87

539

2054

Fracture of lumbar spine and pelvis

1290

6889

1.99

104.02

3.8

3.5

89.07

93.53

ng/l

0.92

1071

5791

Chronic periodontitis, complicated

2660

17068

1.60

103.84

5.9

3.7

114.19

89.75

ng/l

19.26

2333

14758

Abnormal findings on diagnostic imaging of lung

2482

15176

1.63

103.33

4.2

3.8

96.02

94.44

ng/l

0.28

2161

12926

Personality disorders, excluding more controls

1031

5069

2.12

102.95

3.5

4.1

86.09

86.18

ng/l

0.01

894

4547

Coagulation defects, purpura and other haemorrhagic conditions

1053

5287

2.12

101.79

5.5

3.9

108.98

88.90

ng/l

5.79

940

4557

Chronic lower respiratory diseases

5608

21874

1.39

101.34

4.0

94.07

88.55

ng/l

3.19

4922

19000

Other diseases of hard tissues of teeth

2909

9720

1.59

100.96

4.3

3.3

93.57

88.58

ng/l

1.86

2482

8308

Malignant neoplasm of urinary organs

611

2477

2.73

100.85

5.9

3.9

134.11

97.11

ng/l

9.10

539

2090

Iron deficiency anaemia secondary to blood loss (chronic)

964

4722

2.20

100.49

5.6

3.6

124.34

88.93

ng/l

11.59

808

4003

Pacemaker

1823

10449

1.76

99.56

4.1

3.7

117.52

95.96

ng/l

13.88

1529

8717

Coxarthrosis

2380

9857

1.65

98.87

3.7

3.6

89.44

91.68

ng/l

0.52

2030

8419

711

3088

2.46

98.80

6.1

3.5

107.73

81.08

ng/l

7.27

633

2704

Unspecified fall

2500

15917

1.60

98.09

4.1

4.0

94.30

91.33

ng/l

0.71

2123

13738

All influenza (not pneumonia)

749

3341

2.38

97.45

6.4

3.8

116.54

83.51

ng/l

9.26

667

2907

Vitamin deficiency, wide

356

1111

3.69

96.20

4.6

4.0

89.61

89.71

ng/l

0.01

291

969

Vitamin deficiency

356

1111

3.69

96.20

4.6

4.0

89.61

89.71

ng/l

0.01

291

969

Myocardial infarction, without ST-elevation

2104

11955

1.67

96.11

5.4

3.7

130.82

95.81

ng/l

26.55

1808

10042

Chronic pancreatitis

682

2965

2.49

95.55

5.6

4.2

114.41

95.21

ng/l

3.14

588

2555

Disorders of phosphorus metabolism and phosphatases

22.54

95.41

9.3

4.3

107.99

73.72

ng/l

1.55

Hypoglycaemia, other or unspecified

445

1580

3.14

95.31

6.5

4.3

120.23

89.94

ng/l

6.08

399

1380

Other CVD

1156

6168

2.00

94.22

4.7

3.6

110.86

96.74

ng/l

3.31

969

5164

Any operation in hilmo

145

11.82

94.00

3.9

1.8

75.66

53.89

ng/l

2.83

133

Malignant neoplasm of kidney, except renal pelvis

557

2244

2.75

93.26

6.1

3.9

132.77

97.46

ng/l

8.17

495

1892

Reimbursement for rheumatic diseases

2798

18656

1.54

93.16

4.1

3.8

81.67

89.17

ng/l

3.43

2480

16034

Exclusions for E4_PCOS_CONSORTIUM

3380

14487

1.50

93.11

3.6

84.29

81.74

ng/l

0.66

2888

12658

Lumbar disc prolapse

2862

14621

1.54

93.10

3.4

4.1

84.05

94.37

ng/l

6.72

2531

12670

All anxiety disorders

2609

13475

1.57

92.71

3.6

4.0

79.13

87.14

ng/l

4.56

2271

11909

Viral and other specified intestinal infections

1171

6012

1.95

92.56

6.8

3.6

100.90

81.20

ng/l

6.06

1067

5248

Injuries to the thorax

2183

13870

1.63

92.30

4.1

4.0

95.96

95.64

ng/l

0.05

1845

11957

Other neurological diseases

3550

19471

1.47

92.24

4.0

3.8

95.88

91.54

ng/l

1.67

3083

16639

Dental operations

3067

10510

1.54

91.73

4.0

3.5

93.74

89.63

ng/l

1.44

2613

9009

Noninfective enteritis and colitis

2182

13866

1.62

91.51

4.5

4.0

91.14

89.19

ng/l

0.38

1936

12063

Recurrent or chronic depression

1719

7118

1.75

91.47

3.6

4.3

81.14

90.56

ng/l

3.61

1488

6324

Benign neoplasm of other and unspecified endocrine glands

767

3575

2.33

91.38

4.7

3.8

97.75

90.72

ng/l

1.00

679

3072

Acute nephritic syndrome

199

430

5.83

91.25

11.7

3.8

128.59

77.22

ng/l

7.14

188

380

Disorders of synovium and tendon

2395

13568

1.59

91.18

4.0

3.8

86.91

89.73

ng/l

0.75

2090

11742

Other disorders of lacrimal gland

1781

10831

1.72

91.11

3.9

3.6

87.37

87.80

ng/l

0.06

1515

9271

Injuries to the elbow and forearm

3345

20387

1.48

91.09

3.9

91.08

87.84

ng/l

1.01

2832

17672

Amputation of foot

236

588

5.03

90.80

11.0

3.9

176.31

99.69

ng/l

8.60

211

511

Convulsions, not elsewhere classified

1017

5145

2.03

90.65

4.6

3.8

90.05

86.25

ng/l

0.53

897

4488

Other and/or unspecified nontoxic goitre

536

2157

2.76

90.28

2.9

3.4

63.79

88.46

ng/l

14.94

491

1825

Disorders of continuity of bone

551

2241

2.68

89.49

4.2

3.8

89.20

83.39

ng/l

0.36

489

1961

Streptococcal septicaemia

516

2038

2.77

89.36

7.2

3.4

136.87

82.44

ng/l

13.21

456

1735

Other diseases of anus and rectum

1497

8718

1.79

88.84

4.3

3.6

100.75

90.29

ng/l

3.16

1269

7407

Acute bronchitis

2008

12371

1.65

88.82

5.2

3.8

105.44

89.67

ng/l

7.46

1705

10604

Hypotension

1013

5283

2.06

88.72

4.8

3.6

110.57

97.54

ng/l

2.63

842

4399

Asthma/COPD (KELA code 203)

4392

21844

1.41

88.41

3.6

4.0

88.91

88.58

ng/l

0.08

3818

18971

Other viral diseases

1583

9296

1.75

88.14

7.2

4.1

105.74

84.67

ng/l

10.02

1434

8267

Mycoses

1326

7507

1.86

88.07

5.3

3.9

107.46

90.04

ng/l

3.79

1162

6463

Other diseases of pleura

2276

12911

1.61

87.89

5.1

3.8

114.68

94.73

ng/l

10.11

1937

10988

Multiple myeloma, including Hilmo

349

1144

3.57

87.86

4.2

3.6

93.86

95.89

ng/l

0.13

307

959

Other diseases of liver

943

4805

2.09

87.52

4.3

3.8

92.23

89.63

ng/l

0.32

826

4164

Disorders of skin appendages

2119

13514

1.62

87.32

5.1

3.9

102.25

86.35

ng/l

7.75

1880

11855

Benign neoplasm: Colon, unspecified

1348

7715

1.85

87.14

5.1

3.7

109.00

93.41

ng/l

5.92

1171

6549

Visual disturbances

2341

15332

1.58

86.88

4.0

3.8

89.46

88.94

ng/l

0.08

2064

13194

Deforming dorsopathies

1360

7781

1.83

86.55

3.8

4.0

81.46

90.14

ng/l

2.89

1183

6728

Other anxiety disorders

1885

10096

1.66

86.49

3.5

4.0

78.11

85.86

ng/l

3.40

1635

8962

Irritable bowel syndrome

1286

7241

1.85

86.20

3.3

3.5

78.11

84.88

ng/l

2.52

1107

6261

Angina pectoris

2744

12245

1.54

86.11

4.7

3.4

112.11

83.31

ng/l

28.26

2357

10347

Other headache syndromes

1925

12054

1.65

85.90

3.2

3.8

78.38

86.07

ng/l

3.60

1679

10491

Selective serotonin reuptake inhibitors

4542

17235

1.40

85.67

3.5

4.3

86.05

94.20

ng/l

6.37

3896

15032

Diabetic neuropathy

764

3663

2.31

85.54

7.8

4.8

147.84

109.77

ng/l

8.52

680

3151

Gonarthrosis

2887

11052

1.53

85.15

3.5

3.6

84.33

90.54

ng/l

3.43

2514

9499

Viral and other specified intestinal infections

898

4396

2.08

84.88

7.7

3.7

105.31

80.58

ng/l

6.32

814

3854

Injuries to the knee and lower leg

5477

22837

1.36

84.81

4.1

3.9

92.31

89.27

ng/l

1.17

4790

19775

Tubulo-interstitial nephritis, not specified as acute or chronic

392

1379

3.11

84.57

7.1

2.2

130.08

68.06

ng/l

12.66

342

1148

Substance abuse, excluding more controls

2305

12800

1.57

84.28

3.8

4.3

94.46

95.51

ng/l

0.16

1982

11303

Fracture of rib(s), sternum and thoracic spine

1499

8893

1.76

84.25

4.0

3.9

95.60

95.88

ng/l

0.03

1244

7627

Acute upper respiratory infections of multiple and unspecified sites

3367

17473

1.46

84.20

4.9

3.8

97.50

87.91

ng/l

5.06

2957

15181

Injury, poisoning and certain other consequences of external causes

2443

7900

1.59

83.94

4.2

3.7

87.31

82.36

ng/l

1.61

2124

6874

COPD (mode)

1462

6692

1.79

83.81

4.4

3.4

110.78

87.71

ng/l

9.86

1222

5680

Other systemic involvement of connective tissue

1464

8661

1.78

83.63

3.3

3.4

79.92

87.97

ng/l

2.92

1269

7327

Soft tissue disorders related to use, overuse and pressure

1319

7560

1.82

83.62

4.0

3.8

96.65

91.89

ng/l

0.61

1161

6490

Asthma, hospital admissions , main diagnosis only

3765

23899

1.42

82.90

3.8

4.0

90.86

88.81

ng/l

0.61

3310

20665

Disorders of lacrimal system

2125

13758

1.60

82.45

3.8

3.6

87.50

87.66

ng/l

0.02

1817

11737

Other diseases of intestine

762

3675

2.22

82.36

5.9

3.7

113.75

91.37

ng/l

3.22

676

3121

Viral warts

543

2279

2.58

82.30

8.7

4.0

116.58

83.45

ng/l

6.31

490

2006

Persons encountering health services in other circumstances

1802

11181

1.66

81.99

4.3

3.6

95.08

85.13

ng/l

3.03

1505

9743

Thyrotoxicosis with toxic multinodular goitre

455

1793

2.90

81.44

3.3

3.4

69.80

86.60

ng/l

3.87

401

1489

Rotator cuff syndrome

2809

13727

1.51

81.35

3.7

3.8

85.79

93.33

ng/l

4.13

2465

11800

Stroke, excluding SAH

2968

14962

1.49

81.19

4.5

3.8

108.04

92.93

ng/l

10.40

2520

12723

Asthma, including avohilmo

5402

22898

1.35

81.17

3.7

4.1

89.81

90.15

ng/l

0.08

4736

19825

Exposure to other specified factors

3319

21555

1.45

81.06

4.2

4.1

93.43

89.11

ng/l

1.21

2924

18846

Other obstructive and reflux uropathy

251

690

4.05

81.00

8.0

2.3

139.36

63.00

ng/l

8.34

220

600

Sequelae of external causes of morbidity and mortality

1313

7616

1.81

80.48

5.6

3.8

115.81

89.97

ng/l

8.86

1183

6498

Calcific aortic valvular stenosis

1588

9402

1.72

80.20

5.2

3.6

123.69

97.33

ng/l

14.07

1365

7788

Calcific aortic valvular stenosis, operated

1588

9402

1.72

80.20

5.2

3.6

123.69

97.33

ng/l

14.07

1365

7788

Carpal tunnel syndrome

2885

17588

1.49

80.01

3.9

3.7

88.84

88.86

ng/l

0.00

2548

15073

Wegener granulomatosis

167

352

6.29

79.95

9.2

3.8

120.43

85.35

ng/l

3.30

159

314

Calcific aortic valvular stenosis, diagnosis (helper)

1582

9384

1.72

79.30

5.2

3.6

124.04

97.44

ng/l

14.23

1359

7772

Operations 2 for CAVS

1582

9384

1.72

79.30

5.2

3.6

124.04

97.44

ng/l

14.23

1359

7772

Drug-induced cataract

215

554

4.83

79.06

10.8

3.9

148.09

80.40

ng/l

3.51

196

497

Stroke, including SAH

3087

15650

1.47

79.05

4.6

3.8

108.13

92.15

ng/l

12.00

2625

13330

Calcific aortic valvular stenosis, including rheumatic fever

1587

9420

1.71

79.03

5.2

3.6

123.86

97.36

ng/l

14.21

1364

7800

Diseases of pulp and periapical tissues and dental caries

3292

11759

1.47

78.89

4.1

3.5

93.37

88.69

ng/l

1.76

2800

10088

Polycystic ovarian syndrome, consortium definition

3324

13843

1.46

78.88

3.4

3.2

80.43

78.88

ng/l

0.37

2811

11922

Dental caries, including avohilmo

3622

13160

1.44

78.41

4.2

3.6

93.17

89.46

ng/l

1.40

3104

11302

Molar incisor enamel hypoplasia

250

681

4.08

77.86

15.0

5.3

68.89

54.64

ng/l

2.12

244

657

Rheumatoid arthritis

1514

8200

1.72

77.61

3.4

83.98

88.02

ng/l

0.68

1315

6996

DVT of lower extremities and pulmonary embolism

2102

13740

1.58

77.59

4.3

3.7

102.25

92.73

ng/l

3.78

1812

11657

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1050

5694

1.90

77.58

3.2

4.0

82.60

86.07

ng/l

0.47

900

5110

Benign neoplasm of other and ill-defined parts of digestive system

996

5405

1.97

77.28

4.4

3.7

97.50

91.11

ng/l

1.17

856

4585

Acute upper respiratory infections

4818

22262

1.36

77.02

4.4

3.7

92.16

89.16

ng/l

1.12

4199

19187

Acute sinusitis

2212

13529

1.55

76.95

4.6

3.8

92.08

86.49

ng/l

1.51

1946

11863

Other diseases of arteries and capillaries

525

2258

2.54

75.87

8.3

3.5

141.89

88.02

ng/l

13.51

465

1917

Cardiomyopathies, Primary/intrinsic

585

2621

2.38

75.69

5.7

3.7

133.46

82.73

ng/l

16.95

531

2266

Gastric ulcer

937

5006

1.98

75.46

5.1

3.7

109.04

95.17

ng/l

3.10

813

4193

Myocardial infarction, strict

2177

10191

1.57

75.44

5.5

3.5

127.26

85.39

ng/l

42.31

1885

8577

Polyuria

1090

6103

1.88

75.34

4.0

3.8

92.63

93.55

ng/l

0.12

938

5192

Other disorders of ear

4282

20779

1.38

75.24

3.8

4.0

91.54

90.97

ng/l

0.12

3636

18074

Candidiasis

1362

8126

1.75

74.79

4.3

3.6

92.78

86.07

ng/l

0.99

1157

6993

Non-selective monoamine reuptake inhibitors

1846

11421

1.61

74.64

3.3

3.9

86.81

91.60

ng/l

1.28

1557

9810

Viral hepatitis, IBD co-morbidity

207

519

4.23

74.55

4.4

3.0

98.48

76.07

ng/l

2.58

190

474

Thyroiditis, ILD-related definition

624

2900

2.31

74.37

3.8

3.5

83.37

80.07

ng/l

0.44

543

2495

Hypoplasia of dental enamel , including avohilmo

237

649

4.10

74.32

14.9

5.4

69.69

54.62

ng/l

2.16

231

627

Cardiomyopathy (excluding other)

604

2764

2.33

74.24

5.7

3.7

132.24

82.45

ng/l

17.24

548

2388

Caries of dentine, including avohilmo

3822

14134

1.41

74.13

4.1

3.7

92.09

89.09

ng/l

1.07

3280

12179

Symptoms and signs involving the nervous and musculoskeletal systems

2710

18875

1.48

73.62

3.7

4.0

88.59

90.81

ng/l

0.56

2331

16323

Need for other prophylactic measures

375

1404

2.99

73.19

7.3

4.2

93.59

84.59

ng/l

1.05

360

1243

Multiple myeloma and malignant plasma cell neoplasms

352

1289

3.15

72.86

4.3

3.8

97.21

96.73

ng/l

0.03

310

1106

Paralytic ileus and intestinal obstruction

1253

7363

1.77

72.58

4.7

3.6

103.87

92.30

ng/l

2.06

1074

6228

Amputation of ankle bones

188

466

4.92

72.28

12.7

4.0

205.34

96.88

ng/l

10.32

167

404

Hernia of abdominal wall

2090

13904

1.55

72.11

5.2

3.9

109.02

92.74

ng/l

7.25

1822

12042

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2277

14942

1.52

71.98

4.0

4.2

84.54

94.31

ng/l

5.09

1994

13046

Diseases of the ear and mastoid process

5147

19640

1.34

71.93

4.2

4.0

89.89

90.18

ng/l

0.07

4451

17212

Cardiac arrest

289

776

3.40

71.90

6.7

2.3

143.42

65.34

ng/l

16.07

254

656

Polyarthrosis

1076

5638

1.87

71.86

3.2

3.3

77.89

88.34

ng/l

4.40

885

4734

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

514

2255

2.52

71.80

4.8

3.5

98.80

92.31

ng/l

0.71

443

1885

Primary_lymphoid and hematopoietic malignant neoplasms

1227

7224

1.79

71.53

4.0

89.36

95.07

ng/l

1.21

1061

6131

Fracture of lower leg, including ankle

2556

17527

1.48

71.39

4.2

3.9

94.69

88.96

ng/l

1.97

2220

15102

2140

13177

1.55

70.72

4.3

3.6

104.22

94.71

ng/l

3.27

1818

10988

Skin changes due to chronic exposure to nonionizing radiation

2045

12576

1.56

70.18

4.3

3.6

105.08

95.17

ng/l

3.30

1737

10463

Disorders of parathyroid gland, other and/or unspecified

105

167

10.22

69.69

5.9

2.8

121.68

73.89

ng/l

2.76

143

Undetermined asthma, excluding more controls

610

2876

2.24

69.11

4.0

3.2

89.14

78.85

ng/l

1.68

533

2446

Actinic keratosis

1993

12282

1.57

69.07

4.3

3.6

105.58

95.46

ng/l

3.32

1696

10200

Ischaemic Stroke, excluding all haemorrhages

2748

14369

1.47

68.86

4.5

3.8

108.44

93.45

ng/l

9.49

2335

12177

Acute pancreatitis

942

5184

1.91

68.85

5.0

4.0

110.04

94.25

ng/l

3.31

817

4455

Disturbances of skin sensation

1199

7059

1.76

68.78

3.7

80.68

87.07

ng/l

1.68

1064

6123

Drug-induced osteoporosis with pathological fracture

172

424

5.36

68.32

3.5

3.6

77.69

80.54

ng/l

0.18

147

371

Intestinal malabsorption

306

1069

3.23

68.09

6.3

3.9

105.05

84.35

ng/l

2.54

270

937

Melanocytic naevi

1323

8027

1.71

67.96

5.9

3.8

104.36

87.91

ng/l

5.53

1203

6969

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2352

10879

1.51

67.92

4.4

3.8

99.12

92.27

ng/l

2.24

2002

9205

Open wound of head

2437

16270

1.48

67.71

4.0

4.3

95.96

94.27

ng/l

0.30

2020

14132

Any death

3006

15407

1.44

67.66

4.7

3.8

125.87

86.29

ng/l

37.68

2621

13173

Functional dyspepsia

1254

7517

1.74

67.60

3.7

3.6

85.00

86.94

ng/l

0.34

1077

6482

Adrenocortical insufficiency

243

746

3.73

67.44

4.2

3.5

75.54

75.76

ng/l

0.01

201

653

Mycoses

3748

24224

1.37

67.40

3.9

4.0

90.09

90.20

ng/l

0.02

3238

21063

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

737

3784

2.07

67.25

4.9

4.3

100.36

98.23

ng/l

0.20

652

3280

Fibrosis and cirrhosis of liver

464

2008

2.55

66.75

5.3

3.9

99.67

92.66

ng/l

0.66

418

1726

Nonorganic sleeping disorders, excluding more controls

776

4042

2.00

66.31

4.0

86.92

87.24

ng/l

0.03

675

3608

Other skin changes

962

5408

1.88

66.21

6.0

3.7

110.37

91.91

ng/l

4.50

866

4568

Other noninfective gastroenteritis and colitis

1191

7085

1.75

66.05

5.0

3.9

94.08

86.68

ng/l

1.55

1049

6096

Other disorders of adrenal gland

278

935

3.33

65.85

4.3

3.7

77.00

75.75

ng/l

0.08

230

823

Other diseases of upper respiratory tract

5078

20380

1.32

65.34

3.9

4.0

87.49

92.60

ng/l

3.09

4420

17579

Unspecified contracted kidney

114

11.88

65.08

8.8

3.1

168.74

73.01

ng/l

4.65

101

Purpura and other haemorrhagic conditions

701

3579

2.09

65.05

5.5

4.1

109.50

89.89

ng/l

3.91

629

3090

Intracranial injury

2597

17343

1.45

64.71

3.6

4.1

91.43

91.22

ng/l

0.03

2146

15070

Fibromyalgia

466

2033

2.46

64.49

2.6

3.5

70.82

81.81

ng/l

1.88

411

1768

Sequelae with surgical and medical care as external cause

1037

6007

1.82

64.30

5.8

3.7

116.96

91.04

ng/l

6.81

930

5112

Fracture of forearm

2615

16966

1.45

64.20

3.9

3.7

90.26

86.45

ng/l

1.16

2204

14619

Symptoms and signs involving speech and voice

1596

10290

1.61

64.15

3.7

83.94

89.72

ng/l

1.52

1385

8831

Amyloidosis

181

477

4.57

63.96

5.6

3.0

121.55

87.08

ng/l

1.02

157

408

Diseases of pulp and periapical tissues, including avohilmo

4810

19126

1.32

63.26

4.0

3.9

93.60

87.71

ng/l

3.21

4151

16615

Disorders of adult personality and behaviour

1090

6398

1.76

62.76

3.4

4.1

83.86

86.31

ng/l

0.36

948

5736

Excessive, frequent and irregular menstruation

1747

6166

1.60

62.58

3.6

3.3

78.88

79.50

ng/l

0.11

1498

5328

Other renal tubulo-interstitial diseases

170

431

4.58

62.49

9.3

2.3

124.26

63.98

ng/l

6.92

153

385

KRA_PSY_EATING, excluding more controls

297

1042

2.98

62.40

4.1

3.5

74.78

65.19

ng/l

0.89

265

973

Pain in thoracic spine

712

3695

2.02

62.20

3.2

4.0

74.66

91.83

ng/l

7.27

632

3191

Disorders of vitreous body and globe

2467

16755

1.46

62.19

5.0

3.7

107.17

89.38

ng/l

10.20

2132

14347

Other viral diseases, not elsewhere classified

827

4493

1.92

62.10

7.3

4.2

100.79

84.18

ng/l

3.61

745

3982

Elevated blood glucose level

461

2044

2.45

62.09

5.9

4.0

108.47

90.00

ng/l

2.59

408

1775

Amyloidosis, other/unspecified

162

405

4.96

62.04

5.5

2.9

121.20

85.94

ng/l

0.94

143

346

Speech therapy

1306

8110

1.68

61.90

4.5

3.8

93.79

90.89

ng/l

0.44

1126

6938

Early onset COPD, excluding more controls

847

4644

1.90

61.89

4.5

3.7

103.62

87.63

ng/l

3.71

724

4026

Renal agenesis and other reduction defects of kidney

112

11.64

61.85

9.7

4.1

127.49

67.42

ng/l

3.83

103

SLE (Finngen)

232

730

3.61

61.79

5.6

3.3

92.12

77.29

ng/l

1.93

215

639

Misadventures to patients during surgical and medical care

720

3776

2.02

61.63

5.8

3.5

111.69

88.06

ng/l

5.24

634

3229

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1068

6195

1.76

61.37

5.8

3.9

78.75

79.54

ng/l

0.09

953

5561

Diseases of male genital organs

1909

6317

1.56

61.31

5.6

5.1

113.82

103.24

ng/l

2.63

1693

5637

Disorders of magnesium metabolism

136

9.41

61.13

4.6

3.4

98.88

91.80

ng/l

0.18

117

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

543

2591

2.26

61.10

6.5

3.9

127.82

90.52

ng/l

4.53

499

2239

Schizophrenia or delusion, excluding more controls

1180

7049

1.71

61.10

3.3

4.1

84.99

90.99

ng/l

1.19

984

6214

Undetermined asthma

610

3018

2.13

60.93

4.0

3.3

89.14

81.88

ng/l

0.98

533

2560

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

487

2224

2.36

60.93

4.7

3.7

98.11

84.33

ng/l

1.88

430

1911

Disorders of vitreous body

2398

16360

1.46

60.92

4.9

3.7

106.73

89.22

ng/l

9.62

2078

14010

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2193

10340

1.50

60.88

4.2

3.7

97.43

92.39

ng/l

1.32

1863

8720

Other blood glucose lowering drugs, excl. Insulins

838

4638

1.91

60.79

4.5

3.7

108.81

92.21

ng/l

4.04

699

3892

Late syphilis

130

279

5.99

60.58

9.1

3.9

150.73

83.68

ng/l

5.91

118

250

Benign neoplasm: Transverse colon

596

2962

2.18

60.49

4.9

3.9

101.94

96.33

ng/l

0.66

543

2533

Renal agenesis and other reduction defects of kidney

12.79

60.35

10.1

4.3

132.02

66.12

ng/l

4.03

Zoster [herpes zoster]

953

5490

1.83

60.35

4.9

3.5

100.97

91.19

ng/l

2.06

811

4635

Malignant neoplasm of skin

2348

11226

1.48

60.26

4.3

3.8

98.79

91.95

ng/l

2.16

2005

9512

Decubitus ulcer and pressure area

380

1574

2.66

60.26

7.7

3.4

147.44

92.85

ng/l

8.50

329

1316

Unspecified privation

559

2705

2.21

60.20

5.8

4.0

112.26

89.97

ng/l

4.31

508

2342

Hyperkinetic disorders, excluding more controls

363

1374

2.62

60.17

5.1

4.5

68.24

70.66

ng/l

0.20

323

1306

Somatoform disorder

760

4094

1.95

59.44

3.2

3.8

77.97

85.52

ng/l

1.48

656

3562

Candidiasis

692

3630

2.02

59.28

5.1

3.7

105.49

85.97

ng/l

2.04

586

3120

Ventral hernia

1163

7090

1.71

59.21

4.9

3.7

102.88

91.73

ng/l

2.42

1005

6036

Diagnoses used for exclusion with ILD

1218

7508

1.69

59.19

4.2

3.9

88.45

94.94

ng/l

1.32

1049

6412

Acute pancreatitis (for exclusion)

942

5443

1.81

58.53

5.0

3.9

110.04

94.16

ng/l

3.36

817

4671

Neuromuscular dysfunction of bladder

469

2145

2.35

58.36

4.4

3.8

97.16

91.92

ng/l

0.40

405

1834

Disorders of sclera, cornea, iris and ciliary body

2389

16986

1.44

57.98

4.6

3.8

98.42

89.66

ng/l

3.40

2097

14721

Personality disorders

1031

6094

1.75

57.96

3.5

4.0

86.09

85.87

ng/l

0.02

894

5455

Weight loss

558

2747

2.19

57.93

3.6

4.1

78.28

90.79

ng/l

2.78

483

2351

Cholecystectomy

3274

21082

1.37

57.65

4.0

3.7

93.59

90.02

ng/l

1.23

2835

18074

Sarcoidosis

661

3449

2.04

57.58

4.4

3.7

85.70

89.85

ng/l

0.40

590

2977

Haemolytic anaemias

246

840

3.36

57.53

8.6

4.0

124.52

84.55

ng/l

4.95

215

741

Pulmonary heart disease, diseases of pulmonary circulation

1558

10244

1.58

57.37

4.1

3.7

104.30

92.71

ng/l

4.08

1330

8677

Other infectious diseases

499

2361

2.28

57.29

7.0

3.9

135.78

92.98

ng/l

5.17

433

2015

Acidosis

149

368

4.77

57.01

6.4

3.5

129.12

85.43

ng/l

2.85

125

323

Injuries to the ankle and foot

2871

18682

1.39

56.99

4.8

4.0

95.10

86.95

ng/l

3.65

2499

16441

Persons encountering health services for specific procedures, not carried out

393

1680

2.49

56.83

5.8

2.7

106.89

74.98

ng/l

6.04

353

1455

Other specified disorders of kidney and ureter

229

758

3.47

56.52

9.2

3.4

158.53

80.82

ng/l

6.30

206

660

Late syphilis

143

349

5.07

56.47

9.0

3.7

148.25

81.56

ng/l

6.62

128

314

Unspecified mental disorder

1646

10947

1.54

56.40

3.3

4.1

83.48

90.96

ng/l

2.29

1390

9582

Trochanteric bursitis

731

3976

1.95

56.02

3.5

3.4

85.79

87.15

ng/l

0.15

643

3375

Other infectious diseases

438

1988

2.39

55.99

7.3

3.8

139.05

92.57

ng/l

4.99

379

1702

Noninfectious colitis NAS

681

3623

1.99

55.74

5.2

3.9

97.35

87.00

ng/l

1.54

609

3123

Endocarditis

211

668

3.53

55.28

8.4

3.4

170.39

80.16

ng/l

11.00

191

581

Specific personality disorders

894

5169

1.79

54.53

3.3

4.0

82.56

85.31

ng/l

0.42

778

4629

Fracture of foot, except ankle

1035

6240

1.72

54.46

5.1

3.9

91.96

87.25

ng/l

0.71

898

5471

Other and unspecified local infections of skin and subcutaneous tissue

491

2351

2.23

54.40

7.4

4.1

119.25

87.55

ng/l

5.40

441

2051

Chronic rhinitis, nasopharyngitis and pharyngitis

1384

8952

1.60

54.33

3.8

4.0

82.87

89.81

ng/l

2.23

1215

7820

Degeneration of macula and posterior pole

2334

13263

1.44

54.32

4.0

3.5

101.06

91.95

ng/l

3.61

1910

11171

Alcohol use disorder, Swedish definition

2200

14253

1.45

54.32

3.9

4.4

98.43

97.63

ng/l

0.11

1908

12491

Transient ischemic attack

2486

14526

1.42

54.16

3.9

3.7

100.36

92.50

ng/l

3.07

2141

12300

Hyperplasia of prostate

1369

4898

1.63

54.10

4.9

4.8

113.49

107.66

ng/l

0.81

1197

4304

Complications of internal orthopaedic prosthetic devices, implants and grafts

1137

7072

1.68

53.82

4.2

3.3

101.35

89.29

ng/l

1.82

966

5932

Migraine

1953

10927

1.48

53.72

3.2

3.9

71.21

82.98

ng/l

9.83

1752

9643

Other local infections of skin and subcutaneous tissue

511

2496

2.18

53.63

7.3

4.0

117.20

87.45

ng/l

5.12

457

2179

Seborrhoeic keratosis

1112

6888

1.69

53.55

5.6

3.3

111.15

88.94

ng/l

7.57

987

5796

Abnormal weight loss

512

2518

2.20

53.44

3.6

4.1

77.49

91.40

ng/l

3.19

441

2160

Familial hypercholesterolemia

702

3819

1.93

53.44

5.5

3.3

115.83

89.72

ng/l

6.17

604

3193

Sequelae of cerebrovascular disease

1726

10106

1.52

53.35

4.6

3.7

107.08

95.27

ng/l

4.39

1448

8497

2316

14982

1.43

52.96

3.9

4.4

98.50

97.08

ng/l

0.23

1996

13121

Complications of cardiac and vascular prosthetic devices, implants and grafts

162

452

4.26

52.75

13.2

3.6

202.95

86.68

ng/l

12.46

142

394

Mental and behavioural disorders due to psychoactive substance use

2386

15930

1.42

52.65

3.8

4.3

95.10

96.07

ng/l

0.15

2045

13982

Multiple myeloma

205

667

3.61

52.63

3.6

3.5

95.89

93.20

ng/l

0.13

184

569

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

205

667

3.61

52.63

3.6

3.5

95.89

93.20

ng/l

0.13

184

569

Cardiomyopathy, other and unspecified

387

1709

2.43

52.35

4.9

3.5

126.41

81.13

ng/l

11.85

351

1484

Persons with potential health hazards related to communicable diseases

1388

8955

1.57

52.33

6.9

4.1

108.31

82.43

ng/l

11.81

1242

8026

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

660

3111

1.94

52.19

5.8

4.8

74.14

74.65

ng/l

0.05

596

2886

Localized swelling, mass and lump of skin and subcutaneous tissue

1409

9248

1.57

52.07

4.1

3.8

85.25

89.19

ng/l

1.04

1260

7954

Benign neoplasm: Ascending colon

727

4056

1.91

51.91

4.6

3.8

107.94

94.55

ng/l

2.96

643

3434

Thiazolidinediones

570

2936

2.07

51.83

4.8

3.9

116.79

93.48

ng/l

4.75

483

2497

Acquired haemolytic anaemia

187

581

3.79

51.75

8.6

3.8

128.73

87.53

ng/l

3.74

165

509

Substance abuse

2305

15585

1.42

51.40

3.8

4.4

94.46

96.18

ng/l

0.30

1982

13679

Other or unspecified ileus, impaction or obstruction

856

4989

1.79

51.37

4.6

3.6

102.46

92.00

ng/l

1.91

725

4203

Benign neoplasm: Sigmoid colon

938

5631

1.75

51.25

4.8

3.8

99.17

95.10

ng/l

0.62

835

4779

Diseases of the myoneural junction and muscle

622

3314

2.00

51.10

4.1

4.0

93.95

92.83

ng/l

0.09

524

2839

Open wound of lower leg

725

4043

1.88

51.03

5.5

4.0

112.72

91.90

ng/l

2.76

637

3452

Poisoning by drugs, medicaments and biological substances

936

5590

1.73

50.86

3.3

4.1

89.56

86.77

ng/l

0.28

806

4973

Voice disturbances

1240

7971

1.62

50.72

3.6

3.7

80.63

88.98

ng/l

2.44

1092

6866

Ovarian cyst

1568

5979

1.56

50.72

3.5

3.3

81.90

80.19

ng/l

0.28

1359

5161

Immunodeficiencies

289

1144

2.80

50.60

5.2

4.0

86.25

81.22

ng/l

0.46

269

1024

Special screening examination for infectious and parasitic diseases

718

2868

1.88

50.56

3.2

3.6

76.82

83.55

ng/l

1.16

623

2571

Other problems related to primary support group, including family circumstances

490

2330

2.15

50.47

8.0

4.0

69.61

71.34

ng/l

0.22

451

2126

Cervicalgia

935

5608

1.73

50.44

3.4

3.9

80.94

92.59

ng/l

3.81

837

4785

Abnormal involuntary movements

660

3596

1.94

50.36

3.7

3.9

88.89

90.37

ng/l

0.15

573

3086

Haemorrhoids and perianal venous thrombosis

1422

9393

1.56

50.27

3.7

3.5

85.36

90.56

ng/l

1.57

1216

7979

Other symptoms and signs involving the digestive system and abdomen

821

4770

1.80

50.09

3.8

3.3

87.14

83.35

ng/l

0.44

680

4105

Vascular disorders of the intestines

387

1748

2.40

50.04

6.2

3.5

127.89

95.43

ng/l

4.99

345

1451

Conductive and sensorineural hearing loss

3607

18699

1.33

50.03

3.7

3.9

91.29

92.18

ng/l

0.20

2986

16159

Budesonide

610

3235

1.97

50.01

3.7

3.6

84.58

87.37

ng/l

0.34

538

2801

Kela-code for severe mental illness

1472

9819

1.54

49.94

3.2

4.1

84.05

91.74

ng/l

2.11

1234

8585

Non-allergic asthma (mode), excluding more controls

788

4466

1.81

49.92

3.8

3.2

90.27

77.95

ng/l

2.79

698

3832

Enlarged lymph nodes

667

3639

1.91

49.84

3.9

3.7

77.55

87.73

ng/l

2.54

585

3151

2405

15409

1.40

49.74

3.9

4.3

98.84

96.42

ng/l

0.45

2073

13510

Intestinal stricture

1454

9716

1.55

49.68

4.9

3.8

107.15

92.78

ng/l

3.35

1256

8251

Pulmonary embolism

1403

9312

1.56

49.52

4.1

3.7

102.16

92.73

ng/l

2.66

1197

7886

Menorrhagia

1573

5800

1.55

49.51

3.2

3.3

76.22

81.21

ng/l

1.73

1319

4991

Zoster [herpes zoster]

2300

16460

1.41

49.30

4.1

3.6

92.23

89.71

ng/l

0.65

1972

14048

Spondylolisthesis/Spondylolysis

834

4890

1.78

49.16

3.6

4.0

82.09

93.13

ng/l

2.87

728

4203

Persistent mood disorders

849

4998

1.77

49.07

3.5

3.7

89.87

87.50

ng/l

0.27

720

4304

Basal cell carcinoma

2058

10082

1.45

49.07

4.1

3.7

97.13

92.70

ng/l

1.07

1734

8488

Allergic asthma (mode), excluding more controls

836

4767

1.76

49.06

3.5

3.3

79.86

75.69

ng/l

0.73

757

4177

In situ neoplasms

1791

12497

1.48

49.00

4.3

3.5

100.78

89.63

ng/l

4.35

1529

10598

Basal cell carcinoma, including avohilmo

2123

10412

1.44

48.97

4.1

3.7

96.58

92.51

ng/l

0.98

1792

8788

Other and unspecified drugs and medicaments

452

2189

2.22

48.95

4.8

3.9

100.08

87.04

ng/l

1.53

398

1886

Pulmonary heart disease

1403

9336

1.56

48.93

4.1

3.7

102.16

93.14

ng/l

2.47

1197

7911

Artrosis, including avohilmo

3529

14747

1.33

48.93

3.5

4.2

85.53

96.47

ng/l

8.81

3040

12870

Other degenerative diseases of the nervous system

1214

5772

1.62

48.83

2.9

3.7

85.60

91.44

ng/l

1.48

991

4938

Type 1 diabetes, definitions combined

388

1750

2.32

48.72

8.0

4.6

111.48

67.89

ng/l

8.85

358

1617

Generalized anxiety disorder

577

3020

1.98

48.63

3.1

3.9

72.51

78.17

ng/l

1.08

511

2713

Gonarthrosis,primary

4067

19604

1.30

48.36

3.4

3.9

85.05

94.37

ng/l

9.86

3516

16804

Osteonecrosis

345

1511

2.50

48.29

5.1

3.8

108.22

91.03

ng/l

1.53

297

1307

Donors of organs and tissues

109

240

5.37

48.22

2.6

2.9

63.68

69.58

ng/l

0.59

102

220

Rheumatism, unspecified

685

3828

1.89

48.13

3.0

3.4

77.26

85.85

ng/l

2.76

592

3245

Disorders of conjunctiva

3547

21999

1.32

48.12

4.1

3.9

84.53

87.77

ng/l

1.25

3094

19114

Hypopituitarism

322

1361

2.53

47.95

4.8

4.5

84.69

76.34

ng/l

0.55

285

1243

Other viral diseases, not elsewhere classified

1044

6474

1.65

47.83

6.6

4.1

94.58

83.66

ng/l

2.48

942

5757

Sensorineural hearing loss

3451

18010

1.33

47.81

3.6

3.9

91.69

92.79

ng/l

0.25

2837

15520

Background retinopathy and retinal vascular changes

159

468

4.00

47.78

8.4

3.8

146.08

86.00

ng/l

6.34

148

409

Systemic lupus erythematosus

232

849

3.08

47.68

5.6

3.4

92.12

79.50

ng/l

1.52

215

748

Fitting and adjustment of other devices

1595

9842

1.51

47.61

3.7

2.7

95.25

81.42

ng/l

6.19

1307

8213

Artificial opening status

307

1288

2.61

47.34

5.8

3.2

112.73

82.98

ng/l

2.49

280

1120

Cervical disc disorders

1530

10409

1.51

47.31

3.5

4.1

84.09

94.96

ng/l

4.68

1350

8990

Later onset COPD, excluding more controls

997

4736

1.70

47.30

4.0

3.3

112.76

91.26

ng/l

5.62

830

3941

Injuries to the shoulder and upper arm

3677

23057

1.31

47.27

4.0

90.42

92.10

ng/l

0.45

3183

19906

Other pleural conditions

542

2836

2.04

47.22

5.8

3.8

129.53

97.71

ng/l

6.47

477

2418

Organic, including symptomatic, mental disorders

2436

12728

1.40

47.21

3.2

3.9

90.85

97.27

ng/l

2.81

1972

10790

DVT of lower extremities

908

5514

1.72

47.16

4.8

3.7

106.28

93.06

ng/l

3.02

800

4698

Type 1 diabetes, strict (exclude DM2)

384

1749

2.30

47.11

8.0

4.7

111.60

67.70

ng/l

8.85

354

1621

Abnormal results of function studies

439

2132

2.20

46.96

4.9

4.2

100.80

87.37

ng/l

1.94

394

1863

Other complications of surgical and medical care, not elsewhere classified

477

2386

2.12

46.92

4.4

3.5

97.25

82.68

ng/l

2.29

429

2059

Other disorders of eyelid

2123

14628

1.42

46.80

3.7

3.6

92.14

91.62

ng/l

0.09

1816

12393

Seropositive rheumatoid arthritis

1112

7068

1.62

46.67

3.3

3.4

84.33

88.09

ng/l

0.45

972

5962

Unstable angina pectoris

1684

9187

1.49

46.60

4.5

3.5

114.93

87.28

ng/l

17.53

1458

7669

Inflammatory bowel disease

1286

8469

1.56

46.52

4.0

4.2

88.09

90.30

ng/l

0.32

1147

7436

Hyperaldosteronism

181

586

3.53

46.31

5.7

3.3

108.80

81.44

ng/l

3.22

162

516

Nonalcoholic fatty liver disease

468

2338

2.13

46.31

3.4

4.0

80.53

84.71

ng/l

0.52

414

2054

Other diseases of pericardium

243

920

2.90

46.14

7.2

3.5

149.99

80.61

ng/l

7.53

218

794

Abnormal findings on diagnostic imaging of other body structures

686

3890

1.86

46.09

4.5

3.6

93.18

87.87

ng/l

0.71

595

3331

Delirium, not induced by alcohol and other psychoactive substances

626

3450

1.92

46.01

3.7

3.8

103.22

99.83

ng/l

0.32

498

2929

Use of pramipexole

1083

6923

1.63

45.82

5.3

3.6

109.73

90.49

ng/l

5.36

917

5871

Poisoning by medicine

834

4978

1.73

45.49

3.4

4.1

91.06

86.43

ng/l

0.49

722

4431

Subjective visual disturbances

1128

7273

1.61

45.45

3.6

3.7

87.97

88.13

ng/l

0.02

998

6238

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

634

3518

1.90

45.43

5.0

3.6

117.77

100.24

ng/l

2.35

545

2889

Abnormalities of gait and mobility

624

3462

1.92

45.37

4.3

4.1

97.66

94.22

ng/l

0.34

540

2947

Other and unspecified disorders of skin and subcutaneous tissue

355

1619

2.38

45.06

5.0

3.5

102.30

85.23

ng/l

2.14

291

1391

Pruritus

544

2892

1.99

44.88

6.3

3.4

117.84

85.38

ng/l

7.17

486

2451

Fall on same level involving ice and snow

2488

18572

1.37

44.87

3.9

92.63

89.63

ng/l

0.73

2169

16035

Phlebitis and thrombophlebitis (not including DVT)

1033

6552

1.64

44.79

5.5

3.7

111.13

90.65

ng/l

6.26

900

5618

Benign neoplasm: Stomach

533

2836

2.02

44.55

3.9

3.7

95.49

90.84

ng/l

0.49

464

2394

Other endocrine disorders

279

1097

2.64

44.39

7.3

5.2

72.61

64.43

ng/l

0.65

233

1014

Chronic sinusitis

1763

12448

1.45

44.34

3.7

3.9

82.97

91.17

ng/l

3.31

1539

10809

Viral warts

869

5285

1.70

44.34

6.7

4.0

100.16

85.20

ng/l

3.11

780

4656

COPD-related respiratory insufficiency

596

3283

1.93

44.22

5.8

3.9

131.50

99.46

ng/l

7.60

496

2799

Phobic anxiety disorders

464

2329

2.06

43.98

4.2

4.1

81.55

77.56

ng/l

0.35

415

2129

Speech and linguistic disorders, excluding more controls

316

1281

2.43

43.96

7.6

4.7

70.23

74.59

ng/l

0.50

293

1182

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

136

381

4.12

43.61

10.7

4.4

103.26

69.02

ng/l

3.44

128

354

Crystal arthropathies, rheuma endpoint

151

458

3.92

43.59

4.9

3.6

94.78

94.29

ng/l

0.02

123

384

Nontoxic diffuse goitre

207

749

3.12

43.53

3.2

3.4

64.99

85.67

ng/l

4.46

174

636

Allergic asthma (mode)

836

4928

1.70

43.49

3.5

3.4

79.86

78.73

ng/l

0.14

757

4308

Substance use, excluding alcohol

759

4473

1.76

43.48

3.9

4.3

90.19

91.16

ng/l

0.08

643

3979

Melanocytic naevi of trunk

537

2872

1.97

43.31

6.9

3.9

107.90

87.60

ng/l

3.68

492

2516

Other diseases of blood and blood-forming organs, wide

1004

6381

1.64

43.30

5.0

3.9

98.90

90.87

ng/l

1.58

886

5489

Other crystal arthropathies

151

461

3.89

43.16

4.9

3.7

94.78

98.00

ng/l

0.13

123

385

Unspecified acute lower respiratory infection

646

3656

1.84

43.08

5.6

4.0

108.04

90.79

ng/l

3.06

577

3197

Diseases of external ear

1463

10061

1.50

43.08

4.5

4.0

97.76

90.23

ng/l

1.70

1195

8719

Superficial injury of lower leg

1069

6891

1.60

42.87

4.5

3.8

98.29

87.02

ng/l

2.67

918

5940

Haemorrhage, not elsewhere classified

229

878

2.88

42.68

8.3

3.6

150.22

89.27

ng/l

7.34

202

740

Corns and callosities

359

1680

2.31

42.68

7.1

3.5

137.50

84.91

ng/l

7.74

323

1435

Hallux valgus (acquired)

1481

7298

1.50

42.17

3.0

3.3

77.27

86.17

ng/l

4.54

1257

6217

Other and unspecified myopathies

448

2285

2.10

42.15

3.8

3.9

97.12

95.72

ng/l

0.09

368

1952

Extrapyramidal and movement disorders

1733

12358

1.44

42.07

3.2

3.8

84.18

92.61

ng/l

3.03

1467

10544

Procreative management

1286

7169

1.53

42.06

5.1

4.3

78.94

86.43

ng/l

1.92

1172

6367

COPD

2023

12041

1.41

42.05

4.2

3.9

107.27

95.01

ng/l

4.53

1698

10278

Umbilical hernia

1090

7089

1.59

41.99

5.7

4.2

113.92

95.33

ng/l

4.85

961

6181

Adenocarcinoma and Papillary adenocarcinoma of kidney

217

5.56

41.97

9.7

4.4

162.97

96.42

ng/l

3.99

194

Other extrapyramidal and movement disorders in other diseases

1089

7103

1.59

41.94

3.5

3.8

86.87

91.04

ng/l

0.78

938

6081

Visual impairment including blindness (binocular or monocular)

384

1858

2.23

41.92

6.2

3.9

124.99

91.40

ng/l

4.24

327

1558

Pleural effusion

734

4362

1.76

41.61

5.5

3.8

122.18

97.80

ng/l

6.40

627

3696

Lung transplant status

154

6.86

41.46

8.0

5.3

115.03

85.55

ng/l

1.77

141

Lung transplantation

154

6.84

41.44

8.0

5.3

115.03

85.55

ng/l

1.77

141

Nontoxic single thyroid nodule

367

1754

2.25

41.19

2.9

3.6

64.16

88.32

ng/l

10.52

302

1501

Coronary artery bypass grafting

1145

5585

1.58

41.18

5.4

3.6

134.86

89.03

ng/l

24.72

1002

4652

Myocarditis

179

605

3.13

41.02

4.4

2.1

96.98

60.73

ng/l

5.18

162

523

Urticaria and erythema

1493

10395

1.47

40.93

4.3

3.9

86.67

85.56

ng/l

0.14

1309

9084

Fracture of shoulder and upper arm

1631

11541

1.45

40.91

4.1

3.9

93.00

90.78

ng/l

0.37

1390

9862

Status post-ami

1163

5837

1.57

40.90

5.4

3.5

130.44

88.84

ng/l

24.23

1020

4849

Vitamin B12 deficiency anaemia

540

2957

1.93

40.78

4.3

3.5

106.74

90.54

ng/l

2.59

448

2475

Covid-19 suspected case

842

5186

1.68

40.74

5.1

3.8

94.76

84.38

ng/l

2.04

708

4587

Non-allergic asthma (mode)

788

4728

1.71

40.66

3.8

3.3

90.27

82.22

ng/l

1.40

698

4047

Disorders of ocular muscles, binocular movement, accommodation and refraction

1870

13428

1.41

40.64

4.5

4.0

84.90

86.51

ng/l

0.26

1621

11802

Cyst of kidney

376

1830

2.22

40.54

7.3

3.5

126.29

90.86

ng/l

7.20

333

1573

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1050

6812

1.58

40.51

3.2

4.0

82.60

85.86

ng/l

0.44

900

6064

Emotionally unstable personality disorder

437

2220

2.05

40.40

2.9

3.8

76.38

76.64

ng/l

0.02

385

2002

Other disorders of bone

775

4688

1.71

40.40

4.2

3.8

88.98

85.92

ng/l

0.33

682

4122

Congenital malformations and deformations of the musculoskeletal system

474

2476

2.00

40.16

5.0

4.6

67.47

73.07

ng/l

0.96

437

2236

Open wound of ankle and foot

450

2329

2.03

39.98

7.3

4.2

131.26

90.15

ng/l

7.63

389

2054

Trigger finger

633

3644

1.81

39.94

4.8

3.8

94.29

89.74

ng/l

0.52

547

3160

Mixed hyperlipidaemia

207

778

2.91

39.86

5.0

3.4

129.62

89.88

ng/l

3.39

174

669

Pyogenic arthritis

317

1444

2.34

39.82

6.8

3.8

115.67

91.65

ng/l

2.83

274

1235

Superficial injury of head

1047

6836

1.58

39.74

3.5

4.0

92.17

89.77

ng/l

0.34

879

5899

Drug-induced hypoglycaemia without coma

118

323

4.27

39.38

7.5

3.9

123.33

82.75

ng/l

3.55

106

285

SLE, ICD10

216

842

2.87

39.36

5.7

3.4

90.43

77.53

ng/l

1.52

200

745

SLE, strict definition

216

842

2.87

39.36

5.7

3.4

90.43

77.53

ng/l

1.52

200

745

Other congenital malformations of the digestive system

252

1044

2.62

39.35

9.8

5.5

87.73

72.95

ng/l

1.59

243

955

Nail disorders

399

1999

2.12

39.27

6.1

4.0

121.50

84.26

ng/l

5.66

351

1747

Acquired absence of limb

175

5.84

39.17

12.6

3.7

201.03

80.35

ng/l

5.36

153

Enthesopathies of lower limb, excluding foot

894

5654

1.63

38.91

3.7

4.1

83.83

91.68

ng/l

1.83

782

4904

Disorders of psychological development

446

2135

2.01

38.91

6.9

5.0

67.92

74.55

ng/l

1.18

408

1952

Other chronic obstructive pulmonary disease

1930

11653

1.40

38.70

4.2

3.9

108.11

95.29

ng/l

4.59

1615

9948

ILD, hospital admission 2, with pulmonary infections

463

2456

1.99

38.53

4.4

3.5

109.67

90.31

ng/l

2.47

404

2085

Other embolism and thrombosis

609

3514

1.82

38.43

5.3

3.7

109.99

91.74

ng/l

2.73

535

2991

Other diseases of pancreas

410

2096

2.09

38.38

5.6

4.0

111.31

93.86

ng/l

2.30

353

1794

Panic disorder

520

2849

1.89

38.17

3.5

3.9

82.27

78.83

ng/l

0.42

454

2555

Syphilis

158

530

3.36

37.97

8.1

4.1

140.26

84.27

ng/l

5.59

143

478

Syphilis

158

530

3.36

37.97

8.1

4.1

140.26

84.27

ng/l

5.59

143

478

COPD related to multimorbidity

1768

10831

1.42

37.94

4.3

3.8

110.71

97.26

ng/l

5.14

1478

9184

Migraine without aura

705

4222

1.72

37.86

3.6

4.1

75.41

78.53

ng/l

0.41

633

3791

Duodenal ulcer

509

2797

1.91

37.78

5.3

3.9

125.38

99.43

ng/l

3.64

436

2366

Other diseases of stomach and duodenum

335

1600

2.25

37.76

5.1

3.7

102.52

93.26

ng/l

0.97

305

1362

Retinal detachments and breaks

1568

11198

1.44

37.76

5.1

3.6

110.02

90.27

ng/l

9.00

1357

9612

Other enthesopathies

1196

8110

1.51

37.68

3.3

3.8

81.57

89.45

ng/l

2.40

1040

7046

Mouth breathing

1590

11360

1.43

37.58

4.1

4.5

94.12

91.95

ng/l

0.34

1392

10047

Idiopathic hypoparathyroidism

12.16

37.54

4.5

4.0

56.74

79.84

ng/l

0.82

Congenital malformations and deformations of the musculoskeletal system

386

1928

2.10

37.39

5.6

4.9

65.14

71.44

ng/l

0.97

360

1756

Other respiratory disorders and diseases

940

6093

1.60

37.27

5.1

3.9

119.24

96.06

ng/l

4.31

787

5160

Other diseases of the respiratory system

940

6093

1.60

37.27

5.1

3.9

119.24

96.06

ng/l

4.31

787

5160

Other disorders of veins

1786

12987

1.40

37.12

3.7

3.5

91.08

86.80

ng/l

1.23

1490

11132

Other abnormal uterine and vaginal bleeding

1075

5084

1.57

37.05

3.2

3.3

79.14

82.32

ng/l

0.62

859

4341

Transport accidents

1712

10640

1.41

36.82

4.1

4.0

90.74

87.06

ng/l

0.74

1518

9408

Migraine with aura

890

5685

1.61

36.82

2.8

3.8

68.07

82.11

ng/l

9.62

816

5016

Other respiratory diseases principally affecting the interstitium

848

5394

1.64

36.75

5.1

3.8

116.99

97.32

ng/l

2.85

747

4551

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1670

12018

1.41

36.72

3.6

4.5

96.65

97.90

ng/l

0.17

1437

10573

Pain and other conditions associated with female genital organs and menstrual cycle

734

4109

1.69

36.53

3.1

3.4

69.50

76.42

ng/l

1.57

627

3635

Suicide or other Intentional self-harm

916

5909

1.59

36.49

3.3

4.0

86.05

87.71

ng/l

0.17

780

5242

Other general symptoms and signs

236

972

2.56

36.46

3.6

4.0

70.06

78.81

ng/l

1.25

199

869

5-aminosalicylic acid

784

4875

1.65

36.46

3.8

3.9

85.41

87.66

ng/l

0.25

696

4267

Nonorganic sleeping disorders

776

4821

1.66

36.39

4.0

86.92

86.41

ng/l

0.05

675

4237

Other chronic obstructive pulmonary disease, including avohilmo

2356

14837

1.34

36.23

4.0

3.9

103.06

95.19

ng/l

2.63

1984

12721

Nonischemic cardiomyopathy

446

2384

1.97

36.12

5.3

3.7

117.75

86.15

ng/l

7.79

402

2019

Postprocedural disorders of digestive system, not elsewhere classified

204

808

2.82

35.99

5.4

3.7

87.25

86.37

ng/l

0.03

183

701

Epilepsy

1246

8565

1.49

35.97

4.1

4.3

87.51

90.42

ng/l

0.46

1063

7460

Viral pneumonia (known virus, not influenza)

169

610

3.13

35.86

7.4

4.5

117.96

85.21

ng/l

2.98

149

540

Ulcerative colitis

968

6352

1.57

35.81

4.1

87.68

90.21

ng/l

0.34

861

5563

Scoliosis

382

1944

2.07

35.72

3.9

4.1

74.67

80.55

ng/l

0.69

329

1664

Leiomyoma of uterus

2800

12302

1.32

35.70

3.3

3.2

82.47

80.18

ng/l

0.75

2348

10584

Neovascular glaucoma

235

996

2.59

35.62

6.9

3.8

138.31

90.23

ng/l

4.56

205

860

Mental and behavioural disorders due to alcohol

1923

13729

1.37

35.48

3.7

4.4

96.88

97.51

ng/l

0.08

1646

12088

Other disorders starting during childhood or adolecense, excluding more controls

180

630

2.88

35.47

9.7

5.4

70.62

59.44

ng/l

1.28

175

602

Primary biliary cholangitis (PBC)

148

500

3.39

35.46

3.6

2.9

82.90

79.94

ng/l

0.13

134

430

Immunodeficiency with predominantly antibody defects

162

574

3.18

35.43

5.7

4.1

84.44

78.12

ng/l

0.45

155

518

Infection of intervertebral disc (pyogenic)

102

274

4.46

35.29

5.5

4.1

135.88

91.39

ng/l

1.59

238

Carcinoma in situ of skin of upper limb, including shoulder

183

702

3.03

35.26

6.2

3.8

121.82

97.96

ng/l

1.27

159

597

Glaucoma secondary to other eye disorders

235

1003

2.57

35.07

6.9

4.0

138.31

93.61

ng/l

4.02

205

870

Spondyloarthritis

722

4449

1.68

35.05

4.2

3.7

100.60

91.85

ng/l

0.97

637

3825

Follicular adenocarcinoma of thyroid gland, including Hilmo

232

4.89

34.99

2.2

3.7

45.09

76.15

ng/l

9.48

206

Valvular operations

572

3325

1.79

34.81

4.7

3.8

123.30

82.43

ng/l

11.50

496

2842

Irregular menses

1797

10427

1.39

34.68

3.7

3.3

79.80

76.50

ng/l

0.80

1599

9130

Disease of hard tissues of teeth, NOS

2330

9219

1.34

34.58

3.6

3.3

84.01

87.77

ng/l

1.25

1989

7924

Abnormal serum enzyme levels

1193

8029

1.49

34.38

4.6

4.5

96.87

102.62

ng/l

1.07

1090

6949

Keratitis

1439

10278

1.43

34.36

4.6

3.9

98.91

89.84

ng/l

2.49

1254

8907

Other shoulder lesions

401

2104

2.00

34.23

3.7

3.9

80.60

88.96

ng/l

1.14

352

1828

Other benign neoplasms of skin

1641

12005

1.40

34.20

4.4

3.7

98.04

90.38

ng/l

1.87

1399

10279

Amiodarone users

485

2720

1.89

34.20

4.3

4.0

123.25

99.70

ng/l

6.05

438

2331

Other coagulation defects

350

1760

2.11

34.16

4.9

3.8

104.23

86.92

ng/l

1.77

310

1532

Crohn disease

520

2958

1.83

34.15

4.3

4.1

91.01

86.61

ng/l

0.37

466

2617

Inflammatory diseases of female pelvic organs

2547

14494

1.32

34.06

3.3

76.65

79.32

ng/l

0.91

2168

12485

Problems related to lifestyle

387

2006

2.01

33.96

4.1

3.7

95.64

85.45

ng/l

0.88

339

1786

Other disorders of bladder

507

2875

1.85

33.92

4.2

4.1

104.53

98.16

ng/l

0.51

399

2463

Other and unspecified coagulation defects

248

1096

2.44

33.86

5.1

3.8

102.69

80.61

ng/l

1.95

224

980

Acquired absence of organs, not elsewhere classified

236

4.63

33.81

10.7

3.2

161.53

74.82

ng/l

3.84

204

Cystic fibrosis

14.82

33.80

5.1

2.7

77.94

64.97

ng/l

0.49

Fissure and fistula of anal and rectal regions

933

6164

1.56

33.44

3.6

3.8

90.29

89.40

ng/l

0.09

797

5325

Erosion of teeth , including avohilmo

912

5995

1.56

33.43

6.2

4.1

98.05

86.14

ng/l

2.22

799

5314

Disorders of muscles

427

2306

1.94

33.37

4.1

4.0

85.89

92.17

ng/l

0.65

374

1988

Respiratory insufficiency

369

1896

2.04

33.36

4.0

3.4

108.53

92.29

ng/l

2.16

294

1603

Benign neoplasm: Rectum, anus and anal canal

912

6026

1.57

33.33

4.4

3.8

99.71

94.73

ng/l

0.85

791

5122

Disorders of lacrimal system and orbit in diseases classified elsewhere

162

595

3.07

33.31

2.8

3.4

51.26

80.94

ng/l

11.59

144

533

Glaucoma

2564

17213

1.31

33.30

4.1

3.7

98.91

92.52

ng/l

2.21

2135

14624

Anosmia

233

4.21

33.28

3.0

2.2

74.56

76.96

ng/l

0.12

194

Meniscus derangement

2142

10913

1.34

33.26

3.6

3.7

88.19

90.47

ng/l

0.49

1847

9409

Polymyalgia rheumatica

675

4176

1.70

33.23

3.3

3.4

82.82

94.51

ng/l

3.11

576

3427

Alcohol use disorder, ICD-based

1533

11124

1.41

33.14

3.6

4.5

95.83

97.68

ng/l

0.25

1323

9791

Arterial embolism and thrombosis

299

1438

2.23

33.06

6.5

3.4

149.11

91.52

ng/l

5.85

262

1209

Personal history of other diseases and conditions

421

2255

1.93

33.02

5.5

2.9

86.90

63.45

ng/l

4.92

384

2010

Graves ophthalmopathy, strict

149

527

3.22

32.97

2.8

3.5

51.51

81.20

ng/l

9.64

134

466

Other sleep disorders

461

2564

1.88

32.75

4.3

4.1

95.51

90.74

ng/l

0.51

401

2248

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1266

8921

1.46

32.73

4.6

4.0

92.70

90.21

ng/l

0.35

1068

7763

Cirrhosis of liver, NAS

279

1320

2.29

32.56

6.1

4.1

114.83

95.75

ng/l

1.71

249

1145

Other symptoms and signs involving the circulatory and respiratory systems

298

1435

2.20

32.53

5.1

3.8

92.69

83.46

ng/l

0.85

255

1224

Urticaria

1174

8167

1.47

32.49

4.2

3.9

86.54

83.70

ng/l

0.35

1033

7142

Cholangitis (primary sclerosing, PSC)

312

1538

2.17

32.38

5.8

4.1

96.11

91.26

ng/l

0.40

284

1328

Eating disorder

297

1420

2.17

32.36

4.1

3.8

74.78

67.93

ng/l

0.56

265

1307

Acute suppurative otitis media

832

5014

1.58

32.36

6.6

4.2

92.38

81.40

ng/l

1.80

749

4504

Ascites

360

1867

2.05

32.29

6.2

3.6

121.60

92.00

ng/l

4.57

330

1585

Schizophrenia or delusion

1180

8222

1.47

32.26

3.3

4.1

84.99

91.15

ng/l

1.25

984

7209

Asthma and allergy, excluding more controls

427

2285

1.90

32.26

3.2

76.87

71.33

ng/l

0.73

383

2019

Adhesive capsulitis of shoulder

700

4380

1.66

32.23

4.5

3.8

91.58

92.20

ng/l

0.05

627

3759

Squamous cell neoplasms and carcinomas of the skin

423

2316

1.94

32.17

4.9

3.5

115.10

97.93

ng/l

1.80

369

1891

Diseases of salivary glands

1332

9510

1.44

32.08

4.0

3.8

86.08

87.80

ng/l

0.27

1158

8218

Alcoholic liver disease

425

2326

1.92

32.08

3.8

4.3

96.04

100.04

ng/l

0.33

370

2029

Small fibre neuropathy

174

676

2.88

32.05

6.1

3.9

104.18

88.41

ng/l

0.90

154

592

ILD, hospital admissions 3, with pneumonia sepsis

405

2190

1.96

32.00

4.4

3.5

108.39

90.05

ng/l

2.00

352

1859

Primary gonarthrosis, bilateral

2314

15351

1.32

31.88

3.3

3.8

85.25

94.11

ng/l

5.87

1968

13040

Acute posthaemorrhagic anaemia

199

823

2.65

31.85

7.3

3.4

162.06

85.84

ng/l

8.04

172

715

COPD, hospital admission 2, with asthma infections

1398

8617

1.43

31.78

4.3

3.9

112.88

97.76

ng/l

4.15

1164

7294

Benign neoplasm: Descending colon

361

1892

2.05

31.77

4.8

3.9

105.48

94.59

ng/l

1.20

333

1639

Other congenital malformations of the digestive system

274

1288

2.28

31.73

9.4

5.2

87.86

73.73

ng/l

1.63

262

1172

Schizophrenia, schizotypal and delusional disorders

1182

8271

1.46

31.59

3.3

4.1

84.78

91.11

ng/l

1.30

983

7253

Conjunctivitis (acute, non atopic)

1096

7551

1.48

31.35

4.9

4.1

90.22

85.52

ng/l

0.80

975

6634

Iridocyclitis

935

6279

1.54

31.29

5.0

3.8

97.63

89.65

ng/l

1.31

835

5404

Eating disorders

366

1911

1.98

31.25

4.4

3.8

87.10

72.57

ng/l

1.53

324

1737

Clear cell adenocarcinoma of kidney

242

1102

2.40

31.17

5.5

3.8

126.85

95.31

ng/l

3.35

215

947

Other inflammation of eyelid

606

3699

1.71

31.11

3.8

84.08

89.08

ng/l

0.62

520

3173

Heartburn

463

2620

1.84

31.10

3.6

91.22

87.41

ng/l

0.30

391

2249

Injuries to unspecified part of trunk, limb or body region

464

2640

1.85

30.88

5.1

4.1

102.23

89.34

ng/l

1.50

403

2299

Aortic aneurysm

900

5892

1.54

30.84

5.0

3.7

113.02

95.22

ng/l

4.57

771

4999

Traumatic subdural haemorrhage

548

3123

1.75

30.72

4.4

3.9

114.83

98.93

ng/l

2.14

451

2638

Diplopia

573

3460

1.73

30.67

3.7

3.8

91.02

91.15

ng/l

0.01

507

2962

Other hammer toe(s) (acquired)

805

4854

1.59

30.58

3.3

83.57

88.34

ng/l

0.92

681

4046

Benign neoplasm: Rectum

813

5347

1.58

30.50

4.5

3.9

99.83

95.03

ng/l

0.75

712

4566

Other epidermal thickening

233

1053

2.40

30.43

5.2

3.6

113.19

82.76

ng/l

3.50

215

917

Special screening examination for other diseases and disorders

396

2142

1.91

30.41

5.7

3.5

137.49

89.55

ng/l

6.57

353

1839

Other diseases of lip and oral mucosa

1656

12355

1.37

30.35

3.8

84.90

87.52

ng/l

0.51

1400

10704

Pulmonary oedema

124

414

3.41

30.31

8.9

3.7

194.27

95.11

ng/l

2.95

114

353

Lichen simplex chronicus and prurigo

312

1577

2.11

30.29

5.3

3.7

116.73

88.98

ng/l

3.40

273

1363

Conjunctivitis

3045

20436

1.26

30.27

4.0

3.9

81.76

86.28

ng/l

2.08

2674

17781

Viral pneumonia (unknown virus, not influenza)

306

1531

2.12

30.26

6.7

4.2

123.30

89.72

ng/l

3.58

264

1350

Renal cell carcinoma of kidney

190

789

2.65

30.26

5.4

3.5

131.56

92.22

ng/l

4.12

167

670

Post-traumatic stress disorder

273

1300

2.18

30.19

3.4

3.8

76.61

72.06

ng/l

0.37

240

1192

Malignant neoplasm of breast, including Hilmo

1909

9340

1.35

30.18

2.6

3.3

76.88

81.20

ng/l

1.55

1641

7921

Otitis externa

892

5977

1.54

30.15

4.8

4.0

96.63

88.48

ng/l

1.35

765

5215

Disorders of vestibular function (Vertigo)

2079

15773

1.32

30.11

3.5

3.7

83.04

90.02

ng/l

3.51

1741

13477

Malignant neoplasm of breast, HER2-negative, including Hilmo

1908

9340

1.35

30.07

2.6

3.3

76.89

81.20

ng/l

1.54

1640

7921

Pain associated with micturition

519

3070

1.77

30.04

4.2

3.6

84.78

85.60

ng/l

0.07

443

2621

Graves ophthalmopathy

160

617

2.92

30.04

2.8

3.5

51.42

80.27

ng/l

10.66

143

548

Asthma and allergy

427

2338

1.85

30.01

3.2

3.4

76.87

74.09

ng/l

0.29

383

2065

Dilated cardiomyopathy

512

3023

1.78

29.93

5.3

4.3

133.61

99.24

ng/l

7.27

464

2615

Fentanyl

457

2605

1.83

29.84

4.7

3.5

118.21

95.15

ng/l

2.43

388

2175

Coxarthrosis, primary

2679

18041

1.28

29.73

3.5

3.8

88.36

93.86

ng/l

2.33

2258

15340

Disorders of orbit

230

1044

2.38

29.68

3.5

3.8

64.23

82.95

ng/l

3.63

203

917

Sequelae of other external causes

278

1357

2.19

29.68

5.6

3.9

124.93

86.89

ng/l

3.67

259

1187

Cervicobrachial syndrome

859

5727

1.54

29.60

3.3

3.9

76.92

89.62

ng/l

4.62

782

4943

Mental retardation, excluding more controls

176

685

2.68

29.60

6.1

5.4

71.18

67.21

ng/l

0.27

161

649

Chronic laryngitis and laryngotracheitis

602

3714

1.69

29.55

3.6

3.8

74.75

91.75

ng/l

5.29

512

3198

Invasive ventilation

341

1791

2.02

29.54

6.0

4.3

123.42

91.21

ng/l

4.14

294

1565

Malignant neoplasm of breast

1875

9254

1.35

29.45

2.6

3.3

75.42

81.28

ng/l

2.66

1607

7843

Other eating disorders

192

800

2.52

29.39

4.2

4.0

75.68

64.31

ng/l

0.64

165

740

Diseases of inner ear

2369

18019

1.30

29.31

3.5

3.7

84.50

91.20

ng/l

3.36

1988

15450

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

582

3560

1.68

29.12

3.3

4.0

86.06

82.75

ng/l

0.27

503

3193

Malignant neoplasm of breast, HER2-negative

1858

9204

1.35

29.10

2.6

3.3

75.11

81.41

ng/l

3.06

1590

7798

Coeliac disease

526

3148

1.74

29.10

4.1

4.0

91.88

83.91

ng/l

0.87

445

2722

Suppurative and unspecified otitis media

1202

7562

1.43

28.94

5.5

4.0

91.39

84.71

ng/l

1.07

1064

6692

Other and unspecified nonorganic psychotic disorders

668

4235

1.62

28.78

3.0

4.1

81.83

87.79

ng/l

0.72

563

3774

Hydrocele

433

2457

1.83

28.67

6.6

4.8

130.62

105.85

ng/l

3.26

394

2157

Carcinoma in situ of skin of other and unspecified parts of face

458

2671

1.83

28.66

5.3

3.4

122.24

96.31

ng/l

3.48

387

2200

Dermatophytosis

557

3400

1.71

28.63

5.5

4.0

111.37

94.79

ng/l

2.56

502

2942

Internal derangement of knee

1342

9709

1.40

28.62

3.8

88.19

89.17

ng/l

0.13

1128

8445

Impingement syndrome of shoulder

942

6447

1.50

28.62

3.6

4.0

81.50

93.58

ng/l

3.88

841

5595

Disturbance of activity and attention

357

1864

1.93

28.58

5.1

4.9

66.87

70.58

ng/l

0.36

320

1742

Alcohol-induced chronic pancreatitis

266

1292

2.18

28.56

5.4

4.6

116.01

98.22

ng/l

1.26

227

1159

Pericarditis

171

691

2.67

28.48

7.8

3.5

127.66

78.91

ng/l

4.46

157

610

Carcinoma in situ of skin of trunk

200

880

2.54

28.45

5.6

3.8

124.97

100.15

ng/l

1.56

178

746

Other congenital malformations

359

1933

1.95

28.43

5.2

4.8

91.39

73.23

ng/l

2.00

331

1743

Other postsurgical states

298

1513

2.09

28.42

4.9

3.1

91.29

78.04

ng/l

1.01

271

1324

Magnesium deficiency

9.52

28.36

4.2

4.1

96.03

88.23

ng/l

0.15

Spondylopathies (FG)

490

2886

1.75

28.35

3.6

3.7

85.40

87.75

ng/l

0.18

431

2527

Other osteochondrodysplasias

259

4.13

28.29

4.8

4.1

56.92

68.73

ng/l

1.65

235

COPD, hospital admissions

1935

12576

1.33

28.20

4.2

3.9

107.73

96.52

ng/l

3.69

1616

10733

Hepatic failure, not elsewhere classified

200

877

2.49

28.17

5.3

3.9

98.63

89.71

ng/l

0.55

176

773

Crohn's disease NAS

277

1372

2.13

28.14

4.5

4.4

96.45

82.79

ng/l

0.97

250

1235

Type of accident

1164

8310

1.44

28.06

4.5

4.0

90.94

90.24

ng/l

0.08

983

7217

Nonsuppurative otitis media

781

4446

1.55

27.83

5.7

4.1

87.51

82.34

ng/l

0.68

704

3929

Varicose veins

2715

16422

1.27

27.77

3.6

90.94

90.24

ng/l

0.15

2312

14011

COPD, hospital admissions 3, with asthma pneumonia sepsis

1180

7212

1.44

27.73

4.2

3.9

115.74

99.13

ng/l

4.03

977

6095

COPD, early/later onset

1947

12667

1.32

27.51

4.2

3.9

108.12

96.49

ng/l

3.94

1628

10813

1416

9119

1.39

27.48

3.7

3.4

104.22

95.05

ng/l

2.14

1129

7571

Ulcerative colitis, NAS

541

3307

1.69

27.38

4.2

4.1

89.92

87.69

ng/l

0.19

478

2913

Speech and linguistic disorders

340

1741

1.95

27.37

7.7

5.3

68.22

72.39

ng/l

0.53

317

1607

Sulfasalazine

1090

7724

1.44

27.30

3.2

3.6

80.41

87.52

ng/l

1.12

966

6667

Paracetamol or NSAID medication

639

1978

1.66

27.21

4.2

5.7

85.09

94.20

ng/l

1.64

579

1773

Faecal incontinence

465

2753

1.78

27.21

3.6

3.0

89.29

84.54

ng/l

0.39

368

2316

Fibroblastic disorders

927

6388

1.49

27.19

3.9

94.35

95.58

ng/l

0.15

810

5475

Extreme obesity with alveolar hypoventilation

211

961

2.38

27.14

4.3

3.7

120.93

88.28

ng/l

3.75

172

846

Primary adrenocortical insufficiency

233

4.21

26.98

3.5

57.70

76.85

ng/l

2.35

209

Type 1 diabetes, strict definition

263

1287

2.11

26.96

7.7

5.1

108.28

63.14

ng/l

6.57

244

1216

Alzheimer disease, excluding more controls

773

3351

1.57

26.83

2.7

3.8

86.61

94.53

ng/l

1.72

621

2817

Other symptoms and signs involving the urinary system

428

2476

1.81

26.83

5.1

4.0

102.56

92.61

ng/l

0.92

385

2144

Oesophageal varices

212

972

2.36

26.83

5.3

4.1

95.22

92.35

ng/l

0.15

191

853

Vascular diseases of the intestine

213

979

2.36

26.80

6.0

3.4

130.39

92.47

ng/l

3.34

189

820

Seborrhoeic dermatitis

399

2264

1.84

26.79

5.0

4.0

102.32

91.06

ng/l

1.01

343

1973

Mixed and other personality disorders

295

1517

2.03

26.75

3.4

4.0

93.71

81.30

ng/l

0.95

253

1375

Type 1 diabetes, strict definition, subgroup 1

251

1212

2.15

26.71

7.6

5.2

108.91

63.84

ng/l

6.12

233

1146

Melanocytic naevi, other sites/unspecified

343

1862

1.94

26.70

7.0

3.9

127.26

84.98

ng/l

5.42

309

1641

Infections with a predominantly sexual mode of transmission

991

6911

1.46

26.70

4.8

3.8

90.12

82.72

ng/l

1.52

886

6151

Rheumatoid arthritis, including avohilmo

1648

12534

1.34

26.64

3.4

3.6

82.64

89.63

ng/l

1.73

1431

10683

Hyperfunction of pituitary gland

196

866

2.39

26.54

4.7

3.3

87.72

70.81

ng/l

0.92

169

779

Schizoaffective disorder

303

1580

2.01

26.51

3.3

4.0

87.30

81.53

ng/l

0.31

258

1415

Cerebral palsy and other paralytic syndromes

476

2846

1.74

26.46

3.8

4.2

82.24

88.70

ng/l

0.85

419

2464

Other disorders of eye and adnexa

584

3686

1.64

26.12

4.5

3.9

89.23

85.06

ng/l

0.52

530

3185

Benign neoplasm: Adrenal gland

368

2065

1.89

26.09

4.0

3.9

97.16

90.62

ng/l

0.65

326

1779

Ingrowing nail

244

1191

2.18

25.99

6.6

4.1

122.49

82.38

ng/l

4.54

216

1058

Benign neoplasm: Caecum

505

3096

1.72

25.96

4.4

3.8

100.29

95.19

ng/l

0.54

441

2621

Pneumonia due to other infectious organisms, not elsewhere classified

168

706

2.58

25.93

6.2

3.6

104.01

82.25

ng/l

2.29

150

616

Left ventricular outflow tract obstruction (LVOTO), broad definition

394

2248

1.83

25.91

6.8

4.7

132.68

87.41

ng/l

6.71

363

2029

Pneumocystosis

124

455

3.13

25.90

6.8

4.1

108.50

84.69

ng/l

1.92

117

407

Other bursopathies

540

3351

1.67

25.89

4.0

3.9

91.63

94.23

ng/l

0.23

468

2852

Superficial injury of hip and thigh

647

4190

1.60

25.87

4.0

3.7

102.87

92.83

ng/l

1.23

532

3527

Other and unspecified nerve root and plexus disorders, also in other diseases

764

5122

1.54

25.82

3.1

3.9

76.74

91.04

ng/l

4.07

672

4453

Redundant prepuce, phimosis and paraphimosis

630

3996

1.60

25.82

5.3

5.2

115.78

104.16

ng/l

1.21

565

3586

Acute pharyngitis

481

2862

1.71

25.80

5.7

4.3

79.75

83.82

ng/l

0.46

441

2602

Manic episode

147

580

2.73

25.78

3.2

3.9

85.10

78.21

ng/l

0.26

132

522

Intestinal adhesions without obstruction

378

2139

1.86

25.75

4.8

3.7

98.96

91.48

ng/l

0.53

316

1803

Other disorders of nervous system

307

1634

1.99

25.63

5.3

4.0

95.34

91.38

ng/l

0.29

263

1424

Systemic lupus erythematosus, unspecified

170

726

2.58

25.62

5.2

3.5

85.75

78.32

ng/l

0.68

157

647

Other specified/unspecified necrotizing vasculopathies

307

3.62

25.48

9.2

3.6

151.66

81.63

ng/l

2.91

274

Other and unspecified effects of external causes

1002

7089

1.45

25.36

4.4

4.1

88.80

86.66

ng/l

0.27

867

6252

Secondary parkinsonism, excluding more controls

127

470

2.94

25.36

2.5

3.5

77.57

91.10

ng/l

0.84

101

410

Malignant neoplasm of breast, ER-positive, including Hilmo

1471

8512

1.37

25.36

2.5

3.2

72.60

81.62

ng/l

5.25

1260

7177

Follow-up examination after treatment for malignant neoplasms

422

2472

1.78

25.23

3.5

3.3

93.97

93.08

ng/l

0.07

368

2078

Anterior Iridocyclitis

811

5533

1.51

25.23

5.0

3.9

97.21

90.73

ng/l

0.84

721

4774

Hyperkinetic disorders

375

2067

1.83

25.21

5.2

5.3

67.55

71.19

ng/l

0.36

335

1931

Xerosis cutis

104

351

3.40

25.17

4.2

3.5

101.11

81.15

ng/l

1.34

310

Acute and subacute iridocyclitis

760

5128

1.53

24.99

5.2

3.8

98.41

89.94

ng/l

1.16

675

4429

Flat foot [pes planus] (acquired)

419

2464

1.78

24.88

3.3

3.5

79.13

86.11

ng/l

0.70

358

2124

Fall on and from stairs and steps

1056

7580

1.43

24.86

3.9

3.8

91.26

89.65

ng/l

0.22

891

6489

Combinations of oral blood glucose lowering drugs

1075

7739

1.42

24.83

3.7

3.9

90.05

92.68

ng/l

0.41

936

6673

Other mental disorders due to brain damage and dysfunction and to physical disease

543

3422

1.66

24.83

3.5

3.8

87.87

97.42

ng/l

1.79

449

2899

Metatarsalgia

400

2322

1.80

24.81

3.6

3.8

82.21

86.29

ng/l

0.44

353

1999

Disorders of refraction and accommodation

976

6874

1.45

24.80

4.9

4.1

82.77

83.57

ng/l

0.08

844

6086

Other diseases of oesophagus

420

2475

1.77

24.76

4.3

3.7

101.74

94.66

ng/l

0.54

349

2092

Allergic purpura

156

650

2.61

24.58

6.4

4.1

115.05

82.18

ng/l

2.27

142

579

Malignant neoplasm of breast, HER-positive

1441

8448

1.36

24.54

2.4

3.2

72.12

81.68

ng/l

6.01

1235

7123

Osteonecrosis due to drugs

101

343

3.44

24.41

4.4

3.7

72.25

80.06

ng/l

0.41

307

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

159

668

2.57

24.36

6.9

6.2

101.92

68.29

ng/l

2.23

151

633

Gonarthrosis, primary, with knee surgery

2527

16271

1.26

24.15

3.2

3.9

83.48

94.59

ng/l

10.39

2142

13824

Familial hypercholesterolemia, with ischemic heart disease

425

2536

1.76

24.14

5.6

3.5

120.61

89.05

ng/l

5.06

364

2110

Non-Hodgkin lymphoma, all, including Hilmo

555

3532

1.63

24.13

3.6

3.9

85.01

96.48

ng/l

2.00

469

2983

Other enthesopathy of foot (+metatarsalgia)

421

2497

1.75

24.12

3.6

3.7

82.01

85.95

ng/l

0.44

373

2151

Other specified and unspecified personality disorders

329

1819

1.88

23.93

3.8

4.0

83.73

80.88

ng/l

0.26

290

1632

Calculus of lower urinary tract

239

1196

2.13

23.91

4.6

4.5

101.05

104.73

ng/l

0.16

213

1045

Heart failure and hypertrophic cardiomyopathy

117

435

3.06

23.81

6.1

3.8

125.57

88.34

ng/l

3.31

111

379

Otitis media, unspecified

402

2162

1.77

23.78

5.8

4.3

69.14

74.90

ng/l

1.01

361

1938

Other inflammatory liver diseases

301

1632

1.95

23.74

3.9

3.8

91.90

90.17

ng/l

0.13

264

1419

Behavioural syndromes associated with physiological disturbances and physical factors

3693

21946

1.21

23.73

3.6

4.0

83.21

89.50

ng/l

3.73

3212

19101

Malnutrition

136

546

2.80

23.69

5.2

5.0

88.67

79.09

ng/l

0.49

115

490

IBD patients in KELA-register

802

5522

1.49

23.55

4.1

4.2

86.92

89.57

ng/l

0.31

722

4890

Other/unspecified enthesopathies of lower limb, excluding foot

288

1538

1.96

23.53

3.0

4.1

73.85

86.80

ng/l

2.64

252

1341

Aortic valve malfunction, age under 60 years

358

2049

1.82

23.36

7.0

4.6

138.73

89.01

ng/l

6.88

332

1841

Other arterial embolism and thrombosis

149

625

2.59

23.21

8.4

3.7

168.26

93.68

ng/l

4.00

135

538

Paget disease

109

5.99

23.20

2.7

4.1

71.38

88.47

ng/l

0.92

Cardiodefibrillation

1497

11453

1.33

22.99

4.3

3.9

113.58

97.16

ng/l

7.67

1284

9737

Other and unspecified mood [affective] disorders

243

1231

2.05

22.95

3.2

3.9

81.14

74.70

ng/l

0.67

214

1113

Juvenile arthritis (FINNGEN)

182

829

2.31

22.94

5.7

4.9

103.07

69.76

ng/l

1.11

170

753

Unspecified misadventure during surgical and medical care

260

1363

2.03

22.89

5.4

3.8

109.14

91.23

ng/l

1.50

239

1197

Superficial injury of thorax

587

3826

1.58

22.81

4.2

4.0

97.01

93.43

ng/l

0.33

507

3307

Cramp and spasm

215

1054

2.18

22.79

3.6

4.3

89.47

86.55

ng/l

0.16

186

941

Stomatitis and related lesions

773

5331

1.49

22.79

3.9

84.88

86.93

ng/l

0.25

667

4626

Childhood asthma (age<16), excluding more controls

312

1330

1.88

22.78

5.4

3.6

74.25

69.95

ng/l

0.30

280

1222

Attention to artificial openings

189

883

2.29

22.73

5.7

2.9

105.42

82.95

ng/l

1.81

168

760

Overexertion and strenuous or repetitive movements

388

2293

1.76

22.58

4.1

4.0

86.08

88.27

ng/l

0.15

356

2020

Other follicular disorders

275

1466

1.96

22.57

5.6

4.0

123.27

82.72

ng/l

3.73

248

1317

Emotional disorders starting during childhood or adolecense, excluding more controls

134

519

2.62

22.56

5.8

5.0

67.53

57.47

ng/l

0.61

119

495

Excessive attrition of teeth

2050

16367

1.27

22.34

5.1

4.0

88.51

87.68

ng/l

0.13

1783

14440

Amenorrhoea

230

1154

2.07

22.32

3.8

3.6

80.08

72.62

ng/l

0.64

207

1040

Endometriosis

1345

5904

1.36

22.25

3.3

76.55

80.58

ng/l

1.19

1155

5094

Seronegative rheumatoid arthritis

484

3040

1.65

22.23

3.1

3.4

77.06

87.95

ng/l

2.53

423

2563

Other congenital malformations

482

3021

1.65

22.14

4.7

4.5

87.56

77.48

ng/l

1.16

441

2686

Paralytic ileus

181

840

2.31

22.13

5.4

3.8

125.68

96.77

ng/l

0.83

165

716

Mental and behavioural disorders due to tobacco

349

2017

1.81

22.11

5.1

4.0

99.49

89.39

ng/l

0.86

307

1784

Acute gastritis

330

1879

1.84

22.08

4.3

3.7

100.82

92.60

ng/l

0.73

281

1589

Lesion of ulnar nerve

523

3346

1.61

22.07

4.0

94.75

93.72

ng/l

0.08

451

2913

Sequelae of injuries, of poisoning and of other consequences of external causes

872

6180

1.45

22.06

3.8

4.1

85.72

91.40

ng/l

1.06

759

5426

Superficial injury of abdomen, lower back and pelvis

574

3749

1.58

22.03

4.4

4.0

94.95

87.86

ng/l

0.80

487

3265

Smoking dependency

349

2019

1.81

22.03

5.1

4.0

99.49

89.74

ng/l

0.82

307

1779

Migraine without aura and triptan purchases

529

3386

1.60

22.00

3.5

3.9

71.47

77.94

ng/l

1.28

478

3054

Benign neoplasm of urinary organs

239

1238

2.07

21.96

5.4

3.6

101.98

90.73

ng/l

0.92

214

1070

Discitis, unspecified

350

3.18

21.94

5.2

4.0

134.49

89.47

ng/l

2.43

302

Glucosamine medication

2206

14193

1.27

21.94

3.0

3.6

82.77

92.21

ng/l

5.79

1832

11949

Carcinoma in situ of skin

419

2564

1.73

21.92

5.0

3.5

113.27

94.19

ng/l

2.94

345

2142

Temporomandibular joint disorders, including avohilmo

1546

11780

1.31

21.87

3.4

3.7

73.62

82.76

ng/l

4.30

1335

10382

Sicca syndrome [Sjögren]

404

2446

1.74

21.86

3.1

3.3

76.73

82.96

ng/l

0.73

344

2055

Other and unspecified urticaria

753

5208

1.48

21.83

4.4

3.9

83.14

83.35

ng/l

0.02

657

4548

Retinal vascular occlusion

543

3530

1.60

21.73

5.8

3.5

121.49

95.61

ng/l

5.31

467

2968

Papulosquamous disorders

1555

12065

1.31

21.69

3.9

87.93

90.36

ng/l

0.46

1322

10461

Caries of enamel

3402

20600

1.20

21.59

5.1

3.9

88.54

87.76

ng/l

0.18

3038

17992

Oter anti-inflammatory and antirheumatic agents, non-steroids

1002

3965

1.43

21.57

3.6

5.6

95.05

119.11

ng/l

7.70

847

3431

Other disorders of conjunctiva

609

4062

1.55

21.53

4.7

3.8

100.78

92.90

ng/l

0.93

512

3463

Traction detachment of retina

157

4.49

21.53

10.5

3.5

227.07

82.22

ng/l

4.02

136

Childhood asthma (age<16)

312

1357

1.84

21.44

5.4

3.8

74.25

72.15

ng/l

0.13

280

1248

Other and unspecified tonsillitis

970

5870

1.41

21.44

5.3

4.3

83.95

86.39

ng/l

0.31

886

5293

Blepharochalasis

1292

9818

1.35

21.35

3.6

88.09

90.91

ng/l

0.55

1092

8332

Benign neoplasm: Kidney

190

918

2.25

21.35

5.3

3.7

101.40

88.08

ng/l

0.98

169

796

Other Crohn's disease

263

1408

1.95

21.34

4.9

4.2

93.15

81.81

ng/l

1.00

238

1266

Strabismus

993

7216

1.40

21.33

4.4

4.1

86.91

85.53

ng/l

0.13

871

6305

Thyrotoxicosis with toxic single thyroid nodule

187

4.16

21.25

3.7

3.2

69.93

75.50

ng/l

0.20

168

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

356

3.11

21.24

8.6

5.5

112.14

69.59

ng/l

1.65

331

Ulcer of oesophagus

300

1689

1.87

20.96

4.4

3.9

116.52

101.00

ng/l

1.19

258

1443

Inflammatory bowel disease, strict (require KELA)

802

5653

1.45

20.84

4.1

4.2

86.92

89.61

ng/l

0.32

722

5012

Presence of other devices

980

7132

1.40

20.80

4.4

3.0

101.70

86.59

ng/l

4.07

866

6020

Striking against or struck by other objects

1137

8479

1.36

20.75

4.4

4.6

90.38

92.01

ng/l

0.15

981

7514

Cholangitis (primary sclerosing, PSC), with reimbursement 202

101

371

3.01

20.75

8.2

4.8

96.65

78.04

ng/l

0.90

339

Fall involving bed

186

903

2.25

20.72

4.2

4.0

109.95

95.31

ng/l

0.79

155

759

Total colectomy operation

185

889

2.22

20.70

5.6

4.1

114.49

85.09

ng/l

1.65

168

789

Total colectomy

185

889

2.22

20.70

5.6

4.1

114.49

85.09

ng/l

1.65

168

789

Acute and transient psychotic disorders

430

2667

1.67

20.69

3.5

4.0

89.89

86.47

ng/l

0.22

360

2355

Other/unspecified synovitis and tenosynovitis

444

2777

1.65

20.67

4.4

3.8

87.78

90.02

ng/l

0.18

378

2397

Other juvenile arthritis

158

710

2.34

20.64

5.8

5.0

106.04

66.89

ng/l

1.14

147

650

1011

7003

1.40

20.54

3.5

3.3

97.35

94.97

ng/l

0.31

791

5793

Retinal vascular disorders

546

3600

1.58

20.49

5.8

3.5

121.02

95.86

ng/l

5.10

470

3023

Herpesviral [herpes simplex] infections

462

2930

1.63

20.40

4.7

3.6

93.12

85.49

ng/l

0.88

393

2542

Osteopathy in diseases classified elsewhere

165

4.42

20.39

8.5

3.7

147.78

71.59

ng/l

1.86

144

Benign paroxysmal vertigo

1252

9532

1.35

20.38

3.6

84.01

90.03

ng/l

1.85

1028

8145

Psoriasis

1081

8045

1.37

20.35

4.1

4.0

85.99

91.73

ng/l

1.25

915

7006

Adverse effects, not elsewhere classified

728

5072

1.47

20.31

4.7

4.0

89.35

83.33

ng/l

0.92

629

4432

Other or ill-defined heart diseases

212

1073

2.07

20.31

6.8

3.6

123.13

77.49

ng/l

3.96

192

935

Pure hyperglyceridaemia

108

414

2.83

20.26

5.7

3.7

129.22

89.46

ng/l

2.67

357

Impotence

201

1001

2.11

20.25

7.0

5.0

130.92

106.29

ng/l

1.58

182

889

Collagenous colitis

402

2477

1.70

20.23

4.4

3.7

86.20

87.18

ng/l

0.08

347

2118

Certain conditions originating in the perinatal period

285

1402

1.86

20.10

7.9

5.2

64.38

64.71

ng/l

0.03

271

1308

Moderate visual impairment, binocular

167

785

2.31

20.08

6.5

3.6

142.63

88.65

ng/l

3.48

138

652

Necrobiosis lipoidica, not elsewhere classified

100

5.42

20.00

7.9

3.0

115.87

70.01

ng/l

1.72

Disorders of breast

1994

14589

1.26

19.99

3.1

3.3

75.26

80.29

ng/l

2.61

1722

12497

Infections with a predominantly sexual mode of transmission

1203

8459

1.34

19.98

4.7

3.8

87.05

83.05

ng/l

0.74

1068

7549

Alcohol abuse, main dg, excluding more controls

470

2997

1.61

19.94

3.4

4.5

91.66

95.03

ng/l

0.27

401

2692

conjunctival haemorrhage

349

2085

1.76

19.92

4.9

4.0

104.27

91.73

ng/l

1.43

296

1778

Methotrexate

566

3772

1.55

19.92

3.3

3.4

75.38

85.36

ng/l

2.65

500

3230

Olecranon bursitis

238

1264

1.97

19.90

5.3

4.7

110.94

102.51

ng/l

0.40

214

1114

Special screening examination for neoplasms

206

1039

2.07

19.88

6.0

3.6

110.63

91.91

ng/l

1.22

179

896

Other chondrocalcinosis

317

3.26

19.86

4.6

3.6

92.43

87.12

ng/l

0.21

280

Oesophagitis

240

1284

1.97

19.80

5.1

4.0

99.26

93.22

ng/l

0.39

214

1110

Postmenopausal bleeding

1245

5008

1.36

19.76

3.0

3.2

79.20

83.63

ng/l

1.19

1051

4267

Follicular adenocarcinoma of thyroid gland

141

4.69

19.74

2.5

3.9

45.62

78.54

ng/l

5.38

127

Dermatophytosis

2320

19013

1.23

19.72

3.7

4.1

87.62

91.95

ng/l

1.50

2015

16565

Other hearing loss

1209

8998

1.34

19.68

3.9

3.7

106.24

96.52

ng/l

1.61

971

7584

Atopic dermatitis, strict definition with reimbursement

965

6831

1.39

19.62

4.4

4.0

77.39

80.04

ng/l

0.45

852

6112

Disorders of purine and pyrimidine metabolism

102

5.37

19.61

8.1

3.0

105.82

81.24

ng/l

0.95

Orchitis and epididymitis

310

1788

1.79

19.58

5.7

5.0

110.70

104.11

ng/l

0.45

266

1578

Carcinoma in situ of skin of lower limb, including hip

137

606

2.55

19.57

6.1

3.3

105.46

87.75

ng/l

1.39

120

506

Neuralgia and neuritis, unspecified

215

1112

2.04

19.55

3.5

3.8

83.81

88.79

ng/l

0.24

186

958

Carcinoma in situ of skin of scalp and neck

148

675

2.43

19.49

6.2

4.1

129.74

104.72

ng/l

0.93

125

575

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

349

2101

1.74

19.31

5.8

3.6

117.78

88.08

ng/l

3.67

299

1803

Early onset COPD

847

6122

1.42

19.31

4.5

4.2

103.62

94.31

ng/l

1.54

724

5328

Herpesviral [herpes simplex] infections

883

6419

1.40

19.26

4.0

3.6

82.81

83.95

ng/l

0.15

763

5596

Crohn's disease of small intestine

259

1428

1.89

19.22

4.2

4.1

96.42

83.13

ng/l

0.90

231

1281

Polyp of the female genital tract

1278

5580

1.34

19.22

3.4

3.3

79.52

82.11

ng/l

0.55

1099

4797

Vasculitis limited to skin, not elsewhere classified

144

650

2.42

19.21

5.3

3.4

98.66

81.54

ng/l

1.38

128

567

Monoarthritis, not elsewhere classified

181

887

2.16

19.16

4.3

3.8

89.44

86.57

ng/l

0.15

156

771

Impacted cerumen

448

2873

1.63

19.15

4.3

4.0

97.08

93.11

ng/l

0.29

315

2467

Drug-induced adrenocortical insufficiency

110

443

2.78

19.10

5.2

3.7

82.81

75.99

ng/l

0.32

398

Other symptoms and signs involving the nervous and musculoskeletal systems

1610

12750

1.28

19.01

3.5

3.9

83.90

88.61

ng/l

1.18

1375

11071

Rash and other nonspecific skin eruption

410

2576

1.66

19.00

4.5

3.9

95.00

87.87

ng/l

0.70

368

2208

Suppurative and necrotic conditions of lower respiratory tract

235

1267

1.96

18.96

5.1

4.3

114.40

98.35

ng/l

1.19

212

1116

Otitis externa, unspecified

417

2628

1.64

18.89

5.1

4.2

87.69

86.18

ng/l

0.12

375

2315

Protozoal diseases

155

726

2.32

18.88

6.1

3.8

108.12

84.73

ng/l

2.06

144

641

Acne

287

1629

1.80

18.88

7.0

4.2

110.92

70.19

ng/l

5.18

266

1487

Alcohol dependence

928

6826

1.39

18.79

3.4

4.6

97.32

99.93

ng/l

0.27

795

6049

Leisure time condition

699

4911

1.46

18.76

4.2

3.9

89.85

90.41

ng/l

0.05

577

4257

Disorders of tooth development and eruption

528

2816

1.55

18.70

6.0

3.2

88.80

78.45

ng/l

1.74

472

2462

Amputation of thigh

154

721

2.31

18.65

9.4

3.7

177.98

103.00

ng/l

5.30

129

609

Fracture at wrist and hand level

1218

9314

1.33

18.57

4.5

4.3

93.38

92.32

ng/l

0.10

1067

8169

Artificial joint operation, meniscal resection

3798

21154

1.18

18.49

3.4

4.0

84.57

94.43

ng/l

7.62

3278

18183

Alcohol-induced acute pancreatitis

148

682

2.31

18.44

5.3

4.4

104.37

94.45

ng/l

0.64

132

610

Superficial injury of wrist and hand

701

4935

1.45

18.44

4.1

4.2

89.87

85.98

ng/l

0.45

609

4361

Abscess of anal and rectal regions

296

1716

1.78

18.42

5.5

4.2

116.38

91.06

ng/l

2.45

263

1522

Unspecified urinary incontinence

414

2639

1.64

18.24

3.3

3.4

83.44

84.34

ng/l

0.07

314

2205

Other disorders of patella

563

3808

1.51

18.23

3.1

3.7

75.50

86.16

ng/l

1.85

497

3356

Other (seronegative) rheumatoid arthritis, wide

808

5861

1.42

18.23

3.3

3.5

78.61

89.44

ng/l

3.49

694

4959

Urethral stricture

223

1195

1.96

18.22

4.1

4.3

118.49

105.69

ng/l

0.58

194

1040

Psychotic depression

225

1206

1.94

18.20

3.6

4.3

92.45

87.00

ng/l

0.23

188

1068

Personal history of malignant neoplasm

303

1785

1.78

18.19

3.2

2.9

77.43

72.40

ng/l

0.65

275

1528

Follicular cysts of skin and subcutaneous tissue

676

4749

1.46

18.15

4.9

3.9

105.95

91.08

ng/l

2.70

603

4117

ILD, hospital admissions

639

4457

1.48

18.12

4.3

3.8

102.31

97.48

ng/l

0.47

560

3770

Other/unspecified crystal arthropathies

151

4.42

18.08

5.1

3.4

98.65

82.65

ng/l

0.46

130

Prurigo nodularis

136

616

2.42

18.06

5.8

3.5

121.63

82.66

ng/l

2.79

121

537

Thoracic aortic aneurysm

511

3407

1.55

18.05

5.2

3.9

112.39

94.22

ng/l

2.58

439

2942

Unknown and unspecified causes of morbidity

261

1470

1.84

18.00

4.5

3.7

110.28

85.31

ng/l

2.35

233

1266

Other specified/unspecified systemic involvement of connective tissue

258

1457

1.87

17.99

3.5

80.64

79.93

ng/l

0.06

236

1252

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1214

9288

1.32

17.99

4.0

85.05

84.54

ng/l

0.07

1066

8237

Type1 diabetes, definitions combined, early onset

228

1227

1.92

17.94

8.5

5.8

112.47

70.30

ng/l

5.12

209

1155

Agoraphobia

110

448

2.58

17.92

3.0

4.4

70.11

75.34

ng/l

0.34

417

Mixed connective tissue disease

281

1629

1.81

17.91

3.1

3.5

83.46

81.55

ng/l

0.11

255

1409

Thrombocytopenia, unspecified

303

1794

1.77

17.83

5.8

4.2

105.60

92.12

ng/l

1.40

263

1561

Thyroiditis

295

1734

1.78

17.77

3.2

3.6

78.47

83.31

ng/l

0.46

256

1491

Anankastic personality disorder

152

717

2.24

17.76

2.9

3.9

77.25

77.95

ng/l

0.04

133

648

Polyarteritis nodosa

137

4.39

17.75

7.5

3.4

124.71

79.85

ng/l

1.62

122

Colonic or urogenital fistula

1015

7645

1.36

17.73

3.7

4.0

90.47

91.81

ng/l

0.15

869

6634

Progressive vascular leukoencephalopathy

210

1129

2.01

17.59

3.0

3.2

90.58

97.04

ng/l

0.54

181

922

Reactive arthropathies, FINNGEN

260

1475

1.83

17.57

3.8

3.9

93.44

86.94

ng/l

0.46

238

1278

Recurrent aphthous stomatitis , including avohilmo

572

3925

1.50

17.56

3.8

3.9

79.12

86.06

ng/l

1.31

485

3379

Other disorders of the musculoskeletal system and connective tissue

605

4202

1.49

17.51

3.5

3.8

91.90

91.62

ng/l

0.02

536

3587

Right bundle-branch block

160

777

2.18

17.46

4.5

3.2

94.11

79.84

ng/l

0.99

126

669

Disorders of oesophagus in diseases classified elsewhere

116

498

2.56

17.45

5.7

3.7

114.87

86.64

ng/l

1.91

423

Other strabismus

779

5622

1.41

17.44

4.2

4.0

80.85

83.28

ng/l

0.26

679

4961

Cushing syndrome

211

3.52

17.43

3.4

2.9

92.85

66.31

ng/l

2.10

187

Diseases of middle ear and mastoid

1984

13231

1.24

17.43

5.0

4.0

94.55

87.75

ng/l

1.64

1754

11601

Necrosis of pulp, including avohilmo

2038

16670

1.23

17.39

4.1

91.56

89.27

ng/l

0.42

1755

14721

Bronchiectasis

365

2287

1.67

17.37

3.7

86.90

91.29

ng/l

0.46

299

1925

Parkinson's disease, excluding more controls

501

3151

1.54

17.34

2.9

4.0

86.31

95.65

ng/l

0.89

403

2698

Chronic hepatitis, not elsewhere classified

164

809

2.17

17.34

3.7

3.5

85.14

80.46

ng/l

0.29

151

718

Injury of unspecified body region

325

1978

1.72

17.21

5.2

4.1

103.53

89.74

ng/l

1.19

283

1717

Other and unspecified injuries of head

296

1758

1.76

17.18

3.5

4.0

90.32

90.05

ng/l

0.02

252

1531

Disorder of pancreatic internal secretion, other and/or unspecified

160

4.09

17.17

6.5

3.8

92.08

75.16

ng/l

0.84

146

Abdominal aortic aneurysm (AAA)

378

2361

1.64

17.15

5.1

3.7

117.09

102.40

ng/l

1.75

322

1983

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

198

1019

1.98

17.12

9.3

5.8

76.57

62.43

ng/l

1.43

191

970

Cardiomyopathy in other diseases

114

4.80

17.12

3.6

2.7

106.54

82.21

ng/l

0.98

Cardiac murmurs and other cardiac sounds

353

2166

1.66

16.99

5.2

4.3

87.20

75.09

ng/l

1.59

318

1891

Hypermobility syndrome

187

968

2.02

16.88

2.9

3.5

64.13

73.72

ng/l

1.59

164

869

Crohn's disease of large intestine

197

1040

1.98

16.86

4.9

4.3

97.65

83.50

ng/l

0.99

179

941

Other interstitial pulmonary diseases

640

4527

1.46

16.83

4.3

3.8

102.23

97.20

ng/l

0.50

561

3822

Hypertrophic cardiomyopathy

195

1034

2.01

16.79

5.9

4.2

120.04

91.43

ng/l

3.31

181

903

Polyarteritis nodosa and related conditions

310

2.99

16.71

6.6

3.9

109.58

76.27

ng/l

1.98

280

Diseases of spleen

100

410

2.69

16.67

5.6

3.8

109.60

81.23

ng/l

1.37

362

Left bundle-branch block

290

1726

1.75

16.65

3.4

3.2

94.61

82.73

ng/l

1.51

246

1459

Algoneurodystrophy

141

665

2.25

16.64

3.9

3.7

91.00

78.73

ng/l

0.46

132

600

Obsessive-compulsive disorder

194

1018

1.96

16.62

4.1

4.3

80.44

74.07

ng/l

0.42

175

938

Ptosis of eyelid

478

3210

1.55

16.59

4.1

3.7

95.75

94.12

ng/l

0.13

431

2708

Ankylosing spondylitis

301

1807

1.72

16.54

3.9

4.4

86.93

94.31

ng/l

0.53

266

1604

Other and unspecified visual disturbances

413

2686

1.59

16.54

3.8

93.05

87.01

ng/l

0.51

372

2292

Radiculopathy

625

4407

1.45

16.51

3.6

3.9

93.36

95.84

ng/l

0.21

537

3721

Reactive arthropathies

315

1916

1.70

16.51

4.2

3.7

93.37

87.71

ng/l

0.43

284

1660

Interstitial lung disease endpoints

640

4544

1.45

16.49

4.3

3.8

102.23

97.42

ng/l

0.47

561

3838

Interstitial lung disease

640

4544

1.45

16.49

4.3

3.8

102.23

97.42

ng/l

0.47

561

3838

Hyperprolactinaemia

124

555

2.35

16.46

4.5

3.1

95.19

69.76

ng/l

0.91

107

505

Bulimia nervosa (incl. atypical)

113

485

2.44

16.44

3.7

3.4

75.29

65.43

ng/l

0.88

104

444

Hepatomegaly and splenomegaly, not elsewhere classified

188

3.61

16.43

6.1

4.1

118.47

82.71

ng/l

0.51

170

ILD, hospital admissions 1, main diag only

573

3995

1.48

16.38

4.3

3.8

105.71

96.77

ng/l

0.98

503

3372

Acute bronchiolitis

223

1107

1.88

16.31

8.6

5.8

79.50

64.11

ng/l

1.39

210

1029

Psoriatic and enteropathic arthropathies

400

2584

1.59

16.27

3.6

3.7

82.41

87.89

ng/l

0.62

343

2248

Assault

391

2508

1.60

16.26

3.6

4.5

90.86

88.26

ng/l

0.18

349

2295

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1085

8368

1.33

16.19

3.3

3.5

83.39

89.15

ng/l

0.81

950

7118

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

251

1444

1.80

16.13

5.0

3.1

93.77

72.47

ng/l

3.32

230

1311

Hyperosmolality and hypernatraemia

287

3.02

16.11

3.3

88.15

83.85

ng/l

0.17

243

Cervicocranial syndrome

401

2601

1.59

16.11

3.4

3.8

79.33

89.74

ng/l

1.90

362

2218

Migraine with aura and triptan purchases

492

3324

1.51

16.10

2.7

3.9

64.37

78.45

ng/l

7.75

448

2960

Specific development disorders of scholastic skills

153

739

2.13

16.09

8.0

5.7

62.73

64.88

ng/l

0.16

142

706

Superficial injury of ankle and foot

397

2569

1.59

15.99

5.3

4.2

98.21

81.82

ng/l

1.87

363

2306

Other disorders of optic [2nd] nerve and visual pathways

264

1552

1.78

15.99

5.5

4.2

105.41

86.29

ng/l

1.35

236

1367

Restless leg syndrome

541

3746

1.49

15.98

3.2

3.7

84.71

88.96

ng/l

0.56

468

3207

Hypothyroidism due to medicaments and other exogenous substances

251

3.20

15.93

3.7

3.2

77.23

75.75

ng/l

0.06

225

Atopic dermatitis, strict definition

918

6768

1.35

15.86

4.5

4.3

76.85

79.38

ng/l

0.42

822

6084

Astigmatism

246

1419

1.81

15.78

5.3

4.6

73.66

77.94

ng/l

0.37

215

1271

Other/unspecified seropositive rheumatoid arthritis

1103

8555

1.32

15.78

3.3

3.6

83.89

89.61

ng/l

0.81

966

7273

Anorexia (incl.atypical)

199

1074

1.92

15.75

4.3

3.9

90.68

73.37

ng/l

1.34

176

975

Any dementia, excluding more controls

1543

8525

1.27

15.75

2.9

3.7

90.51

98.31

ng/l

2.84

1216

7152

Noninflammatory disorders of female genital tract

1559

6235

1.27

15.74

3.4

3.3

76.20

79.12

ng/l

0.71

1325

5394

Monoamine oxidase A inhibitors

450

3010

1.54

15.72

3.4

4.1

85.34

93.56

ng/l

1.21

374

2594

Hyperhidrosis

120

541

2.34

15.71

2.9

3.6

63.71

77.40

ng/l

1.91

476

Neuroendocrine tumor and carcinoma of pancreas

126

4.36

15.70

5.8

4.2

59.78

81.23

ng/l

1.47

107

Sleep disorders

3412

21270

1.17

15.68

3.3

4.0

80.88

89.47

ng/l

6.84

2961

18508

Benign neoplasm: Endocrine pancreas

146

4.14

15.66

4.5

3.7

89.56

79.68

ng/l

0.39

128

Other diseases of biliary tract

373

2406

1.61

15.60

4.6

3.7

99.55

90.34

ng/l

0.99

321

2024

Vasomotor and allergic rhinitis

1284

9942

1.28

15.60

3.7

4.2

76.17

87.84

ng/l

6.05

1129

8759

Colectomy operation

688

4992

1.42

15.59

4.5

3.8

107.63

94.30

ng/l

2.13

612

4239

Fenamates

642

3087

1.44

15.57

2.8

5.7

82.88

113.86

ng/l

15.28

548

2705

Ovarian dysfunction

199

1076

1.90

15.56

3.3

2.7

90.75

65.05

ng/l

0.85

179

965

Other and unspecified vasculitis limited to skin

125

582

2.33

15.53

5.7

3.5

102.37

81.96

ng/l

1.54

112

506

Atopic dermatitis

1994

13491

1.22

15.52

3.8

3.9

76.85

83.67

ng/l

3.60

1756

11942

Mental retardation

176

918

2.02

15.52

6.1

6.5

71.18

69.90

ng/l

0.07

161

862

Other/unspecified rheumatoid arthritis

542

3781

1.48

15.49

3.8

3.5

88.19

90.21

ng/l

0.10

461

3162

Speech disturbances, not elsewhere classified

378

2450

1.60

15.48

4.1

3.9

93.55

95.63

ng/l

0.14

308

2082

Benign neoplasm: Small intestine

199

1095

1.95

15.45

5.0

3.7

118.64

88.60

ng/l

3.09

169

941

Carcinoma in situ of skin of ear and external auricular canal

336

2.83

15.40

6.9

4.5

132.03

112.59

ng/l

0.67

288

Mental disorders, not otherwise specified

275

1645

1.73

15.36

4.1

3.9

79.18

78.90

ng/l

0.02

243

1480

Ocular pain

321

2003

1.66

15.36

4.1

3.8

86.80

81.38

ng/l

0.46

287

1746

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

571

4011

1.46

15.35

3.4

3.3

70.22

77.76

ng/l

1.85

494

3488

Postprocedural musculoskeletal disorders, not elsewhere classified

320

2005

1.67

15.32

3.3

3.8

97.49

92.42

ng/l

0.18

288

1717

Plantar fascial fibromatosis

367

2363

1.60

15.30

3.2

3.7

80.00

87.78

ng/l

1.09

323

2043

Seropositive rheumatoid arthritis, wide

1111

8664

1.31

15.25

3.3

3.6

84.33

89.64

ng/l

0.73

972

7367

Memory loss

401

2646

1.58

15.25

3.1

3.7

90.13

96.72

ng/l

0.88

334

2244

Benign neoplasm: Skin of other and unspecified parts of face

448

3022

1.53

15.19

4.5

3.7

105.26

91.36

ng/l

1.30

364

2562

Cholecystitis

562

3953

1.46

15.17

4.4

3.7

101.10

94.14

ng/l

0.89

493

3325

Granulomatous disorders of skin and subcutaneous tissue

126

593

2.28

15.13

5.5

3.6

96.98

75.08

ng/l

1.75

110

527

Periapical abscess

1630

13273

1.25

15.13

4.3

4.1

97.63

90.09

ng/l

1.62

1392

11655

Other disorders starting during childhood or adolescence

183

967

1.95

15.09

9.7

6.1

70.05

59.11

ng/l

1.32

178

918

Psoriasis vulgaris

669

4858

1.41

14.93

4.4

4.1

91.25

93.32

ng/l

0.20

564

4244

Congenital malformations of the circulatory system

517

3484

1.48

14.81

5.8

4.8

80.03

82.84

ng/l

0.34

469

3116

Alzheimer’s disease (Atypical or mixed), excluding more controls

351

1781

1.62

14.81

2.6

3.6

96.42

99.55

ng/l

0.22

249

1479

Tobacco use

199

1103

1.89

14.72

4.4

4.0

97.12

88.08

ng/l

0.46

181

980

Benign neoplasm: Liver/bile ducts

118

547

2.31

14.69

4.0

3.6

89.99

79.06

ng/l

0.53

497

Dermatitis due to substances taken internally

224

1289

1.82

14.65

5.1

3.8

100.92

83.33

ng/l

1.53

193

1128

Emotional disorders and disorders of social functioning with onset specific to childhood

158

795

2.02

14.63

5.8

69.15

60.30

ng/l

0.60

142

760

Abnormal findings in nipple discharge synovial fluid wound secretions

338

2.74

14.60

6.7

3.9

107.22

79.47

ng/l

1.23

306

Cerebral cysts

213

1207

1.84

14.60

5.1

4.2

96.05

87.30

ng/l

0.56

186

1074

Fracture of skull and facial bones

736

5441

1.38

14.58

4.3

4.4

91.24

94.30

ng/l

0.31

638

4790

Inflammatory disease of uterus

478

3283

1.49

14.55

3.1

3.4

73.53

77.41

ng/l

0.63

420

2862

Crohn disease (strict definition, require KELA, min 2 HDR)

221

1266

1.81

14.54

4.1

88.29

80.74

ng/l

0.53

197

1142

Retinal detachment with retinal break

501

3484

1.48

14.48

5.2

3.7

112.42

93.17

ng/l

3.01

437

2973

Acne vulgaris

219

1247

1.80

14.47

6.6

4.3

108.59

69.78

ng/l

3.97

206

1148

Barrett oesophagus

199

1113

1.88

14.41

3.9

4.1

100.62

95.84

ng/l

0.21

175

964

Other symptoms and signs involving general sensations and perceptions

181

984

1.94

14.41

2.8

3.9

77.82

87.42

ng/l

0.91

142

846

Parkinson's disease, strict definition, excluding more controls

457

2968

1.50

14.37

2.9

4.0

82.22

96.65

ng/l

2.98

368

2530

Other noninfective disorders of lymphatic vessels and lymph nodes

168

894

1.99

14.35

5.7

3.4

111.81

84.13

ng/l

2.23

146

776

Arterial embolism and thrombosis of lower extremity artery

159

830

2.03

14.31

4.9

3.6

137.77

93.43

ng/l

2.07

135

705

Injuries to the neck

756

5635

1.37

14.20

3.8

4.0

86.13

89.17

ng/l

0.32

652

4933

Malignant melanoma, including Hilmo

662

4845

1.40

14.19

4.2

3.9

105.09

95.92

ng/l

1.19

566

4094

Myositis

123

589

2.24

14.15

4.2

3.9

81.95

89.87

ng/l

0.42

107

513

Social phobias

230

1337

1.76

14.14

3.9

4.3

81.81

76.05

ng/l

0.42

210

1232

Adrenogenital disorders

4.89

14.14

7.0

3.2

162.04

71.26

ng/l

2.04

Abnormal blood-pressure reading, without diagnosis

188

1038

1.90

14.14

4.7

3.7

83.31

78.54

ng/l

0.29

164

885

Mental retardation, wide definition

180

977

1.93

14.09

6.0

6.3

71.01

70.38

ng/l

0.04

165

917

Diseases of tongue

246

1469

1.74

14.05

4.5

3.2

89.30

87.07

ng/l

0.15

218

1247

Benign neoplasm: Liver

107

487

2.36

13.96

3.7

3.6

84.87

79.59

ng/l

0.22

442

Varicella [chickenpox]

159

833

1.99

13.96

8.2

4.8

96.67

82.42

ng/l

1.17

151

761

Crohn disease (strict definition, require KELA)

221

1282

1.79

13.93

4.1

88.29

80.97

ng/l

0.51

197

1155

Achilles tendinitis

364

2389

1.57

13.93

4.1

4.3

90.88

95.28

ng/l

0.34

324

2096

Giant cell arteritis

208

1199

1.85

13.88

3.5

92.69

92.91

ng/l

0.01

185

1005

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

234

1382

1.75

13.82

4.3

4.1

87.23

81.11

ng/l

0.43

209

1239

Excessive earwax

2186

18023

1.20

13.82

3.8

4.0

90.14

92.75

ng/l

0.61

1809

15529

Pyothorax

176

963

1.93

13.73

4.9

4.2

111.90

100.15

ng/l

0.63

163

846

Deficiency of other B group vitamins

105

479

2.37

13.71

3.5

3.6

81.03

87.67

ng/l

0.39

419

Open wound of forearm

338

2191

1.59

13.70

4.6

4.1

100.83

91.87

ng/l

0.59

281

1910

Gangrene, not elsewhere classified

158

3.62

13.64

13.7

3.7

178.45

82.95

ng/l

4.03

134

Agranulocytosis

444

3057

1.50

13.62

4.9

3.9

100.81

87.21

ng/l

1.73

398

2640

Viral hepatitis

239

1426

1.73

13.58

4.2

4.3

95.78

85.70

ng/l

0.89

215

1287

Glaucoma suspect

1501

12299

1.24

13.41

4.0

3.7

95.08

91.52

ng/l

0.64

1261

10434

Other specified/unspecified bacterial intestinal infections

270

1675

1.68

13.40

4.9

3.8

93.90

88.45

ng/l

0.44

236

1450

Papilloedema, unspecified

103

470

2.35

13.36

5.0

4.2

108.65

80.92

ng/l

0.91

426

Ganglion

704

5240

1.37

13.36

3.5

3.8

79.53

87.46

ng/l

1.86

623

4557

Pre-eclampsia or eclampsia

726

5439

1.36

13.27

4.6

3.3

90.87

77.18

ng/l

3.03

626

4756

Ulcerative enterocolitis

127

629

2.13

13.25

4.8

4.0

105.29

83.76

ng/l

1.03

115

565

Malignant neoplasm of bladder, including Hilmo

437

2990

1.49

13.24

4.2

111.61

104.87

ng/l

0.52

358

2511

Rosacea

429

2947

1.50

13.24

4.7

3.6

88.21

85.28

ng/l

0.29

378

2544

Sleep disorders, other/unspecified

130

648

2.10

13.23

4.0

3.8

101.94

76.90

ng/l

1.01

109

594

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2009

16427

1.20

13.23

3.4

3.7

77.70

84.26

ng/l

3.41

1745

14325

Deviated nasal septum

1116

8839

1.28

13.22

3.6

4.5

88.62

99.42

ng/l

3.60

992

7735

Spontaneous rupture of synovium and tendon

316

2040

1.60

13.16

4.1

3.9

86.34

94.56

ng/l

0.95

262

1728

Degenerative macular diseases

519

3705

1.45

13.15

4.2

3.3

105.76

92.29

ng/l

1.90

419

3096

Corneal ulcer

636

4678

1.39

13.13

5.1

3.9

106.13

89.30

ng/l

2.90

562

4066

Testicular hypofunction

102

464

2.30

13.10

4.9

4.4

108.68

87.72

ng/l

0.71

423

Vascular dementia

405

2659

1.52

13.09

3.0

3.5

100.28

103.22

ng/l

0.26

309

2211

Other and unspecified rosacea

332

2172

1.58

13.06

4.6

3.6

90.69

86.04

ng/l

0.41

292

1887

Somnolence, stupor and coma

173

956

1.89

13.01

4.7

4.1

104.55

95.95

ng/l

0.43

151

841

Testicular dysfunction

112

531

2.20

12.97

4.8

4.6

105.82

92.24

ng/l

0.45

486

Other localized connective tissue disorders

106

499

2.31

12.95

9.3

3.0

138.20

74.72

ng/l

5.02

449

Other and unspecified epidermal thickening

122

603

2.16

12.94

6.3

3.8

123.71

81.66

ng/l

2.80

112

534

Malignant neoplasm of renal pelvis, including Hilmo

251

2.92

12.92

5.8

3.6

128.63

93.75

ng/l

1.50

213

Erythema intertrigo

114

551

2.23

12.91

4.5

3.7

100.22

84.33

ng/l

1.21

103

477

Nummular dermatitis

309

1998

1.60

12.82

4.8

3.9

100.86

91.50

ng/l

0.86

257

1727

Other and unspecified follicular disorders

151

803

1.97

12.82

6.1

4.0

129.86

84.65

ng/l

2.56

135

721

Allergic conjunctivitis

2103

17357

1.19

12.81

3.5

3.8

77.46

84.48

ng/l

4.06

1830

15154

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

236

1428

1.71

12.78

4.1

104.10

80.61

ng/l

1.73

209

1268

Infective dermatitis

414

2846

1.50

12.73

4.8

3.8

104.32

90.98

ng/l

1.57

341

2446

Inflammatory diseases of the central nervous system

305

1968

1.60

12.72

4.3

4.1

84.96

86.50

ng/l

0.11

265

1718

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

202

1171

1.77

12.69

2.9

4.6

81.84

86.26

ng/l

0.24

170

1084

Other viral hepatitis

199

1151

1.79

12.68

4.6

4.3

97.26

84.15

ng/l

1.07

183

1047

Other disorders of pigmentation

194

1122

1.82

12.68

3.9

3.5

95.51

82.37

ng/l

0.99

180

965

Specific development disorders of speech and language

215

1224

1.75

12.65

7.8

5.5

71.19

73.56

ng/l

0.19

200

1118

Mental and behavioural disorders due to sedatives or hypnotics

230

1387

1.71

12.61

2.8

4.1

83.43

84.79

ng/l

0.08

186

1253

Temporal arteritis

184

1055

1.86

12.59

3.4

90.15

90.68

ng/l

0.02

165

885

Macular pucker

629

4669

1.39

12.56

4.3

3.6

96.85

92.92

ng/l

0.40

531

3955

Folate deficiency anaemia

193

3.20

12.54

3.3

3.8

98.34

81.19

ng/l

0.57

172

Pneumonia derived septicemia

147

783

1.98

12.52

7.3

4.4

114.37

86.48

ng/l

1.81

128

687

Other and unspecified vascular occlusions

398

2732

1.51

12.52

6.0

3.5

124.24

93.65

ng/l

5.27

342

2288

Other specified/unspecified soft tissue disorders

206

1213

1.77

12.52

3.4

87.58

89.06

ng/l

0.09

181

1010

Mucosal proctocolitis

408

2803

1.49

12.47

3.7

4.1

87.28

88.95

ng/l

0.13

373

2500

Other disorders of cornea

379

2576

1.52

12.46

4.1

3.8

94.07

88.27

ng/l

0.61

322

2190

Use of antiglaucoma preparations and miotics

361

2439

1.54

12.36

5.0

3.4

106.29

94.95

ng/l

1.20

307

2024

Kyphosis

317

2.65

12.35

4.5

3.9

79.51

80.43

ng/l

0.03

279

Symptoms and signs involving emotional state

117

578

2.13

12.28

3.6

4.3

79.34

80.49

ng/l

0.04

525

Pre-eclampsia

657

4908

1.36

12.28

4.3

3.2

90.13

75.81

ng/l

2.98

565

4300

Superficial injury of forearm

331

2194

1.55

12.14

4.3

4.2

86.77

83.76

ng/l

0.24

286

1935

Early complications of trauma

172

971

1.86

12.12

5.3

4.2

117.89

89.09

ng/l

1.42

139

863

!Aliquae complicationes praecoces traumatis

172

971

1.86

12.12

5.3

4.2

117.89

89.09

ng/l

1.42

139

863

Other and unspecified disorders of vitreous body

1682

13880

1.21

12.08

3.5

3.6

85.31

87.67

ng/l

0.56

1441

11890

Secondary thrombocytopenia

272

2.77

12.07

4.8

3.9

123.59

77.83

ng/l

2.12

246

Other infective otitis externa

227

1385

1.70

12.04

4.9

4.0

98.51

88.82

ng/l

0.59

194

1220

Complications of other internal prosthetic devices, implants and grafts

180

1035

1.83

12.02

4.9

3.4

101.92

86.03

ng/l

1.42

166

886

Other noninflammatory disorders of vulva and perineum

339

2265

1.54

12.02

3.9

3.3

85.13

80.38

ng/l

0.47

292

1975

Other disorders of white blood cells

224

1367

1.71

11.97

5.4

4.0

97.37

89.84

ng/l

0.59

198

1189

Female genital prolapse

1192

5403

1.27

11.97

2.9

3.2

76.95

82.42

ng/l

1.81

994

4627

Other aneurysm

214

1289

1.73

11.96

7.1

3.6

114.15

92.02

ng/l

2.72

196

1119

Coxarthrosis, primary, with hip surgery

1962

15586

1.19

11.88

3.4

3.7

87.71

94.41

ng/l

2.50

1644

13182

Single delivery by forceps and vacuum extractor

197

1986

0.59

11.88

2.6

4.3

64.31

78.92

ng/l

3.22

178

1804

Other abnormalities of plasma proteins

360

2.49

11.87

6.0

3.9

151.69

84.72

ng/l

2.30

321

Malignant melanoma

538

3928

1.40

11.83

4.3

3.8

103.96

95.02

ng/l

0.99

467

3299

Hidradenitis suppurativa

124

633

2.04

11.83

4.7

4.0

107.10

76.93

ng/l

1.50

114

573

Giant cell arteritis with polymyalgia rheumatica

184

1075

1.82

11.83

3.4

3.5

90.15

90.71

ng/l

0.02

165

905

Nephropathy induced by other drugs, medicaments and biological substances

7.63

11.83

10.2

4.5

134.43

88.63

ng/l

0.80

Congenital malformations of heart and great arteries

447

3061

1.45

11.80

6.2

4.9

80.47

81.49

ng/l

0.10

404

2744

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

4.28

11.80

8.3

3.1

115.34

75.54

ng/l

0.92

Dementia, including avohilmo

1959

11402

1.20

11.79

2.9

3.8

87.93

98.71

ng/l

6.47

1560

9595

Iron deficiency

433

2.28

11.78

3.7

4.4

77.21

69.34

ng/l

0.41

389

Scleritis and episcleritis

226

1386

1.69

11.74

4.4

3.5

94.80

79.19

ng/l

1.30

200

1231

Scleritis

257

2.76

11.72

5.0

3.4

84.16

75.51

ng/l

0.35

239

Coxibs

1093

4566

1.28

11.72

2.8

5.8

84.18

116.76

ng/l

23.51

936

3978

Malignant immunoproliferative diseases

248

2.87

11.71

4.3

4.1

95.27

85.22

ng/l

0.32

224

COPD, hospital admissions 1, only main diagnosis

1347

9463

1.24

11.64

4.2

3.9

108.57

98.14

ng/l

2.67

1112

8008

Dissociative [conversion] disorders

130

678

1.99

11.64

3.2

3.6

71.06

72.65

ng/l

0.11

107

615

Inflammatory diseases of prostate (prostatitis)

372

2546

1.49

11.62

4.0

4.7

96.79

103.86

ng/l

0.66

327

2251

Congenital iodine-deficiency syndrome/hypothyroidism

135

720

1.99

11.57

4.2

3.5

115.14

85.17

ng/l

1.40

109

616

Other disorders of electrolyte and fluid balance, not elsewhere classified

185

3.13

11.57

3.4

2.4

96.33

81.90

ng/l

0.44

155

Pneumonitis due to solids and liquids

318

2118

1.55

11.55

4.0

3.9

92.88

98.41

ng/l

0.46

256

1808

Acetic acid derivatives and related substances

1094

4513

1.27

11.55

3.3

5.8

87.50

117.05

ng/l

16.40

931

3933

Synovial cyst of popliteal space [Baker]

285

1856

1.59

11.51

3.4

3.8

81.42

93.81

ng/l

1.54

243

1561

Secondary parkinsonism

127

668

2.03

11.40

2.5

4.0

77.57

96.66

ng/l

1.43

101

584

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

547

4029

1.39

11.38

3.3

4.0

87.07

94.86

ng/l

1.00

470

3413

Tooth eruption problems

375

2512

1.48

11.33

7.6

4.4

80.00

71.20

ng/l

1.18

358

2314

Other otitis externa (chronic)

248

1571

1.64

11.33

4.6

3.9

104.38

86.13

ng/l

1.49

198

1379

Otalgia

305

2025

1.56

11.29

3.5

4.3

73.71

81.54

ng/l

1.35

276

1778

Varicella [chickenpox]

180

1048

1.78

11.28

8.2

4.8

91.78

77.03

ng/l

1.49

172

968

Lactose intolerance

116

590

2.06

11.26

3.6

3.3

87.39

78.29

ng/l

0.45

517

Other female pelvic inflammatory diseases

621

4673

1.36

11.26

3.2

76.21

79.84

ng/l

0.59

504

3996

Palmar fascial fibromatosis [Dupuytren]

536

3942

1.39

11.20

4.1

101.24

100.59

ng/l

0.05

462

3358

Secondary parkinsonism+Parkinsonism in other disease

128

680

2.00

11.15

2.5

3.9

77.29

95.23

ng/l

1.32

102

592

therapeutic use

145

803

1.92

11.13

5.3

3.2

89.23

84.11

ng/l

0.22

123

686

Lung diseases due to external agents

526

3865

1.39

11.12

4.0

92.13

98.96

ng/l

0.98

435

3292

Wet age-related macular degeneration

775

5848

1.32

11.09

3.6

3.4

109.13

95.08

ng/l

2.41

623

4823

Panniculitis affecting regions of neck and back

141

770

1.91

11.08

4.0

4.1

84.51

88.57

ng/l

0.27

124

673

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

569

4227

1.37

11.07

4.1

4.2

87.94

90.02

ng/l

0.19

512

3740

Radial styloid tenosynovitis [de Quervain]

196

1176

1.72

11.04

3.5

3.6

79.12

82.57

ng/l

0.22

168

1030

Benign neoplasm of thyroid gland

151

848

1.89

11.04

2.9

3.4

67.29

80.91

ng/l

1.80

129

742

Sacroiliitis, not elsewhere classified

143

782

1.89

11.03

3.3

4.1

69.19

80.21

ng/l

0.70

128

702

Somnolence

235

2.77

11.01

3.9

4.3

104.73

77.82

ng/l

0.83

213

D07AA Corticosteroids, weak (group I)

507

3698

1.40

11.00

4.0

4.4

78.57

80.76

ng/l

0.20

461

3280

Injuries to the wrist and hand

3851

23773

1.13

10.98

4.1

4.0

90.97

89.39

ng/l

0.38

3352

20719

Bacterial, viral and other infectious agents

293

1936

1.55

10.97

6.6

4.5

108.24

86.68

ng/l

2.88

255

1744

Benign neoplasm of meninges

435

3116

1.44

10.94

3.8

3.4

86.65

88.52

ng/l

0.18

375

2620

Myopia

388

2709

1.46

10.93

4.8

4.0

91.63

78.15

ng/l

1.24

326

2413

Diffuse large B-cell lymphoma, including Hilmo

188

1125

1.75

10.92

4.2

3.7

87.98

93.68

ng/l

0.30

157

960

Diffuse large B-cell lymphoma

188

1125

1.75

10.92

4.2

3.7

87.98

93.68

ng/l

0.30

157

960

Diffuse large B-cell lymphoma, helper endpoint

188

1125

1.75

10.92

4.2

3.7

87.98

93.68

ng/l

0.30

157

960

Recurrent dislocation of patella

140

763

1.89

10.87

3.8

4.0

70.04

70.79

ng/l

0.05

129

691

Disorders of optic nerve and visual pathways

338

2308

1.51

10.85

4.9

4.1

98.50

84.40

ng/l

1.18

300

2025

Hyphaema and other vascular disorders of iris and ciliary body

452

2.23

10.84

7.3

3.6

134.23

86.95

ng/l

2.69

391

Subacute thyroiditis

136

740

1.92

10.84

3.5

3.7

75.70

84.05

ng/l

0.67

117

644

Tinnitus

854

6734

1.29

10.84

3.6

3.9

83.84

90.52

ng/l

1.60

736

5849

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

508

3722

1.39

10.82

4.1

4.3

88.16

90.10

ng/l

0.15

454

3306

Other peripheral vascular diseases

296

1971

1.55

10.79

3.8

3.4

89.68

82.49

ng/l

0.65

262

1679

Benign neoplasm: Pituitary gland, craniopharyngeal duct

195

1180

1.72

10.75

4.3

3.9

79.23

86.57

ng/l

0.65

172

1038

Other prurigo

239

2.76

10.75

5.4

3.4

139.30

75.83

ng/l

3.06

216

Hallux rigidus

513

3776

1.39

10.75

2.9

3.5

79.57

90.38

ng/l

3.04

433

3219

Mental and behavioural disorders due to opioids

109

550

2.05

10.71

3.1

4.5

79.24

81.82

ng/l

0.10

508

Polyglandular dysfunction, other/unspecified

24.48

10.71

2.4

3.6

64.60

81.14

ng/l

—

Other/unspecified reactive arthropathies

236

1498

1.63

10.69

3.9

4.1

93.72

84.68

ng/l

0.65

216

1312

Other condition

488

3566

1.40

10.65

4.9

4.1

92.63

89.54

ng/l

0.26

432

3109

Sequelae of injuries of lower limb

320

2169

1.52

10.65

4.0

88.40

87.53

ng/l

0.06

286

1907

Other disorders of iris and ciliary body

119

626

2.02

10.65

6.7

3.8

123.11

89.04

ng/l

2.22

106

544

Seronegative juvenile rheumatoid arthritis

311

2.46

10.62

4.4

5.4

78.91

64.74

ng/l

0.81

290

Complications following infusion, transfusion and therapeutic injection

333

2.44

10.57

8.0

3.6

113.97

73.78

ng/l

1.86

293

Convalescence

198

1208

1.70

10.56

4.6

2.7

81.52

74.85

ng/l

0.57

169

1032

Bacterial, viral and other infectious agents

274

1802

1.56

10.51

6.8

4.5

111.10

87.36

ng/l

3.06

237

1620

Other and unspecified mononeuropathies, also in other diseases

127

686

1.96

10.48

4.6

3.6

101.74

86.16

ng/l

0.90

103

597

Ulcerative colitis (strict definition, require KELA)

523

3870

1.38

10.48

4.1

4.3

87.92

90.21

ng/l

0.19

468

3431

Delivery

1242

7962

0.81

10.45

2.9

3.5

76.06

83.59

ng/l

3.10

1049

6773

ILD-related respiratory insufficiency

148

841

1.87

10.45

5.0

3.8

113.79

97.26

ng/l

1.04

134

720

Myocardial infarction, with ST-elevation

649

4966

1.33

10.44

5.1

4.0

129.29

99.89

ng/l

7.82

570

4201

Other and unspecified acquired haemolytic anaemias

214

2.87

10.42

7.1

4.0

126.71

85.53

ng/l

1.29

188

Paraplegia, diplegia of upper limbs

479

2.16

10.41

3.6

4.0

71.47

84.97

ng/l

0.82

424

Entropion and trichiasis of eyelid

350

2432

1.49

10.41

3.9

3.7

97.58

98.90

ng/l

0.10

305

2040

Alzheimer’s disease (Late onset), excluding more controls

578

2827

1.37

10.40

2.7

3.7

86.02

96.00

ng/l

2.09

474

2343

Other factor of the environment

267

2.61

10.39

6.6

4.0

137.59

81.94

ng/l

1.73

242

Secondary right heart disease

182

1096

1.74

10.38

3.9

124.77

93.86

ng/l

2.74

155

926

Other abnormal findings in urine

375

2.34

10.38

4.0

3.9

100.98

85.60

ng/l

0.54

329

Other bacterial agents as the cause of diseases classified to other chapters

232

2.77

10.37

8.9

3.7

131.01

76.86

ng/l

3.04

209

Crossbite

244

1448

1.60

10.35

9.6

5.2

68.43

68.24

ng/l

0.02

224

1350

Additional codes for the location of defect, injury or illness

222

1404

1.64

10.29

4.6

4.0

76.60

88.40

ng/l

1.47

196

1230

Other diseases of blood and blood-forming organs

263

1729

1.58

10.28

4.4

3.9

93.20

91.95

ng/l

0.08

227

1496

Secondary and unspecified malignant neoplasm of lymph nodes

304

2059

1.52

10.25

3.3

3.9

79.54

94.53

ng/l

2.41

256

1748

Other ulcerative colitis

196

1202

1.69

10.20

4.8

4.2

90.12

85.90

ng/l

0.18

172

1078

Disorder of thyroid, unspecified

269

2.58

10.20

2.6

2.8

68.79

80.40

ng/l

0.73

237

R07AX Other respiratory system products

+∞

10.19

5.2

9.2

50.30

48.80

ng/l

—

Lesion of lateral popliteal nerve

179

1075

1.73

10.17

4.3

4.0

85.99

93.70

ng/l

0.54

164

946

Insomnia

3233

20884

1.14

10.16

3.2

4.0

79.35

89.37

ng/l

9.65

2810

18171

Benign neoplasm: Cerebral meninges

397

2838

1.45

10.16

3.8

3.4

87.26

86.34

ng/l

0.08

339

2388

Benign neoplasm: Other and unspecified parts of small intestine

399

2.29

10.15

4.3

3.4

122.92

81.93

ng/l

2.12

349

Other bacterial agents as the cause of diseases classified to other chapters

264

2.61

10.15

8.5

3.5

126.99

75.06

ng/l

3.25

239

Status epilepticus

144

815

1.85

10.14

4.9

4.3

107.52

90.53

ng/l

0.69

121

717

Chronic diseases of tonsils and adenoids

2839

15759

1.15

10.14

4.0

4.2

80.68

89.21

ng/l

5.01

2564

13810

Hypotension due to drugs

334

2.41

10.11

3.7

3.8

110.06

87.91

ng/l

0.95

292

Oxicams

932

4209

1.28

10.10

3.2

5.8

84.94

119.52

ng/l

21.83

809

3659

Assault by bodily force

219

1380

1.63

10.09

3.5

4.4

89.27

81.55

ng/l

0.48

199

1262

Other disorders of penis

281

1873

1.54

10.08

5.7

5.5

116.51

100.41

ng/l

0.96

248

1687

Pneumonia due to Streptococcus pneumoniae

147

837

1.82

10.07

4.8

3.8

100.69

87.26

ng/l

0.81

124

728

Gastrojejunal ulcer

246

2.64

10.07

6.1

4.1

121.31

89.52

ng/l

0.94

211

Respiratory disorders in diseases classified elsewhere

322

2.44

10.06

4.8

3.6

67.21

79.03

ng/l

1.15

287

Endometriosis of pelvic peritoneum

510

3602

1.37

10.06

3.2

3.5

70.03

80.14

ng/l

3.84

449

3171

Complications of genitourinary prosthetic devices, implants and grafts

109

568

2.03

10.05

6.6

3.2

137.77

79.44

ng/l

2.99

494

Allergic urticaria

287

1928

1.53

10.02

3.7

3.9

89.09

78.53

ng/l

0.73

257

1692

Biological medication for rheuma

531

3971

1.36

9.95

3.4

4.2

75.32

83.64

ng/l

0.65

494

3536

Single spontaneous delivery

1242

7948

0.82

9.91

2.9

3.5

75.32

83.67

ng/l

3.90

1055

6761

Non-follicular lymphoma

370

2622

1.46

9.90

3.8

4.0

89.12

96.67

ng/l

0.77

316

2245

Other and unspecified psoriasis

249

1631

1.58

9.89

4.5

4.1

92.96

91.10

ng/l

0.10

214

1436

Oesophageal obstruction

147

846

1.83

9.86

3.7

3.8

93.09

97.10

ng/l

0.17

121

725

Brachial plexus disorders

287

1933

1.52

9.83

2.6

3.6

69.93

79.24

ng/l

1.64

264

1723

Other keratitis

372

2634

1.44

9.83

5.5

3.9

104.04

87.33

ng/l

2.04

336

2286

Other noninflammatory disorders of uterus, except cervix

906

4880

1.27

9.82

3.2

3.3

84.77

84.03

ng/l

0.10

742

4152

Traumatic subarachnoid haemorrhage

131

727

1.88

9.81

4.4

3.7

111.59

94.59

ng/l

0.98

108

624

Burns and corrosions

431

3129

1.40

9.79

4.1

4.5

88.53

89.58

ng/l

0.08

373

2795

Other and unspecified mental retardation

408

2.24

9.79

4.5

7.5

58.96

58.58

ng/l

0.02

391

Corneal scars and opacities

120

652

1.95

9.79

5.5

3.7

110.80

81.87

ng/l

1.92

108

567

Infective bursitis

111

586

1.99

9.79

4.4

107.37

93.76

ng/l

0.52

512

Dementia

1818

10701

1.18

9.75

2.8

3.8

86.32

98.66

ng/l

8.11

1441

8993

Juvenile rheumatoid arthirtis

361

2.27

9.75

4.2

109.42

72.27

ng/l

0.42

327

Sequelae of injuries of upper limb

333

2317

1.47

9.74

3.6

4.1

87.99

89.64

ng/l

0.11

287

2037

Atypical facial pain

202

1267

1.66

9.74

2.7

3.5

73.06

83.00

ng/l

1.17

168

1097

Other and unspecified injuries of lower leg

258

1706

1.56

9.72

4.1

4.0

89.93

82.89

ng/l

0.64

231

1504

Other orthopaedic follow-up care

203

1273

1.65

9.72

4.1

2.7

85.64

77.77

ng/l

0.62

181

1083

Psoriatic arthropathies

327

2266

1.48

9.71

3.7

80.87

89.10

ng/l

1.08

278

1971

Adenomyosis (Endometriosis of uterus)

513

3840

1.37

9.71

3.1

3.3

77.14

82.98

ng/l

1.29

453

3314

Other specified and unspecified disorders of eye and adnexa

156

917

1.78

9.70

5.2

3.8

95.52

87.04

ng/l

0.65

149

796

L02BG Aromatase inhibitors

1274

10612

1.22

9.70

2.5

3.2

71.44

82.18

ng/l

7.33

1098

8948

Artificial joint re-operation

306

2108

1.51

9.70

3.9

3.6

95.63

92.10

ng/l

0.11

264

1775

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

122

664

1.91

9.69

9.5

5.1

78.12

66.45

ng/l

0.76

111

610

Other disorders of the genitourinary system

541

4092

1.36

9.69

4.0

3.3

88.16

86.18

ng/l

0.20

445

3424

Lifestyle-related condition

239

2.65

9.69

6.6

3.8

142.89

81.29

ng/l

1.74

214

Hypertrophic disorders of skin

194

1203

1.67

9.68

3.8

3.6

87.75

76.54

ng/l

0.57

171

1059

Encephalitis

120

653

1.94

9.68

4.1

4.2

79.74

82.91

ng/l

0.18

103

582

Other and unspecified disorders of white blood cells

166

995

1.75

9.64

5.2

3.8

91.19

86.23

ng/l

0.29

145

874

Chondrocostal junction syndrome [Tietze]

157

927

1.78

9.64

2.9

3.4

77.66

80.97

ng/l

0.21

146

808

Melanocytic naevi of upper limb, including shoulder

100

514

2.06

9.62

4.8

3.9

95.88

80.00

ng/l

0.95

463

Bell's palsy

407

2941

1.42

9.60

4.2

3.8

94.69

89.99

ng/l

0.40

342

2522

Pre-eclampsia or poor fetal growth

900

7214

1.26

9.53

4.5

3.3

87.47

75.36

ng/l

3.25

783

6395

Lichen simplex chronicus

137

781

1.84

9.50

5.0

3.7

103.42

83.17

ng/l

1.38

120

691

Unspecified protein-energy malnutrition

139

3.32

9.49

4.4

3.4

103.21

73.00

ng/l

0.77

123

Corticotropin deficiency

184

2.91

9.39

3.5

3.7

94.02

75.44

ng/l

0.52

168

Other drug-induced secondary parkinsonism

226

2.71

9.38

2.7

3.8

92.30

80.98

ng/l

0.26

202

Melanocytic naevi of lower limb, including hip

168

1016

1.72

9.38

5.9

3.7

103.21

80.83

ng/l

1.58

154

892

Personal history of risk-factors, not elsewhere classified

211

2.68

9.36

3.4

3.2

80.20

64.03

ng/l

0.73

188

Other pulmonary heart/vessel disease

195

1228

1.66

9.34

3.9

121.59

91.60

ng/l

2.92

167

1033

Dystonia

210

1344

1.62

9.31

2.7

3.7

69.85

81.86

ng/l

2.35

187

1174

Exposure to other and unspecified inanimate mechanical forces

241

1588

1.56

9.26

5.6

4.5

98.10

85.91

ng/l

0.74

223

1416

Malignant neoplasm of small intestine, including Hilmo

127

715

1.87

9.25

4.2

3.8

105.86

89.91

ng/l

1.14

114

620

Alcohol abuse, main dg

470

3494

1.37

9.21

3.4

4.4

91.66

94.21

ng/l

0.20

401

3118

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

267

1800

1.53

9.20

4.2

3.6

103.44

94.96

ng/l

0.73

238

1529

Implicit parasitic Sepsis

3.67

9.20

4.3

2.9

93.05

80.25

ng/l

0.37

Car occupant injured in other and unspecified transport accidents

584

4479

1.32

9.19

4.2

4.0

89.12

87.49

ng/l

0.13

517

3928

Ankylosing spondylitis, ICD10

285

1948

1.50

9.16

3.8

4.2

86.75

89.94

ng/l

0.18

254

1739

Other disorders of bone density and structure

509

2.02

9.09

3.7

3.8

75.14

79.59

ng/l

0.19

460

severe traumatic brain injury, does not include concussion

812

6507

1.27

9.07

4.3

3.9

110.36

98.69

ng/l

1.82

668

5499

Other retinal artery occlusion

107

576

1.98

9.06

5.6

3.8

127.97

96.43

ng/l

1.44

498

Injury of intra-abdominal organs

482

2.05

9.04

5.5

4.3

97.55

83.01

ng/l

0.78

436

Eosinophilic disease (BM)

252

2.49

9.00

5.7

4.0

114.97

82.81

ng/l

1.72

222

Any dementia

1654

9824

1.19

9.00

2.9

3.7

91.24

98.78

ng/l

2.85

1298

8191

Cerebral aneurysm, nonruptured

327

2307

1.46

8.99

5.4

3.7

95.34

89.07

ng/l

0.53

288

1987

Follow-up care involving plastic surgery

150

892

1.75

8.95

3.9

2.7

69.82

72.56

ng/l

0.20

116

774

Short Achilles tendon (acquired)

112

612

1.92

8.94

3.4

3.5

80.23

85.70

ng/l

0.27

105

535

Disorders of adrenal gland, other and/or unspecified

3.78

8.93

4.7

2.7

82.33

72.69

ng/l

0.19

Unspecified lump in breast

615

4785

1.31

8.90

2.9

3.1

79.67

81.13

ng/l

0.19

543

4050

Other encephalitis

111

607

1.92

8.86

4.3

4.1

80.39

81.88

ng/l

0.07

540

Acute laryngitis and tracheitis

323

2230

1.45

8.86

5.3

4.1

78.99

78.23

ng/l

0.04

288

2015

Dentofacial anomalies [including malocclusion]

2405

16981

1.15

8.83

4.1

3.9

76.22

86.11

ng/l

7.02

2080

14953

Hypogonadotropic hypogonadism

437

2.07

8.80

3.7

5.4

99.70

89.36

ng/l

0.25

402

Medicines for HER+ breast cancer

1518

12284

1.19

8.77

2.6

3.3

73.11

82.65

ng/l

6.27

1306

10379

Other autoimmune haemolytic anaemias

303

2.38

8.75

5.2

3.8

99.90

83.48

ng/l

0.71

269

Wide developmental disorders, excluding more controls

436

2.05

8.74

4.0

6.0

50.92

59.66

ng/l

1.33

422

Phakomatoses, not elsewhere classified

226

2.59

8.73

4.8

4.9

110.28

71.61

ng/l

0.74

208

Pneumococcal septicemia

137

802

1.79

8.72

6.6

4.5

108.08

86.71

ng/l

1.19

118

709

Other predominantly sexually transmitted diseases, not elsewhere classified

539

4116

1.33

8.71

4.3

3.7

81.19

79.97

ng/l

0.11

485

3694

Allergic contact dermatitis

456

3408

1.36

8.71

3.7

3.5

85.56

81.04

ng/l

0.34

378

2958

Blindness or visual impairment, binocular

3.67

8.71

7.7

4.1

121.64

74.43

ng/l

1.26

Hypertrophy of breast in women and men

673

5303

1.29

8.68

3.4

3.5

78.16

81.47

ng/l

0.53

581

4632

Vascular dementia (subcortical)

147

881

1.75

8.64

3.0

3.6

89.05

106.42

ng/l

1.82

119

730

Other nutritional anaemias

209

2.66

8.63

6.0

3.7

105.79

80.05

ng/l

0.79

185

Primary coxarthrosis, bilateral

1161

9712

1.21

8.62

3.4

3.7

90.27

94.52

ng/l

0.73

972

8177

Benign neoplasm: Skin of eyelid, including canthus

604

4710

1.31

8.61

3.6

85.52

91.22

ng/l

0.81

514

4001

Unspecified/other endometriosis

259

1756

1.50

8.60

3.6

3.4

69.74

76.77

ng/l

1.19

228

1562

Acute alcohol intoxication

809

6514

1.26

8.59

3.7

4.5

97.93

97.94

ng/l

0.00

677

5749

Autoimmune thyroiditis

348

2.22

8.59

2.6

4.0

57.97

79.44

ng/l

3.79

310

Other/unspecified enthesopathies, not elsewhere classified

298

2084

1.47

8.55

3.9

3.8

97.56

92.21

ng/l

0.32

252

1781

Heterophoria

265

1812

1.50

8.54

3.6

4.0

82.11

78.99

ng/l

0.13

214

1602

Post-traumatic wound infection, not elsewhere classified

105

571

1.93

8.54

5.7

4.0

125.15

84.24

ng/l

1.31

511

Chondropathies

496

3764

1.34

8.53

3.6

4.0

82.75

87.43

ng/l

0.68

434

3303

Congenital malformations of the musculoskeletal system, not elsewhere classified

323

2.26

8.52

5.2

3.9

64.44

68.70

ng/l

0.23

298

Congenital malformations of cardiac septa

248

1623

1.52

8.50

5.8

5.5

76.22

73.09

ng/l

0.30

220

1494

Acute alcohol intoxication, ICD10

604

4705

1.30

8.49

3.5

4.5

93.46

95.89

ng/l

0.21

499

4206

Other acute viral hepatitis

241

2.49

8.49

3.4

4.3

84.81

86.59

ng/l

0.06

221

Iridocyclitis in diseases classified elsewhere

412

2.12

8.47

4.4

4.3

92.62

81.53

ng/l

0.57

369

Amblyopia ex anopsia

157

959

1.70

8.47

6.1

5.0

64.06

75.83

ng/l

1.79

134

868

Paralytic strabismus

264

1812

1.50

8.46

4.5

3.9

108.96

92.53

ng/l

0.83

234

1564

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

219

1419

1.56

8.44

7.2

4.9

71.23

67.77

ng/l

0.29

202

1306

Bullous disorders

232

1555

1.55

8.42

4.3

3.8

119.60

93.09

ng/l

1.97

200

1334

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

895

7303

1.24

8.39

3.7

4.2

82.90

88.25

ng/l

0.88

794

6483

L04AC Interleukin inhibitors

186

1185

1.62

8.36

3.7

4.2

66.94

80.77

ng/l

3.13

176

1068

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

172

2.85

8.34

4.2

3.6

97.14

83.53

ng/l

0.34

147

Bronchitis, not specified as acute or chronic

291

2035

1.46

8.33

5.0

4.0

113.96

92.66

ng/l

1.96

247

1750

Other specified and unspecified retinal disorders

148

897

1.73

8.33

6.0

3.7

106.66

87.42

ng/l

1.02

130

773

Family history of malignant neoplasm

350

2527

1.41

8.33

3.4

2.8

71.50

71.73

ng/l

0.02

301

2198

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

151

922

1.71

8.25

5.0

3.5

88.12

86.30

ng/l

0.10

127

799

Other predominantly sexually transmitted diseases, not elsewhere classified

466

3517

1.34

8.25

4.2

3.7

83.67

79.22

ng/l

0.48

423

3140

Other specified/unspecified dorsopathies

129

753

1.78

8.24

3.3

3.8

96.05

87.12

ng/l

0.29

117

647

Ulcerative proctitis

198

1284

1.59

8.24

4.0

83.34

84.73

ng/l

0.08

180

1155

Medical abortion

2463

11789

1.14

8.21

3.2

3.3

78.10

80.20

ng/l

0.58

2125

10096

Other and unspecified diseases of blood and blood-forming organs

114

646

1.87

8.21

5.1

3.8

105.57

88.43

ng/l

1.02

103

569

Organ-limited amyloidosis

3.81

8.19

6.7

2.4

156.89

88.69

ng/l

1.58

Other misadventures during surgical and medical care

100

545

1.94

8.16

6.9

3.8

106.69

82.29

ng/l

1.00

484

Family history of other conditions

213

2.53

8.16

7.0

2.6

95.62

59.70

ng/l

1.74

193

Enteropathic arthropathies

430

2.05

8.15

3.1

4.4

83.94

83.88

ng/l

0.00

389

Hypersomnia

271

2.37

8.15

2.6

3.6

71.47

73.28

ng/l

0.08

245

Other specified disorders of muscle

111

623

1.86

8.14

4.0

90.23

87.79

ng/l

0.09

536

Hypermetropia

245

1667

1.51

8.12

5.8

4.5

78.19

78.03

ng/l

0.01

220

1480

Episcleritis

182

1164

1.62

8.11

4.5

3.5

99.50

79.04

ng/l

1.47

160

1032

Disorders of myoneural junction and muscle in diseases classified elsewhere

193

2.71

8.08

6.1

3.5

107.54

81.98

ng/l

0.89

170

Anomalies of dental arch relationship, including avohilmo

592

4168

1.30

8.07

6.3

4.1

77.16

79.44

ng/l

0.27

516

3721

Other injuries of upper limb, level unspecified

235

2.47

8.02

5.3

4.3

105.86

81.33

ng/l

0.82

213

Other and unspecified nail disorders

491

1.98

8.00

5.4

3.4

122.89

76.70

ng/l

1.84

440

Emotional disorders starting during childhood or adolescence

137

809

1.72

7.98

5.8

6.3

67.41

59.61

ng/l

0.46

122

774

Pregnancy hypertension

1323

10066

1.19

7.97

4.4

3.2

88.27

75.91

ng/l

4.58

1165

8830

Dislocation, sprain and strain of joints and ligaments at neck level

436

3279

1.35

7.97

3.4

3.9

76.49

84.65

ng/l

1.27

379

2916

Toxic effects of substances chiefly nonmedicinal as to source

356

2599

1.40

7.95

3.8

4.3

91.92

88.31

ng/l

0.20

317

2297

Chronic iridocyclitis

183

1179

1.61

7.95

4.2

3.9

72.22

86.54

ng/l

1.70

162

1029

Myelodysplastic syndrome, including Hilmo

125

734

1.79

7.94

3.3

3.6

83.70

95.04

ng/l

0.93

106

621

Perforation of tympanic membrane

352

2570

1.40

7.93

4.4

4.0

90.15

88.26

ng/l

0.15

306

2224

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

126

739

1.77

7.92

4.1

4.2

84.85

80.90

ng/l

0.20

115

669

Retinal haemorrhage

113

648

1.85

7.86

4.9

3.5

116.74

88.57

ng/l

1.30

554

Use of biperiden

186

1206

1.59

7.84

3.4

3.9

84.71

86.41

ng/l

0.10

157

1072

Allergic rhinitis

940

7675

1.22

7.82

3.7

4.2

73.57

82.56

ng/l

3.15

831

6860

Postviral fatigue syndrome

124

3.04

7.81

2.6

4.2

66.03

72.32

ng/l

0.26

116

216

1440

1.53

7.79

3.1

3.3

75.95

72.68

ng/l

0.17

191

1316

Other overlap syndromes

412

2.07

7.78

3.4

3.7

94.65

78.22

ng/l

0.37

364

Alcoholic gastritis

257

2.36

7.75

3.8

4.7

100.76

93.10

ng/l

0.22

227

Presbycusis

582

4537

1.30

7.75

3.5

104.76

97.74

ng/l

0.80

427

3757

Hypertrophic scar

173

1105

1.61

7.74

3.7

3.6

87.05

75.76

ng/l

0.52

152

974

Melanoma in situ of upper limb, including shoulder

173

2.77

7.72

2.9

3.4

74.40

80.46

ng/l

0.30

150

Urethritis and urethral syndrome

439

2.01

7.72

3.6

3.4

77.80

78.59

ng/l

0.03

382

Other bursitis of hip

505

1.95

7.71

2.8

3.3

89.59

83.73

ng/l

0.28

438

Non-Hodgkin lymphoma, all

164

1040

1.64

7.67

3.2

3.6

93.48

95.71

ng/l

0.08

141

876

Severe visual impairment, binocular

105

3.33

7.66

11.0

3.6

173.62

78.45

ng/l

2.36

Lateral epicondylitis

408

3060

1.36

7.64

2.7

4.0

74.64

90.14

ng/l

3.96

357

2678

Sudden idiopathic hearing loss

367

2717

1.38

7.63

4.0

107.29

93.48

ng/l

0.81

312

2343

Other and unspecified injuries of ankle and foot

137

830

1.70

7.60

3.7

4.3

80.62

76.37

ng/l

0.27

116

750

Contusion of other and unspecified parts of foot

156

976

1.64

7.59

4.9

4.5

89.64

77.42

ng/l

0.73

141

888

Bruxism

380

2.08

7.58

3.8

3.5

64.97

73.04

ng/l

0.63

344

Abscess of lung

320

2.20

7.55

5.4

4.5

113.85

86.09

ng/l

0.98

284

Emphysema

255

1777

1.47

7.55

3.9

89.36

97.77

ng/l

0.92

212

1529

Medial epicondylitis

131

787

1.73

7.55

3.4

4.0

83.43

86.08

ng/l

0.12

112

703

Lactose intolerance, other/unspecified

542

1.88

7.55

3.4

3.2

79.32

77.09

ng/l

0.11

478

Benign neoplasm: Duodenum

117

687

1.80

7.54

5.2

3.7

114.02

89.02

ng/l

1.71

602

Congenital malformations of the musculoskeletal system, not elsewhere classified

280

2.28

7.53

5.5

4.1

64.69

68.96

ng/l

0.20

260

Other injuries of lower limb, level unspecified

180

2.66

7.53

5.2

4.4

95.77

80.69

ng/l

0.68

167

Chromophobe cell carcinoma of kidney

112

3.25

7.52

5.6

4.0

129.59

86.62

ng/l

1.15

Polyarthritis, unspecified

132

797

1.72

7.49

4.2

3.8

89.17

88.60

ng/l

0.02

120

691

Lung cancer and mesothelioma

647

4417

1.27

7.48

3.3

3.4

85.96

91.20

ng/l

0.83

553

3724

Melanoma in situ

185

1217

1.59

7.48

3.8

3.6

92.47

92.41

ng/l

0.00

155

1044

Encephalopathy

199

2.56

7.48

5.0

3.9

115.14

92.90

ng/l

0.49

172

Polycystic ovarian syndrome

121

709

1.74

7.48

3.2

2.7

100.91

61.80

ng/l

0.74

105

637

Malignant neoplasm of bladder

237

1630

1.49

7.47

3.9

102.87

105.42

ng/l

0.12

198

1365

Carrier of infectious disease

487

1.94

7.46

5.9

3.9

94.86

79.37

ng/l

1.00

435

Hemiplegia

182

1188

1.58

7.45

3.5

4.1

84.65

89.60

ng/l

0.35

151

1042

Acute generalized exanthematous pustulosis

173

1119

1.61

7.45

5.2

3.8

106.13

85.00

ng/l

1.50

148

983

516

1.91

7.45

3.5

3.9

105.80

81.38

ng/l

0.65

471

Volvulus

109

627

1.82

7.43

4.5

3.7

99.62

91.46

ng/l

0.34

542

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

332

2432

1.40

7.42

3.7

3.9

85.57

90.90

ng/l

0.54

279

2091

Focal epilepsy

738

5990

1.25

7.40

4.0

4.2

81.47

90.00

ng/l

1.96

633

5221

Congenital deformities of feet

488

1.93

7.40

4.9

4.5

75.38

72.73

ng/l

0.08

446

Other disorders of thyroid

324

2.19

7.39

2.5

3.2

68.71

79.67

ng/l

0.69

288

Malignant melanoma of skin, including Hilmo

506

3936

1.31

7.38

4.4

3.8

105.66

95.80

ng/l

1.05

438

3322

Combined immunodeficiencies

232

2.43

7.38

4.7

3.4

96.05

79.94

ng/l

0.64

208

Other other unspecified disorders of the circulatory system

151

950

1.66

7.37

4.6

3.9

116.84

87.34

ng/l

1.81

133

827

Generalized skin eruption due to drugs and medicaments

154

973

1.65

7.36

5.5

3.9

111.94

83.76

ng/l

2.03

132

861

Other/unspecified disorders of vestibular function

167

1077

1.62

7.34

3.7

3.6

85.90

90.12

ng/l

0.23

147

922

Aneurysms, operations, SAH

598

4754

1.28

7.32

5.0

3.5

98.42

89.90

ng/l

1.24

523

4041

All dysplastic lesions of the vulva

165

1061

1.62

7.31

5.2

3.1

102.26

75.14

ng/l

2.15

147

919

Collapsed vertebra, not elsewhere classified

190

2.62

7.31

4.0

3.1

79.43

81.69

ng/l

0.07

158

Malignant neoplasm of small intestine

523

1.90

7.26

4.7

3.6

114.83

91.04

ng/l

1.43

459

Benign neoplasm of eye and adnexa

380

2854

1.36

7.23

3.8

92.58

90.38

ng/l

0.17

319

2451

Asthma and opportunity respiratory infection

196

1315

1.55

7.23

3.9

3.5

85.03

91.90

ng/l

0.61

172

1119

Alcohol withdrawal state with delirium

213

1446

1.51

7.22

3.7

4.6

85.31

102.63

ng/l

2.18

188

1294

Excessive vomiting in pregnancy

242

1682

1.47

7.21

3.4

3.2

70.88

73.34

ng/l

0.24

207

1489

Behavioural disorders, excluding more controls

256

2.26

7.20

4.5

4.7

102.40

68.74

ng/l

1.01

249

Systemic sclerosis (FG)

538

1.88

7.19

3.6

3.7

77.03

86.13

ng/l

0.65

464

Implicit parasitic Sepsis

3.55

7.18

5.0

3.1

100.89

82.52

ng/l

0.51

Male infertility

108

621

1.78

7.17

7.3

5.6

144.60

101.90

ng/l

1.50

586

Spinal instabilities

101

574

1.83

7.15

3.6

4.0

70.23

83.96

ng/l

1.21

509

Superficial injury of shoulder and upper arm

374

2802

1.36

7.14

3.8

4.1

88.82

91.06

ng/l

0.15

327

2424

Unspecified event, undetermined intent

516

1.88

7.14

4.8

4.6

101.60

83.06

ng/l

0.96

468

Embedded teeth, including avohilmo

231

1592

1.48

7.13

6.5

4.2

91.96

74.60

ng/l

1.86

220

1446

Endocrine disorders, other/unspecified

368

2.06

7.10

2.7

3.0

94.86

73.28

ng/l

0.50

326

Congenital malformations of the respiratory system

498

1.92

7.10

6.6

5.2

74.24

70.96

ng/l

0.18

458

Benign neoplasm: Skin of trunk

159

1021

1.62

7.09

5.6

3.7

95.54

83.94

ng/l

0.80

137

898

Premature rupture of membranes

336

3249

0.73

7.08

2.8

3.6

59.62

76.63

ng/l

7.00

297

2931

Multifocal fibrosclerosis

151

2.82

7.05

4.1

3.2

78.02

87.48

ng/l

0.45

130

Adalimumab

286

2057

1.42

7.05

3.2

4.1

80.75

79.74

ng/l

0.03

266

1853

Pilonidal cyst

218

1490

1.49

7.04

5.7

4.4

103.41

83.40

ng/l

1.59

199

1367

Congenital malformations of the respiratory system

464

1.96

7.03

6.9

5.3

75.80

69.92

ng/l

0.33

431

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

243

1710

1.47

7.03

3.0

3.4

79.61

83.48

ng/l

0.30

189

1454

Other and unspecified glaucoma

287

2076

1.43

7.01

4.1

3.5

100.71

94.82

ng/l

0.43

235

1738

Tumor necrosis factor alpha inhibitors

455

3510

1.32

7.01

3.4

4.1

77.10

81.91

ng/l

0.27

420

3133

Other neurotic disorders

171

1119

1.58

6.97

2.9

3.7

90.84

85.51

ng/l

0.31

141

968

Open bite

161

1037

1.59

6.96

7.5

5.1

64.85

66.43

ng/l

0.14

155

964

Anxious personality disorder

308

2.14

6.96

3.4

4.0

83.88

73.73

ng/l

0.42

280

Other specified/unspecified inflammatory spondylopathies

137

850

1.65

6.92

3.1

4.0

84.16

81.56

ng/l

0.14

117

760

Benign lipomatous neoplasm

1054

8918

1.20

6.92

3.7

3.8

86.63

91.41

ng/l

0.95

894

7688

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

238

2.34

6.92

4.5

3.3

85.74

74.44

ng/l

0.37

216

Other and unspecified abdominal hernia

164

1069

1.60

6.89

5.0

3.5

114.30

88.80

ng/l

1.24

141

928

Schizophrenia

473

3676

1.31

6.89

3.2

4.2

90.25

92.65

ng/l

0.15

389

3266

Benign neoplasm of major salivary glands

348

2599

1.37

6.88

3.8

3.9

91.31

92.62

ng/l

0.10

295

2236

Congenital deformities of feet

125

761

1.70

6.87

4.4

75.59

74.19

ng/l

0.05

112

697

Postzoster neuralgia

375

2.05

6.86

4.3

3.2

97.96

87.25

ng/l

0.60

321

Contusion of ankle

121

731

1.71

6.83

5.2

4.2

85.84

77.52

ng/l

0.53

110

659

Prolonged pregnancy

196

2512

0.67

6.81

2.1

3.7

65.10

77.52

ng/l

3.01

184

2285

Crohn disease (strict definition, all UC cases excluded)

159

1028

1.59

6.80

3.7

4.2

80.28

83.16

ng/l

0.16

144

930

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

153

2.72

6.78

8.9

4.2

140.84

80.91

ng/l

1.61

139

Other specified and unspecified disorders of conjunctiva

202

2.46

6.78

6.0

3.8

97.37

75.61

ng/l

0.50

179

Event of undetermined intent

195

1318

1.52

6.76

4.0

4.5

98.52

82.66

ng/l

1.15

171

1177

Other superficial mycoses

410

1.97

6.75

6.9

4.1

117.75

81.75

ng/l

1.06

371

Anorexia

314

2.13

6.73

3.6

4.0

79.50

75.74

ng/l

0.12

280

Other congenital malformations of intestine

255

2.28

6.71

5.5

4.4

66.92

68.99

ng/l

0.09

231

Benign neoplasm: Oesophagus

255

2.28

6.70

5.2

3.6

116.19

82.12

ng/l

1.37

226

Caught, crushed, jammed or pinched in or between objects

157

1016

1.59

6.69

4.4

4.6

91.23

83.19

ng/l

0.48

139

923

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

841

6912

1.22

6.67

3.0

3.9

97.18

95.54

ng/l

0.15

736

5877

Other disorders of breast

463

3613

1.31

6.66

3.5

3.2

74.58

79.90

ng/l

0.92

405

3084

Later onset COPD

1113

7550

1.19

6.66

3.9

3.8

111.48

99.53

ng/l

2.39

913

6284

Supervision of normal pregnancy

369

2792

0.75

6.65

2.5

3.7

62.68

76.81

ng/l

5.64

343

2524

Myeloproliferative diseases

310

2290

1.39

6.64

3.5

3.8

87.55

93.60

ng/l

0.63

267

1950

Chronic viral hepatitis

142

898

1.62

6.64

5.1

4.4

106.59

84.71

ng/l

1.54

128

820

Mild mental retardation

514

1.85

6.62

7.9

5.4

80.52

72.18

ng/l

0.40

480

Trigeminal neuralgia

209

1442

1.49

6.61

3.4

81.33

83.74

ng/l

0.17

169

1236

Oligomenorrhoea

113

677

1.72

6.60

3.1

3.3

77.12

73.61

ng/l

0.19

101

597

Visual field defects

301

2216

1.39

6.56

4.4

4.0

108.47

91.01

ng/l

1.55

258

1901

Pulmonary eosinophilia, not elsewhere classified

264

2.24

6.56

3.5

3.3

89.53

79.37

ng/l

0.40

231

Unspecified visual impairment (binocular)

353

2.05

6.52

4.0

4.3

124.55

76.63

ng/l

2.13

314

Vulvovaginal ulceration/inflammation in other diseases

176

1174

1.54

6.51

4.2

3.4

71.31

72.26

ng/l

0.07

152

1050

Vascular syndromes of brain in cerebrovascular disorders

177

1189

1.54

6.49

4.5

3.8

107.74

100.02

ng/l

0.42

163

1023

Disorders of speech understanding and production

154

982

1.59

6.49

7.3

5.5

67.57

71.12

ng/l

0.25

143

896

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1494

11326

1.16

6.48

4.4

3.2

88.70

76.20

ng/l

5.18

1323

9884

Examination and encounter for administrative purposes

142

905

1.61

6.47

3.8

3.9

95.58

98.10

ng/l

0.09

127

769

Other disorders of carbohydrate metabolism

3.46

6.45

7.4

4.1

91.47

76.51

ng/l

0.34

Secondary uncertain malignant neoplasm

443

3452

1.31

6.43

3.1

3.8

84.06

96.45

ng/l

1.65

374

2902

Meralgia paraesthetica

122

754

1.68

6.41

2.7

3.7

80.30

87.69

ng/l

0.47

102

663

Salpingitis and oophoritis

649

5296

1.25

6.36

3.6

3.3

82.73

79.84

ng/l

0.32

560

4573

Other complications of labour and delivery, not elsewhere classified

116

1713

0.61

6.35

2.8

3.6

52.14

72.29

ng/l

5.76

104

1552

Atopic conjunctivitis

149

967

1.59

6.32

4.3

4.2

77.25

76.05

ng/l

0.08

132

870

Benign neoplasm: Rectosigmoid junction

163

1084

1.56

6.31

4.1

3.7

91.84

94.02

ng/l

0.12

140

937

Childhood allergy (age < 16)

310

1884

1.37

6.30

5.4

5.6

63.48

67.54

ng/l

0.41

285

1762

Central retinal artery occlusion

547

1.81

6.29

4.7

4.0

112.14

99.62

ng/l

0.55

474

Melanocytic naevi of other and unspecified parts of face

202

1399

1.48

6.28

4.7

3.6

84.31

84.52

ng/l

0.01

186

1220

Secondary polycythaemia

464

1.87

6.28

4.5

4.2

97.60

91.61

ng/l

0.26

413

Ectropion of eyelid

162

1076

1.56

6.27

4.6

3.7

119.20

104.42

ng/l

0.86

145

896

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

940

7944

1.20

6.25

3.7

4.2

86.89

94.25

ng/l

1.36

823

6895

Inguinal hernia

2011

11949

1.13

6.24

4.7

4.2

97.85

97.88

ng/l

0.00

1760

10333

Adult respiratory distress syndrome

276

2.16

6.22

7.6

3.9

136.71

86.29

ng/l

2.24

246

Crowding of teeth, including avohilmo

245

1444

1.43

6.20

9.3

4.9

72.14

63.77

ng/l

0.85

230

1346

Sacrococcygeal disorders, not elsewhere classified

103

614

1.74

6.19

2.7

3.6

69.59

80.26

ng/l

1.25

541

Embolic stroke with flimmer

101

600

1.75

6.19

4.3

3.3

118.50

88.52

ng/l

2.36

500

Single delivery by caesarean section

331

2524

0.74

6.18

3.4

4.3

74.81

79.22

ng/l

0.33

295

2288

Delivery, wide proxy

1069

6647

0.84

6.16

2.9

3.4

77.96

83.74

ng/l

1.68

914

5615

Appendectomy

2227

19101

1.12

6.16

4.0

3.9

86.98

88.46

ng/l

0.24

1951

16704

Other/unspecified soft tissue disorders related to use, overuse and pressure

100

593

1.75

6.15

2.8

3.7

83.98

83.76

ng/l

0.01

528

Chorioretinal inflammation

105

632

1.73

6.14

5.0

3.7

84.44

79.93

ng/l

0.27

563

Other nonscarring hair loss

192

2.41

6.11

4.8

3.8

90.85

75.21

ng/l

0.48

169

Multiple delivery

148

2221

0.65

6.10

3.2

4.1

75.04

83.67

ng/l

0.70

129

1967

Other and unspecified iridocyclitis

157

1041

1.56

6.09

4.6

3.8

87.60

84.45

ng/l

0.18

144

923

Other fall from one level to another

697

5744

1.23

6.09

4.2

4.5

83.78

90.46

ng/l

1.24

609

5072

Benign neoplasm of mouth and pharynx

379

2919

1.33

6.08

4.0

3.9

88.45

90.96

ng/l

0.20

324

2508

Retinal breaks without detachment

552

4449

1.26

6.08

4.1

3.6

84.17

89.76

ng/l

0.94

474

3833

Pustular psoriasis

172

1164

1.53

6.08

3.4

3.7

73.85

82.54

ng/l

1.18

147

1015

Other melanin hyperpigmentation

576

1.78

6.08

4.2

3.1

97.16

81.37

ng/l

0.90

499

Intermittent heterotropia

182

1241

1.50

6.06

5.6

5.0

77.08

72.95

ng/l

0.23

164

1131

Thyroiditis, unspecified

306

2.07

6.04

3.0

3.3

100.49

74.98

ng/l

0.96

270

Open wound of wrist and hand

1370

11673

1.16

6.04

4.1

4.4

92.71

94.65

ng/l

0.28

1192

10312

Ulcerative colitis (strict definition, all Crohn cases excluded)

421

3284

1.30

6.03

3.8

4.2

85.63

89.73

ng/l

0.35

376

2919

Other and unspecified paralytic syndromes

300

2.09

6.02

3.5

3.9

77.18

81.92

ng/l

0.25

268

Anogenital herpesviral [herpes simplex] infection

161

1072

1.53

6.01

4.4

3.6

72.46

73.66

ng/l

0.10

141

969

Other and unspecified types of non-Hodgkin lymphoma, hilmo

160

1071

1.55

6.01

3.6

3.8

81.14

92.69

ng/l

0.87

132

925

Dissection of aorta

114

705

1.68

6.00

4.8

3.8

130.20

96.88

ng/l

1.36

100

609

Other disorders of binocular movement

427

1.88

5.97

4.2

4.0

85.92

70.23

ng/l

0.79

389

Juvenile Open Angle Glaucoma

103

2.98

5.96

7.4

3.4

147.00

79.10

ng/l

0.92

Dental pulpitis, including avohilmo

3135

18557

1.10

5.96

3.8

4.1

87.98

88.67

ng/l

0.11

2748

16362

Dislocation, sprain and strain of joint and ligaments of hip

146

961

1.58

5.94

4.1

3.6

95.80

90.65

ng/l

0.25

133

813

Malignant neoplasm of anus and anal canal, including Hilmo

289

2.11

5.92

3.2

3.4

85.55

87.27

ng/l

0.07

254

Convergent concomitant strabismus

172

1167

1.51

5.91

4.4

4.1

73.39

76.57

ng/l

0.22

160

1056

Mixed conductive and sensorineural hearing loss

447

3532

1.29

5.90

4.0

3.8

99.56

92.93

ng/l

0.60

373

3013

Burns and corrosions of external body surface, specified by site

322

2432

1.35

5.89

4.0

4.7

86.95

89.81

ng/l

0.21

276

2182

Complications of labour and delivery

1814

11356

0.88

5.87

3.1

3.4

75.34

78.87

ng/l

1.20

1578

9829

Pediculosis, acariasis and other infestations

466

3693

1.28

5.87

4.0

4.3

96.73

84.22

ng/l

1.34

409

3285

Autism spe, excluding more controls

272

2.08

5.87

3.1

5.4

53.40

63.77

ng/l

1.09

262

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

203

2.35

5.86

4.0

3.7

76.48

83.54

ng/l

0.25

179

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

213

1506

1.44

5.84

3.7

84.35

82.93

ng/l

0.08

190

1334

Other and unspecified corneal deformities and disorders

119

750

1.65

5.83

4.1

3.8

84.98

84.77

ng/l

0.01

102

664

Other surgical follow-up care

109

671

1.68

5.81

5.8

3.0

95.93

74.59

ng/l

1.63

100

587

Postpartum haemorrhage

453

4806

0.79

5.81

2.9

3.6

63.32

76.61

ng/l

5.65

404

4316

Disorders of iron metabolism

255

2.14

5.80

5.3

3.7

90.93

83.62

ng/l

0.22

228

Mature T/NK-cell lymphomas, hilmo

305

2.06

5.80

3.6

4.1

100.04

85.97

ng/l

0.38

276

Pemphigoid

117

739

1.66

5.78

3.7

3.8

120.05

93.49

ng/l

1.33

100

631

Other specified/unspecified disorders of bone/cartilage

551

1.75

5.77

4.6

3.7

77.95

83.17

ng/l

0.27

492

Portal vein thrombosis

340

1.99

5.76

5.4

4.0

87.46

83.27

ng/l

0.12

303

Other congenital malformations of limb(s)

134

2.64

5.76

4.9

5.5

81.79

63.80

ng/l

0.28

125

Pustulosis palmaris et plantaris

156

1048

1.54

5.75

3.5

72.79

80.30

ng/l

0.91

134

915

Congenital malformations of trachea and bronchus

232

2.24

5.72

6.0

4.5

70.53

71.08

ng/l

0.02

207

Perineal laceration during delivery

224

2595

0.71

5.71

2.4

3.6

55.76

73.93

ng/l

6.31

204

2345

Lesion of radial nerve

128

824

1.61

5.71

3.9

3.7

102.02

88.05

ng/l

0.58

101

722

Pyoderma

413

1.88

5.70

4.8

4.0

84.62

79.66

ng/l

0.18

366

Other lesions of median nerve

116

733

1.65

5.69

4.2

3.2

104.24

89.11

ng/l

0.81

614

Hereditary hypogammaglobulinemia

3.42

5.69

4.2

5.5

75.51

82.65

ng/l

0.23

Unspecified jaundice

168

1146

1.51

5.68

4.5

3.8

92.02

90.93

ng/l

0.05

147

978

Injury of urinary and pelvic organs

406

1.88

5.65

5.3

4.2

107.98

85.05

ng/l

0.90

366

Congenital malformations of genital organs

273

2013

1.37

5.64

4.8

4.2

76.14

69.23

ng/l

0.57

246

1830

Cluster headache, strict

103

629

1.68

5.64

3.5

4.0

71.48

80.56

ng/l

0.70

577

Other diseases of peritoneum

169

1161

1.50

5.59

4.7

3.4

93.58

84.75

ng/l

0.64

145

1003

Idiopathic thrombocytopenic purpura

110

689

1.66

5.55

4.8

4.3

91.95

86.11

ng/l

0.23

614

Intracranial and intraspinal abscess and granuloma

241

2.17

5.52

5.4

3.9

97.90

80.92

ng/l

0.45

221

Pedestrian injured in transport accident

228

1654

1.41

5.50

3.8

90.34

87.74

ng/l

0.15

194

1426

Anogenital herpesviral [herpes simplex] infection

258

1903

1.37

5.50

3.7

3.5

70.04

75.50

ng/l

0.85

225

1707

Human immunodeficiency virus [HIV] disease

316

1.98

5.49

2.0

4.3

73.15

87.61

ng/l

1.14

291

Injury of eye and orbit

405

3184

1.29

5.49

4.7

4.5

94.08

92.17

ng/l

0.13

361

2846

Chronic conjunctivitis

113

715

1.64

5.48

3.8

4.2

74.33

78.32

ng/l

0.30

105

635

Postmenopausal atrophic vaginitis

1051

4978

1.18

5.47

3.0

3.2

75.04

82.94

ng/l

3.52

897

4274

Other specified/unspecified hearing loss

302

2291

1.35

5.47

4.6

4.0

110.60

93.67

ng/l

1.34

268

1965

Benign neoplasm: Skin, unspecified

143

954

1.55

5.47

5.5

3.7

97.90

86.67

ng/l

0.79

127

829

Congenital malformations of eye, ear, face and neck

192

1352

1.45

5.46

5.4

4.7

87.13

76.17

ng/l

0.89

173

1230

Corneal degeneration

391

1.90

5.46

4.7

3.2

90.83

78.47

ng/l

0.73

340

Vascular dementia (mixed)

457

1.82

5.45

2.9

3.9

103.38

103.25

ng/l

0.00

390

Prepatellar bursitis

132

864

1.57

5.43

5.1

4.8

143.12

98.79

ng/l

0.92

119

761

Scabies

372

2897

1.30

5.43

3.8

4.4

95.58

81.53

ng/l

1.30

327

2606

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1056

7188

0.86

5.41

2.8

3.6

69.94

78.24

ng/l

2.94

948

6364

Malignant neoplasm of renal pelvis

115

2.77

5.40

4.1

3.5

95.32

87.72

ng/l

0.17

Benign neoplasm: Choroid

232

1698

1.41

5.40

3.5

3.7

92.03

90.41

ng/l

0.08

193

1464

Neuroendocrine tumor and carcinoma of small intestine

306

2.02

5.40

4.6

3.6

124.13

85.16

ng/l

1.76

267

Striae atrophicae

209

2.23

5.40

3.6

3.7

80.34

69.44

ng/l

0.52

189

Benign neoplasm: salivary glands, exclude unknown (D119)

304

2314

1.34

5.40

3.7

3.9

89.64

92.69

ng/l

0.24

259

1988

Other erythematous conditions

134

886

1.57

5.38

4.4

3.7

84.15

82.11

ng/l

0.11

118

777

Other disorders of male genital organs

100

614

1.67

5.37

5.9

5.6

118.97

96.73

ng/l

1.03

553

Third [oculomotor] nerve palsy

437

1.83

5.37

6.2

4.1

149.38

87.90

ng/l

1.27

391

Lymphoid leukaemia

203

1454

1.44

5.36

4.0

4.4

89.15

92.57

ng/l

0.22

177

1263

Dronedarone medication

105

657

1.66

5.36

2.9

96.40

79.57

ng/l

1.36

565

Campylobacter enteritis

579

1.70

5.35

6.8

3.9

124.09

80.61

ng/l

2.22

517

Migraine, single triptan purchase ok & required. ICD-code if available is included

2632

16225

1.10

5.32

3.2

4.1

73.93

86.94

ng/l

13.67

2334

14230

Triptan medication for migraine, single purchase ok

2632

16225

1.10

5.32

3.2

4.1

73.93

86.94

ng/l

13.67

2334

14230

Viral infections of the central nervous system

246

1817

1.38

5.31

3.6

3.8

81.12

83.40

ng/l

0.16

212

1587

Injuries involving multiple body regions

123

798

1.59

5.31

4.2

3.9

108.47

84.61

ng/l

0.93

106

707

Burns and corrosions of multiple and unspecified body regions

444

1.80

5.30

5.1

4.9

98.09

85.10

ng/l

0.47

406

Focal epilepsy, mode (most common among epilepsy diagnosis)

625

5178

1.22

5.28

3.7

4.2

80.67

90.41

ng/l

2.35

533

4504

Viral infections of the central nervous system

230

1683

1.40

5.27

3.7

3.9

83.26

83.79

ng/l

0.03

197

1473

Injury of other and unspecified intrathoracic organs

205

1473

1.42

5.26

4.0

4.2

88.89

96.44

ng/l

0.56

178

1306

Disorder of carbohydrate metabolism, other/unspecified

3.80

5.25

5.2

4.3

70.60

84.27

ng/l

0.32

Vertical strabismus

119

770

1.60

5.25

3.8

74.07

82.74

ng/l

0.60

688

Adenocarcinoma of pancreas

674

0.43

5.24

3.4

124.42

92.46

ng/l

0.84

583

Disorder of the sleep-wake schedule

336

1.93

5.23

4.0

4.8

82.96

71.94

ng/l

0.38

311

Other and unspecified injuries of abdomen, lower back and pelvis

287

2.01

5.22

4.4

3.7

87.72

79.83

ng/l

0.19

261

Other secondary coxarthrosis

128

844

1.57

5.21

4.2

3.6

92.28

87.69

ng/l

0.20

110

739

Benign neoplasm: Parotid gland

274

2067

1.36

5.20

3.6

4.0

88.28

93.03

ng/l

0.40

232

1778

Congenital deformities of hip

402

1.84

5.20

5.5

5.6

59.48

66.05

ng/l

0.45

377

Pediculosis, acariasis and other infestations

171

1192

1.47

5.17

4.8

4.5

105.39

85.64

ng/l

1.05

155

1071

Sequelae of infectious and parasitic diseases

235

1731

1.38

5.17

4.3

3.8

107.19

90.92

ng/l

0.95

187

1508

Other and specified injuries of hip and thigh

532

1.73

5.16

5.6

3.6

105.20

88.22

ng/l

0.53

455

Autoimmune hepatitis

161

2.39

5.14

2.2

2.8

74.91

70.72

ng/l

0.12

141

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

616

1.66

5.13

4.2

4.0

88.01

81.36

ng/l

0.24

557

Septal defects

220

1573

1.40

5.13

5.6

5.7

73.08

72.47

ng/l

0.05

191

1447

Postprocedural disorders of nervous system

198

1418

1.42

5.13

2.6

3.7

60.11

75.47

ng/l

5.51

178

1275

Muscle strain

101

632

1.65

5.09

4.5

4.2

91.03

87.40

ng/l

0.12

564

Haemoglobinuria due to haemolysis from other external causes

22.13

5.07

13.6

3.4

149.14

62.40

ng/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

840

6836

1.19

5.07

3.0

3.1

84.44

81.37

ng/l

0.46

718

5698

Other peripheral vertigo

334

2600

1.31

5.06

2.6

3.7

75.62

90.12

ng/l

3.65

281

2211

Focal epilepsy, strict definition

661

5530

1.21

5.06

4.0

4.2

81.66

90.45

ng/l

1.93

569

4804

Cluster headache, wide

110

703

1.61

5.05

3.4

4.0

70.17

82.31

ng/l

1.14

637

Other superficial mycoses

284

2157

1.34

5.05

4.0

89.41

81.66

ng/l

0.49

241

1926

Long labour

450

4773

0.80

5.05

2.7

3.6

64.68

76.53

ng/l

4.68

395

4271

Sexual dysfunction

241

2.08

5.05

5.8

4.5

107.73

86.41

ng/l

0.68

223

Hypertrophy of breast

568

4690

1.23

5.02

2.8

3.4

70.90

78.14

ng/l

1.92

488

4083

Human immunodeficiency virus [HIV] disease resulting in other conditions

277

1.99

4.99

2.0

4.4

76.81

88.70

ng/l

0.76

256

Benign neoplasm: Anus and anal canal

110

710

1.61

4.97

3.6

3.8

88.79

87.72

ng/l

0.04

612

Etanercept

200

1446

1.41

4.96

3.5

4.1

88.11

79.73

ng/l

0.20

184

1290

Disturbances of smell and taste

146

1001

1.50

4.91

2.8

3.6

74.67

82.85

ng/l

0.87

126

872

Asthma mixed form (mode), excluding more controls

147

1005

1.49

4.91

3.6

3.1

92.24

76.34

ng/l

1.13

124

869

Hypertrichosis

343

1.87

4.88

4.6

3.7

93.37

71.48

ng/l

0.88

312

Pollen allergy

499

4020

1.24

4.88

3.7

4.5

67.91

75.14

ng/l

1.56

444

3654

Infection due to other mycobacteria

360

1.87

4.88

4.9

2.8

77.70

75.61

ng/l

0.08

313

Hodgkin lymphoma, hilmo

578

1.66

4.87

3.8

4.2

90.51

84.04

ng/l

0.26

515

Viral encephalitis, not elsewhere classified/unspecified

450

1.76

4.84

4.6

3.9

89.85

82.66

ng/l

0.24

406

Panniculitis, unspecified

240

2.09

4.84

3.1

3.2

82.39

81.07

ng/l

0.03

211

Other salmonella infections

139

946

1.51

4.82

4.0

3.5

92.05

82.48

ng/l

0.35

118

836

Motor neuron disease (with DMD)

375

1.83

4.81

3.9

63.44

92.25

ng/l

2.62

340

Bullous pemphigoid

552

1.69

4.80

4.1

3.9

135.12

92.99

ng/l

1.81

477

Open wound of abdomen, lower back and pelvis

587

1.65

4.80

4.1

4.6

109.54

84.64

ng/l

0.74

536

Systemic sclerosis

606

1.65

4.79

3.6

3.4

77.03

80.76

ng/l

0.22

530

Use of disulfiram, acamprosate or naltrexone

234

1743

1.37

4.79

2.8

4.6

83.64

94.29

ng/l

0.83

200

1581

Protein-energy malnutrition of moderate and mild degree

235

2.12

4.79

3.8

5.3

76.56

75.77

ng/l

0.02

209

Alcohol induced polyneuropathy

186

2.23

4.78

4.0

4.2

95.32

85.02

ng/l

0.35

167

Congenital deformities of hip

354

1.85

4.76

6.0

5.6

60.63

61.61

ng/l

0.05

331

Personal history of allergy to drugs, medicaments and biological substances

213

2.13

4.76

3.1

2.9

82.78

66.83

ng/l

0.84

193

Persons encountering health services in circumstances related to reproduction

1848

11201

1.12

4.75

4.7

4.4

78.17

88.64

ng/l

5.19

1681

9920

593

1.64

4.74

12.7

8.1

51.14

51.82

ng/l

0.08

580

Carcinoid syndrome

194

2.21

4.74

2.7

3.2

104.37

75.77

ng/l

0.94

173

Endometriosis of ovary

542

4371

1.22

4.73

3.6

3.3

77.72

81.03

ng/l

0.48

461

3805

Benign neoplasm of breast

449

3651

1.25

4.72

3.0

3.2

75.81

80.79

ng/l

0.67

384

3066

Alopecia areata

552

1.67

4.72

3.3

3.9

79.20

72.83

ng/l

0.44

492

Atrophic disorders of skin

518

4271

1.23

4.72

3.5

3.2

82.64

79.68

ng/l

0.37

454

3605

Malignant neoplasm of digestive organs

1354

9472

1.14

4.72

3.6

3.9

94.17

95.32

ng/l

0.17

1179

7977

Generalized epilepsy

130

877

1.52

4.71

3.7

4.9

82.68

78.11

ng/l

0.20

108

800

Fracture of neck

204

1496

1.40

4.71

4.7

4.0

113.07

96.75

ng/l

0.75

172

1293

Drug-induced obesity

174

2.26

4.71

4.3

4.4

86.85

79.67

ng/l

0.15

158

Arthropathic psoriasis

353

2791

1.29

4.70

3.6

4.0

79.98

89.74

ng/l

1.51

299

2445

Ménière disease

341

2690

1.29

4.69

3.0

3.6

76.85

90.33

ng/l

2.98

289

2294

Assault by sharp object

255

1.99

4.67

2.6

4.5

116.12

84.15

ng/l

0.69

241

Thyrotropin deficiency

222

2.10

4.67

2.5

3.6

109.94

75.95

ng/l

0.41

206

Nystagmus and other irregular eye movements

314

1.91

4.66

6.5

5.1

96.55

73.43

ng/l

0.99

291

Other abnormal findings of blood chemistry

156

1095

1.46

4.66

3.8

3.9

100.62

90.66

ng/l

0.59

132

960

Severe visual impairment, monocular

223

2.11

4.66

7.7

3.0

119.46

76.33

ng/l

1.59

198

Lethal midline granuloma

11.06

4.66

14.6

2.6

95.56

69.79

ng/l

—

malignant neoplasm of male genital organs

830

4320

1.18

4.65

4.2

4.9

107.81

109.50

ng/l

0.16

713

3770

Traumatic ischaemia of muscle

250

2.02

4.63

5.1

4.1

115.93

80.48

ng/l

0.92

225

Suggestive for eosinophilic asthma

299

2322

1.31

4.62

3.5

4.0

91.27

92.64

ng/l

0.09

256

2009

Rare circulating lymphoid malignancy, including Hilmo

106

690

1.59

4.61

4.1

5.1

91.20

87.23

ng/l

0.16

614

Other salmonella infections

121

810

1.54

4.59

4.2

3.5

93.75

82.49

ng/l

0.37

100

713

Disorders of eyelid in diseases classified elsewhere

118

787

1.55

4.59

4.7

3.5

91.32

82.03

ng/l

0.49

686

Focal brain injury

176

1261

1.42

4.58

4.7

4.0

112.37

97.90

ng/l

0.71

149

1096

Biomechanical lesions, not elsewhere classified

175

1259

1.43

4.57

4.0

3.7

86.37

90.41

ng/l

0.29

157

1091

Allergic colitis

448

1.73

4.56

7.6

7.0

58.09

57.33

ng/l

0.05

429

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

214

1589

1.38

4.56

3.2

3.8

84.45

97.39

ng/l

1.97

193

1327

Brain meningioma, including Hilmo

188

1370

1.41

4.56

3.5

3.4

93.34

86.77

ng/l

0.48

158

1154

Exposure to unspecified smoke, fire and flames

183

2.20

4.55

2.6

3.9

70.00

81.56

ng/l

0.70

166

Chronic suppurative otitis media

217

1614

1.37

4.55

4.3

4.1

101.70

87.34

ng/l

0.61

190

1404

Other noninflammatory disorders of vagina

264

2021

1.33

4.54

4.0

3.2

93.66

80.93

ng/l

1.15

221

1745

Nontraumatic intracranial haemmorrhage

714

6078

1.19

4.54

4.7

3.6

107.75

93.99

ng/l

2.76

601

5114

Other benign neoplasms of connective and other soft tissue

326

2566

1.29

4.54

3.9

91.82

88.91

ng/l

0.17

279

2224

Other specified/unspecified spondylopathies

599

1.63

4.51

4.4

3.8

111.43

93.75

ng/l

0.78

511

Ventricular septal defect, a heart condition

535

1.67

4.50

5.8

7.1

73.18

58.80

ng/l

0.95

507

Spondylopathies in diseases classified elsewhere

275

1.97

4.50

3.2

3.8

118.11

86.80

ng/l

0.97

239

Malignant neoplasm of head and neck

253

1928

1.34

4.49

3.1

4.0

79.30

99.98

ng/l

3.28

213

1638

Pleural plaque

319

2509

1.30

4.49

3.8

4.0

96.97

105.76

ng/l

0.90

261

2144

LSIL lesion of the vulva

105

687

1.58

4.49

5.3

3.1

103.63

73.86

ng/l

1.51

613

Macular cyst

118

794

1.55

4.48

5.5

3.8

113.17

91.68

ng/l

1.16

105

689

Superficial injuries involving multiple body regions

536

1.66

4.48

4.3

3.9

90.59

82.69

ng/l

0.29

483

Recurrent dislocation and subluxation of joint

173

1242

1.42

4.45

3.7

3.8

84.59

82.27

ng/l

0.11

156

1111

Labour and delivery complicated by fetal stress [distress]

368

3017

0.79

4.45

3.0

3.6

63.53

74.34

ng/l

3.58

331

2753

Toxic effect of alcohol

392

1.77

4.44

5.3

4.4

129.42

86.46

ng/l

0.92

351

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

479

1.71

4.41

4.1

3.7

117.27

85.70

ng/l

1.49

412

Other and unspecified intracranial injuries

641

1.59

4.40

3.2

4.2

75.35

94.49

ng/l

1.78

569

Other lack of coordination

395

1.78

4.39

3.1

4.1

73.39

80.13

ng/l

0.31

352

Pyogenic granuloma

387

1.78

4.38

4.6

4.0

85.80

78.12

ng/l

0.31

346

Carcinoma in situ of other and unspecified digestive organs

127

871

1.51

4.37

4.6

3.7

101.58

92.35

ng/l

0.50

116

756

Maternal care for other conditions predominantly related to pregnancy

510

4140

1.22

4.36

3.4

3.5

75.58

74.22

ng/l

0.14

465

3731

Seropositive rheumatoid arthritis, strict definition

523

4353

1.22

4.36

2.9

3.6

75.78

87.54

ng/l

3.20

458

3721

Other and unspecified mononeuropathies of lower limb

102

668

1.58

4.36

3.2

3.4

73.15

84.89

ng/l

1.27

580

Hepatocellular carcinoma, including Hilmo

613

1.60

4.31

3.5

3.7

89.94

95.45

ng/l

0.30

518

Arthropod-borne viral fevers and viral haemorrhagic fevers

580

4874

1.20

4.30

4.2

95.02

90.83

ng/l

0.42

543

4213

Gluteal tendinitis

129

888

1.49

4.29

3.3

3.6

77.16

82.93

ng/l

0.40

109

769

Haemorrhagic disorder due to circulating anticoagulants

331

1.85

4.29

4.6

4.0

120.81

93.58

ng/l

1.34

287

Car occupant injured in noncollision transport accident

104

684

1.56

4.29

5.5

4.1

113.21

84.60

ng/l

1.30

617

Systemic sclerosis, icd10

616

1.61

4.28

3.6

3.4

77.25

79.61

ng/l

0.13

542

Congenital malformations of great arteries

542

1.64

4.28

7.3

7.6

65.55

58.34

ng/l

0.59

520

Brain meningioma

181

1326

1.40

4.28

3.3

3.4

86.78

86.35

ng/l

0.03

152

1119

535

1.64

4.28

13.4

8.3

50.71

51.39

ng/l

0.08

523

306

1.85

4.27

4.3

3.3

114.13

68.45

ng/l

1.28

277

Orthopaedic devices associated with adverse incidents

500

1.69

4.27

4.1

3.6

67.49

84.99

ng/l

1.94

436

Intracerebral haemorrhage

450

3699

1.23

4.26

4.6

3.6

113.84

96.06

ng/l

2.57

367

3097

Other conjunctival vascular disorders and cysts

585

1.62

4.25

4.5

3.5

93.59

82.32

ng/l

0.51

517

609

1.61

4.25

3.4

4.1

94.04

94.78

ng/l

0.03

527

Scabies

126

864

1.49

4.24

4.3

4.5

102.17

80.04

ng/l

0.94

117

784

Ulcerative ileocolitis

116

783

1.52

4.23

4.6

4.0

109.63

82.89

ng/l

1.20

107

709

Keratoconus

459

1.69

4.21

4.8

4.2

102.90

81.86

ng/l

1.08

413

Crushed, pushed or stepped on by crowd or human stampede

193

1427

1.37

4.20

4.4

4.8

79.02

80.38

ng/l

0.08

174

1294

UC patients in KELA-register (code 208), prior to 1994

145

1026

1.45

4.19

4.4

4.0

91.36

88.50

ng/l

0.13

136

910

Calcific tendinitis of shoulder

178

1302

1.40

4.19

2.9

3.8

76.76

85.98

ng/l

0.80

160

1137

Malignant neoplasm of breast, HER-negative

747

6315

1.18

4.17

3.0

3.1

82.93

82.47

ng/l

0.05

630

5238

Disorders of synovium and tendon in diseases classified elsewhere

446

1.70

4.17

6.7

4.1

112.34

88.72

ng/l

1.01

392

Spirochaetal infections, other/unspecified

294

2316

1.29

4.14

3.5

4.0

70.83

89.95

ng/l

5.25

263

1995

Other facial nerve disorders

652

1.57

4.12

2.9

3.5

79.32

81.66

ng/l

0.12

562

Oral lichen planus and hypothyroidism or thyroxine medication

489

1.68

4.12

3.0

82.63

76.27

ng/l

0.19

428

Benign neoplasm: Skin of lower limb, including hip

101

669

1.56

4.12

5.0

3.6

109.55

80.55

ng/l

1.86

594

Adenocarcinoma and ductal carcinoma of pancreas

835

0.55

4.11

2.9

3.6

110.93

92.11

ng/l

0.62

722

Separation of retinal layers (serosa)

125

863

1.49

4.10

6.8

4.0

131.29

85.23

ng/l

2.36

115

769

Myotonic disorders

144

2.28

4.09

3.8

3.9

64.96

82.98

ng/l

1.21

132

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

132

920

1.47

4.09

2.8

3.8

70.87

83.73

ng/l

1.84

122

813

Malignant neoplasm of colon, including Hilmo

644

5490

1.19

4.05

3.6

3.8

97.62

96.44

ng/l

0.12

574

4586

Unspecified human immunodeficiency virus [HIV] disease

158

2.20

4.02

2.0

5.3

73.52

94.27

ng/l

1.03

152

Disorders of optic nerve, not elsewhere classified

507

1.65

4.00

6.8

3.6

129.70

85.05

ng/l

1.58

445

Acute otitis externa, noninfective

391

1.74

3.99

4.7

3.5

130.48

75.67

ng/l

1.59

356

Hereditary erythropoietic porphyria

8.71

3.98

7.8

1.9

77.00

69.25

ng/l

—

Hirsutism in women

292

1.84

3.97

4.2

3.8

85.77

70.13

ng/l

0.50

268

Tongue abnormality

222

1698

1.34

3.97

4.2

3.7

88.04

87.27

ng/l

0.05

196

1444

Toxic effect of ethanol

104

696

1.53

3.96

4.7

4.5

100.27

85.32

ng/l

0.39

621

Malignant neoplasm of other connective and soft tissue, including Hilmo

140

997

1.44

3.93

3.4

4.0

93.44

91.48

ng/l

0.11

118

857

Malignant neoplasm of bone and articular cartilage of limbs

2.73

3.91

3.7

5.6

88.91

79.83

ng/l

0.17

Acute lymphadenitis

168

1233

1.39

3.89

4.5

4.3

90.29

79.30

ng/l

0.61

147

1110

Malignant neoplasm of prostate, including Hilmo

830

4279

1.16

3.89

4.1

4.9

106.24

110.11

ng/l

0.43

718

3730

Embedded and impacted teeth

601

4206

1.19

3.88

6.8

4.2

89.69

78.07

ng/l

1.99

554

3822

Vascular dementia (undefined)

147

1046

1.42

3.88

2.9

3.5

111.79

109.24

ng/l

0.10

103

855

Other secondary gonarthrosis

182

1357

1.37

3.87

4.0

80.77

93.33

ng/l

1.58

159

1171

Abnormal findings on diagnostic imaging of central nervous system

148

1066

1.42

3.87

3.7

3.9

78.20

83.26

ng/l

0.25

134

936

Scar conditions and fibrosis of skin

129

908

1.46

3.85

4.6

3.6

84.97

78.73

ng/l

0.33

119

804

Impetigo

127

890

1.46

3.85

5.5

4.7

74.04

73.06

ng/l

0.05

111

813

Eosinophilia

357

1.76

3.84

6.1

4.3

113.43

80.54

ng/l

1.84

320

Myeloproliferative diseases (CML excluded)

267

2101

1.30

3.84

3.3

3.7

87.03

94.49

ng/l

0.75

227

1785

Hypothermia

395

1.71

3.83

4.1

3.8

111.25

86.04

ng/l

1.03

350

Dislocation, sprain and strain of joints and ligaments of head

118

817

1.48

3.82

4.2

4.6

74.44

79.28

ng/l

0.26

743

Right hemicolectomy

211

1612

1.34

3.82

5.2

3.7

113.78

97.08

ng/l

1.33

184

1376

Obstructed labour due to malposition and malpresentation of fetus

410

4629

0.82

3.80

2.9

3.6

68.90

76.51

ng/l

1.50

376

4181

Bitten or struck by other mammals

322

2587

1.26

3.80

4.7

3.9

94.12

80.50

ng/l

0.58

281

2281

Acute appendicitis

2339

20165

1.09

3.80

4.1

4.0

89.95

90.39

ng/l

0.06

2077

17670

Sequelae of injuries of neck and trunk

616

1.55

3.79

3.4

3.8

68.60

85.88

ng/l

1.35

557

Other inflammation of vagina/vulva

103

696

1.52

3.78

3.2

3.4

72.52

73.76

ng/l

0.08

621

Problems related to social environment

632

1.55

3.78

3.5

3.6

83.64

81.84

ng/l

0.07

557

Rheumatic fever incl heart disease

109

748

1.50

3.75

5.6

3.6

135.43

91.54

ng/l

1.72

643

Progressive systemic sclerosis

118

2.43

3.75

3.6

3.0

75.68

76.06

ng/l

0.01

105

Dependent personality disorder

460

1.65

3.74

4.1

3.4

112.90

77.55

ng/l

1.65

411

Viral haemorrhagic fevers, not elsewhere classified/unspecified

511

4306

1.20

3.74

4.2

94.51

89.51

ng/l

0.47

478

3735

Residual foreign body in soft tissue

138

988

1.42

3.72

4.1

4.5

97.65

89.05

ng/l

0.43

119

874

Deep bite

329

2326

1.26

3.71

6.6

4.6

69.17

73.22

ng/l

0.63

294

2112

Malignant neoplasm of larynx, including Hilmo

375

1.71

3.70

2.9

3.9

67.50

100.48

ng/l

2.51

318

Benign neoplasm: Long bones of lower limb

660

1.52

3.69

3.3

4.1

69.58

82.73

ng/l

0.91

597

Mental and behavioural disorders due to use of other stimulants, including caffeine

366

1.70

3.68

3.5

5.4

85.34

83.52

ng/l

0.05

342

Enteropathogenic Escherichia coli infection

2.83

3.68

7.0

4.9

106.50

76.97

ng/l

0.38

Unspecific neurodegenerative disorder

1690

10514

1.11

3.68

2.6

3.7

84.81

99.58

ng/l

10.82

1326

8753

Fistulae involving female genital tract

385

1.71

3.67

4.3

3.2

79.22

73.85

ng/l

0.18

339

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

666

3625

1.17

3.66

3.2

3.4

74.16

70.07

ng/l

0.29

603

3313

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

157

2.12

3.66

2.6

3.3

68.36

62.87

ng/l

0.20

148

Diseases of appendix

2537

21193

1.08

3.66

4.1

4.0

90.33

90.44

ng/l

0.02

2255

18529

Mixed disorders of conduct and emotions, excluding more controls

262

1.83

3.65

7.1

4.9

93.62

59.35

ng/l

0.89

247

Malignant neoplasm of prostate

803

4179

1.16

3.65

4.1

4.9

106.82

109.29

ng/l

0.24

690

3638

Other primary thrombocytopenia

2.70

3.65

3.4

4.4

138.50

72.39

ng/l

0.48

Sequelae of other and unspecified infectious and parasitic diseases

149

1085

1.40

3.65

4.9

4.0

109.80

83.21

ng/l

1.19

121

977

Effects of foreign body entering through natural orifice

706

6117

1.16

3.64

3.9

4.6

84.61

94.81

ng/l

2.21

624

5412

Other obstetric conditions, not elsewhere classified

688

3763

1.17

3.64

3.1

3.4

73.87

70.98

ng/l

0.20

623

3436

Other and unspecified mononeuropathies of upper limb

622

1.54

3.63

3.6

4.2

80.91

86.76

ng/l

0.29

551

Benign mammary dysplasia

542

4614

1.19

3.62

3.2

3.1

74.07

81.75

ng/l

2.33

463

3847

L01XE Protein kinase inhibitors

192

1461

1.35

3.61

3.6

3.9

103.92

92.00

ng/l

0.86

171

1267

Antenatal screening

425

2878

0.82

3.61

3.1

3.7

68.53

77.71

ng/l

1.90

392

2600

Malignant melanoma of skin

356

2913

1.24

3.61

4.4

3.7

105.74

95.64

ng/l

0.81

314

2453

Diffuse brain injury

597

1.54

3.60

2.6

3.9

70.78

88.83

ng/l

1.58

534

Asthma mixed form (mode)

147

1070

1.40

3.59

3.6

3.3

92.24

83.42

ng/l

0.49

124

920

Intentional self-harm by sharp object

377

1.68

3.59

3.4

4.4

84.39

75.89

ng/l

0.14

349

Congenital absence, atresia and stenosis of small intestine

4.87

3.59

16.8

3.6

47.00

44.73

ng/l

0.09

Chalazion

345

2814

1.24

3.58

3.4

4.1

81.22

89.69

ng/l

0.85

300

2434

Haemangioma and lymphangioma, any site

297

2386

1.27

3.58

4.0

84.70

84.30

ng/l

0.03

259

2075

Other intracranial haemorrhages

110

765

1.48

3.57

3.5

3.8

109.65

98.72

ng/l

0.52

658

Paranoid personality disorder

341

1.73

3.56

3.4

3.7

80.72

79.35

ng/l

0.05

310

Vasomotor rhinitis (mode)

235

1839

1.30

3.54

3.7

3.8

83.50

86.47

ng/l

0.21

204

1602

Pregnancy with abortive outcome

2470

11921

1.09

3.54

3.2

3.3

78.05

80.30

ng/l

0.67

2126

10188

Malignant neoplasm of stomach, including Hilmo

191

1455

1.34

3.51

3.6

3.7

93.88

96.46

ng/l

0.15

171

1223

Acute nasopharyngitis (common cold)

292

2326

1.26

3.50

5.7

4.6

107.50

92.77

ng/l

1.31

261

2097

Cutaneous lupus erythematosus

605

1.54

3.50

4.9

3.2

84.26

77.23

ng/l

0.40

527

Conduct disorder

334

1.72

3.50

4.5

5.7

102.04

70.37

ng/l

0.93

323

Disorder of external ear, unspecified

108

752

1.48

3.48

4.7

3.8

109.70

84.56

ng/l

1.32

672

Autism

357

1.69

3.48

3.2

5.6

53.55

67.37

ng/l

1.89

337

Chronic thyroiditis

2.69

3.46

2.0

2.2

59.77

70.05

ng/l

0.49

Endometriosis ASRM stages 1,2

520

4424

1.19

3.44

3.2

3.3

70.61

76.27

ng/l

1.55

457

3858

Other and unspecified erythematous conditions

114

805

1.46

3.44

4.4

3.8

83.68

82.02

ng/l

0.08

708

Atrial septal defect

130

932

1.42

3.43

5.8

5.5

77.58

69.00

ng/l

1.10

115

864

Dislocation, sprain and strain of joints and ligaments of knee

1873

15847

1.09

3.43

3.5

4.0

80.42

87.93

ng/l

3.27

1664

13949

Appendicitis, broad definition

2503

21036

1.08

3.41

4.1

4.0

90.61

90.45

ng/l

0.02

2226

18400

Abrasion of teeth

1124

10085

1.12

3.41

3.9

3.8

79.32

87.39

ng/l

2.59

965

8777

Monoplegia

339

1.72

3.40

3.4

3.3

79.36

74.18

ng/l

0.17

302

Other acute skin changes due to ultraviolet radiation

115

814

1.45

3.40

3.7

3.5

94.52

87.11

ng/l

0.37

100

706

Psoriatic arthropathies, ICD10

318

2589

1.25

3.40

3.7

4.0

81.11

88.23

ng/l

0.86

274

2264

Epiphora

586

1.54

3.38

2.9

3.6

99.19

85.27

ng/l

0.67

515

Diabetes mellitus in pregnancy

754

4206

1.15

3.37

4.4

3.5

81.45

72.55

ng/l

1.82

682

3836

Other disorders of Eustachian tube

683

1.49

3.37

3.8

3.5

73.26

80.51

ng/l

0.68

609

Polycythaemia vera

121

867

1.44

3.36

3.4

3.6

89.04

92.71

ng/l

0.19

104

738

Lesion of plantar nerve

217

1697

1.31

3.35

2.7

3.5

77.48

86.40

ng/l

1.05

192

1433

Disorders of globe

619

1.52

3.34

6.5

3.5

119.97

85.38

ng/l

2.22

535

Alzheimer’s disease (Early onset)

1224

0.66

3.34

2.8

3.5

88.52

96.73

ng/l

0.28

1016

6-mercaptopurine

535

1.54

3.33

3.1

4.6

65.14

78.33

ng/l

1.68

490

Contact with sharp glass

682

1.48

3.33

3.7

4.4

89.07

80.01

ng/l

0.34

622

Acute appendicitis, no complications

1745

15932

1.10

3.33

4.0

4.1

87.58

90.17

ng/l

0.39

1557

14029

Presbyopia

192

1476

1.32

3.33

3.2

3.6

86.01

81.87

ng/l

0.17

166

1312

Benign neoplasm of other and unspecified sites

114

810

1.45

3.32

2.6

3.7

83.11

86.18

ng/l

0.13

710

Other maltreatment syndromes

528

1.55

3.32

3.5

4.4

77.80

84.24

ng/l

0.28

483

Hypertension, portal

2.73

3.32

6.5

4.8

143.78

81.27

ng/l

0.89

Contusion of toe(s) without damage to nail

457

1.60

3.32

5.9

4.3

109.86

73.37

ng/l

1.19

420

Dislocation, sprain and strain of joints and ligaments of thorax

105

734

1.47

3.32

4.6

4.1

87.01

86.82

ng/l

0.01

663

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

269

2160

1.27

3.31

4.0

3.8

90.21

86.81

ng/l

0.18

231

1865

Benign neoplasm of middle ear and respiratory system

247

1964

1.28

3.29

3.9

4.0

94.21

93.55

ng/l

0.04

219

1712

Senility

206

1.91

3.29

2.0

3.2

79.41

91.62

ng/l

0.50

163

229

1.87

3.28

4.4

4.1

128.71

86.85

ng/l

0.55

207

Inflammatory disorders of breast

178

1356

1.33

3.28

3.5

3.2

76.32

72.89

ng/l

0.31

160

1194

Other specified/unspecified deforming dorsopathies

365

1.67

3.27

2.9

3.3

76.35

75.71

ng/l

0.03

317

Primary angle-closure glaucoma

168

1275

1.35

3.27

4.7

3.6

95.00

96.40

ng/l

0.07

136

1066

Other and unspecified injuries of shoulder and upper arm

687

1.48

3.26

4.4

4.0

83.53

86.79

ng/l

0.13

603

Hypertensive encephalopathy

2.54

3.26

10.6

2.8

114.83

79.90

ng/l

0.91

Open wound of shoulder and upper arm

373

1.66

3.25

4.6

4.2

103.32

85.14

ng/l

0.55

333

Helminthiases

382

1.66

3.25

5.4

3.9

98.09

75.71

ng/l

0.90

348

Triptan medication for migraine, min. 3 purchases

1715

11995

1.10

3.23

3.0

3.8

70.88

82.49

ng/l

8.30

1540

10629

Inguinal or femoral hernia, bilateral

315

2577

1.24

3.23

5.0

4.5

94.88

102.59

ng/l

0.67

283

2260

Benign neoplasm: Other/unspecified site

352

1.69

3.22

3.0

3.6

89.81

83.23

ng/l

0.18

320

Benign neoplasm: Connective and other soft tissue of head, face and neck

344

1.69

3.21

4.5

3.7

78.35

77.49

ng/l

0.04

310

Erythema nodosum

104

732

1.46

3.21

4.8

3.4

85.16

80.22

ng/l

0.24

634

Chronic suppurative otitis media, including avohilmo

249

1989

1.27

3.20

4.4

101.81

86.11

ng/l

0.78

220

1741

Peptic ulcer

217

1.89

3.19

5.3

3.8

87.69

87.25

ng/l

0.01

188

Benign neoplasm: Pharynx, unspecified

167

2.03

3.19

4.3

3.1

81.45

73.09

ng/l

0.36

147

LSIL lesion of the cervix uteri, vagina or vulva

381

3177

1.21

3.19

4.0

3.3

80.50

75.48

ng/l

0.49

348

2802

Malignant neoplasm of thymus, including Hilmo

2.62

3.18

6.0

3.9

68.28

88.76

ng/l

1.08

Other psoriatic arthropathies

307

2510

1.24

3.18

3.7

3.9

81.33

88.28

ng/l

0.80

264

2200

Benign neoplasm of bone and articular cartilage

242

1928

1.27

3.17

3.2

3.9

72.00

83.31

ng/l

1.75

215

1707

Other contact dermatitis

240

1910

1.27

3.17

4.4

3.5

93.93

85.41

ng/l

0.59

207

1660

Neuroendocrine tumor and carcinoma of lung

175

2.00

3.16

2.2

3.6

103.24

77.87

ng/l

1.48

156

Persistent delusional disorders

246

1966

1.27

3.16

3.8

92.33

88.29

ng/l

0.27

210

1694

Wide developmental disorders

598

1.50

3.16

4.0

7.1

50.92

62.03

ng/l

2.19

573

Behavioural disorders

345

1.66

3.13

4.5

5.7

102.40

69.40

ng/l

0.99

330

Contracture of joint

248

1.80

3.11

4.9

3.7

107.24

81.99

ng/l

0.45

221

Burn and corrosion of trunk

628

1.49

3.10

3.1

4.6

75.53

83.84

ng/l

0.50

564

Chronic Coagulation defects

539

1.53

3.09

3.9

4.1

87.78

74.19

ng/l

0.51

487

Pneumothorax

210

1651

1.29

3.09

4.4

4.0

90.90

97.04

ng/l

0.44

185

1443

Viral conjunctivitis

109

778

1.43

3.08

5.8

3.9

85.08

75.41

ng/l

0.64

700

Tonsillectomy and adenotomy

1596

10167

1.10

3.07

4.1

4.4

72.66

85.12

ng/l

6.62

1466

9137

Optic atrophy

412

1.61

3.07

5.2

4.5

86.51

79.35

ng/l

0.23

378

Alzheimer disease, including avohilmo

1470

9456

1.10

3.07

2.7

3.6

87.75

99.44

ng/l

6.23

1180

7787

Panhypopituitarism

372

1.64

3.07

3.6

4.4

80.13

84.00

ng/l

0.14

338

Abnormality of white blood cells, not elsewhere classified

184

1.95

3.06

6.0

3.6

95.36

75.02

ng/l

0.91

172

Raynaud syndrome

256

2063

1.26

3.05

2.8

3.7

73.07

81.42

ng/l

1.36

227

1795

Toxic effect of other and unspecified substances

212

1.86

3.05

1.7

3.8

83.65

74.79

ng/l

0.17

194

Inguinal hernia, bilateral

306

2513

1.23

3.05

4.9

4.5

93.06

102.93

ng/l

1.07

276

2205

Benign neoplasm: Pancreas

103

734

1.45

3.03

6.0

3.7

84.47

91.24

ng/l

0.37

631

Other diseases of gallbladder

157

1194

1.34

3.02

4.2

3.7

97.86

90.34

ng/l

0.43

140

1022

Burns classified according to extent of body surface involved

192

1.91

3.01

6.9

4.5

129.30

78.44

ng/l

1.18

174

Burn and corrosion of ankle and foot

266

1.76

3.00

6.6

4.1

85.38

79.83

ng/l

0.19

237

Open wound of hip and thigh

624

1.47

2.99

5.0

4.4

169.67

83.40

ng/l

1.20

567

Carcinoma in situ of skin, other sites/unspecified

401

1.62

2.99

6.2

3.7

136.52

86.52

ng/l

0.90

343

Pedal cyclist injured in transport accident

659

5776

1.15

2.98

3.9

4.1

85.81

89.35

ng/l

0.43

582

5046

Pedal cyclist injured in other and unspecified transport accidents

330

2737

1.22

2.98

4.2

85.35

88.56

ng/l

0.24

281

2401

Other vitreous opacities

131

972

1.38

2.98

3.7

89.84

90.08

ng/l

0.01

102

837

Other and unspecified acute skin changes due to ultraviolet radiation

602

1.49

2.97

4.2

3.5

102.84

90.68

ng/l

0.52

515

Malignant neoplasm of oropharynx, including Hilmo

415

1.59

2.96

3.8

4.1

107.96

94.98

ng/l

0.32

370

Other injuries of spine and trunk, level unspecified

186

1.92

2.96

5.6

3.8

127.75

83.14

ng/l

1.03

171

Other conditions related to polyarteritis nodosa

3.06

2.96

3.5

2.9

72.92

66.92

ng/l

0.11

Autonomic disorders

512

1.53

2.96

4.4

3.6

79.36

82.89

ng/l

0.11

447

Nosocomial condition (hospital)

123

2.17

2.96

2.9

3.5

76.72

83.35

ng/l

0.25

108

Toxic effect of carbon monoxide

376

1.62

2.95

3.4

3.9

76.65

86.85

ng/l

0.63

338

Palindromic rheumatism

208

1.86

2.94

2.4

4.1

78.42

85.81

ng/l

0.23

184

Degenerative diseases of the nervous system

1397

9375

1.10

2.94

2.8

3.6

90.55

99.52

ng/l

3.33

1115

7759

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

2.60

2.94

5.6

4.5

63.36

86.90

ng/l

1.22

Poisoning by narcotics and psychodysleptics [hallucinogens]

244

1.77

2.94

2.7

4.1

59.60

79.18

ng/l

1.91

226

Cysts of oral region, not elsewhere classified

176

1363

1.31

2.94

6.3

4.1

121.81

87.83

ng/l

1.53

159

1211

Abnormal spermatozoa

232

2881

0.80

2.93

3.5

5.0

113.56

111.09

ng/l

0.09

158

2539

Fourth [trochlear] nerve palsy

522

1.52

2.93

4.0

3.7

87.29

84.87

ng/l

0.08

465

Pedestrian injured in collision with pedal cycle

695

1.45

2.91

2.5

4.0

70.78

85.13

ng/l

2.05

618

Ankylosing hyperostosis [Forestier]

269

1.74

2.90

4.3

3.9

104.42

86.33

ng/l

0.66

229

Carcinoma in situ of colon

475

1.55

2.90

3.8

92.98

91.94

ng/l

0.03

412

Abscess of tendon sheath

124

2.13

2.88

6.1

3.3

162.50

78.63

ng/l

1.89

113

Malignant neoplasm of eye and adnexa, including Hilmo

371

1.62

2.88

4.8

3.8

135.13

88.56

ng/l

1.58

321

Contact with heat and hot substances

152

1157

1.34

2.88

5.0

4.8

100.98

83.18

ng/l

1.21

133

1036

Family history of certain disabilities and chronic diseases leading to disablement

112

812

1.40

2.88

4.4

2.7

86.88

65.92

ng/l

2.00

102

722

Ulcer of vagina/vulva

606

1.48

2.87

2.8

3.6

84.48

79.61

ng/l

0.19

527

Hereditary corneal dystrophies

122

903

1.39

2.86

3.4

89.75

85.36

ng/l

0.20

102

769

Cytomegaloviral hepatitis

2.77

2.86

13.6

2.8

107.27

66.45

ng/l

0.82

Dermatographic urticaria

190

1492

1.29

2.85

3.5

92.83

78.00

ng/l

0.59

168

1311

Haemangioma, any site

272

2227

1.24

2.84

3.9

4.0

81.98

84.51

ng/l

0.20

236

1942

Malignant neoplasm of liver and intrahepatic bile ducts

607

1.47

2.84

3.7

92.03

96.00

ng/l

0.21

509

Female infertility, associated with anovulation

144

1087

1.34

2.83

2.5

3.6

86.91

73.20

ng/l

0.24

125

1004

Malignant neoplasm of larynx

286

1.70

2.82

3.2

4.2

70.51

103.61

ng/l

1.75

246

Inguinal hernia, unilateral

701

1.44

2.82

4.1

3.8

99.46

89.15

ng/l

0.37

621

Femoral hernia, unilateral

701

1.44

2.82

4.1

3.8

99.46

89.15

ng/l

0.37

621

Inguinal of femoral hernia, unilateral

701

1.44

2.82

4.1

3.8

99.46

89.15

ng/l

0.37

621

Viral agents as the cause of diseases classified to other chapters

542

1.50

2.82

6.6

4.6

96.20

80.26

ng/l

0.90

492

Burns and corrosions confined to eye and internal organs

492

1.52

2.82

3.0

4.2

78.00

85.40

ng/l

0.31

441

Impacted teeth

399

3002

1.19

2.81

6.9

4.3

90.38

75.83

ng/l

1.75

358

2744

Other and unspecified injuries of forearm

146

2.01

2.81

3.8

4.0

73.94

76.71

ng/l

0.05

135

Unspecified parasitic disease

168

1.94

2.80

6.4

4.1

134.65

82.11

ng/l

1.25

151

Other and unspecified papulosquamous disorders

133

2.08

2.79

2.3

3.4

112.67

70.28

ng/l

1.27

123

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

153

1173

1.33

2.79

3.0

3.8

81.50

97.51

ng/l

2.40

140

985

Viral conjunctivitis

413

1.57

2.78

5.8

3.8

100.69

76.63

ng/l

1.19

374

Erectile dysfunction

228

1837

1.26

2.78

5.3

4.8

121.35

110.29

ng/l

0.68

193

1605

Peritonsillar abscess

540

4692

1.16

2.77

3.9

4.3

84.91

94.08

ng/l

1.27

468

4174

Viral agents as the cause of diseases classified to other chapters

471

1.53

2.76

7.0

4.5

100.02

77.46

ng/l

1.29

432

Assault by unspecified means

326

1.63

2.76

3.8

4.5

109.83

79.84

ng/l

0.98

307

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1326

0.71

2.76

3.0

3.4

77.62

78.97

ng/l

0.07

1152

Circumscribed brain atrophy

530

1.50

2.74

3.1

3.9

77.03

90.54

ng/l

0.95

467

Other articular cartilage disorders

496

1.51

2.74

3.7

3.8

115.40

93.77

ng/l

0.39

429

Postpartum hemorraghe, all women as controls

453

5177

0.86

2.71

2.9

3.5

63.32

74.92

ng/l

4.57

404

4685

HSIL lesion of the vagina

330

1.64

2.70

4.8

2.9

127.30

75.07

ng/l

2.14

297

Other and unspecified injuries of thorax

361

1.60

2.68

3.8

4.0

93.65

83.54

ng/l

0.42

326

Other and unspecified parapsoriasis

2.29

2.68

4.0

4.2

90.82

88.13

ng/l

0.06

Malignant neoplasm of vulva, including Hilmo

396

1.59

2.67

3.6

2.8

95.79

78.81

ng/l

0.70

339

Vitamin A deficiency

2.28

2.67

1.9

3.1

60.75

76.33

ng/l

0.72

Varus deformity, not elsewhere classified

253

1.73

2.67

3.5

4.3

62.34

81.70

ng/l

1.19

221

Maltreatment syndromes

120

892

1.36

2.67

2.9

4.4

87.63

78.50

ng/l

0.36

104

813

Use of cabergoline

245

1.73

2.65

6.9

3.9

100.85

82.87

ng/l

0.31

224

Personal history of certain other diseases

244

1.72

2.65

3.5

2.8

97.11

61.64

ng/l

1.96

221

Postpartum hemorraghe, parous women as controls

453

4473

0.86

2.65

2.9

3.2

63.32

73.24

ng/l

3.41

404

4038

Nasal polyp

568

4976

1.15

2.64

3.6

4.3

88.93

97.42

ng/l

1.54

495

4349

Otitis media in diseases classified elsewhere

5.28

2.64

6.0

4.3

103.43

91.00

ng/l

—

Respiratory distress of newborn

405

1.56

2.64

10.1

9.2

44.14

48.68

ng/l

0.83

400

Uterine polyps

317

2656

1.21

2.64

3.5

3.3

83.05

82.61

ng/l

0.03

275

2316

Hepatocellular carcinoma

444

1.53

2.62

2.8

3.9

86.24

99.34

ng/l

0.81

382

Impacted maxillary molar

113

834

1.37

2.62

6.8

4.1

86.94

68.77

ng/l

1.27

102

755

Spasmodic torticollis

106

779

1.40

2.61

2.4

3.5

65.95

80.06

ng/l

2.03

688

Pathological resorption of teeth

107

787

1.39

2.61

5.1

4.3

98.13

86.53

ng/l

0.67

706

Chronic lymphocytic leukaemia

671

1.42

2.57

3.1

3.6

80.36

93.35

ng/l

1.34

573

Chronic lymphocytic leukaemia, helper endpoint

671

1.42

2.57

3.1

3.6

80.36

93.35

ng/l

1.34

573

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

671

1.42

2.57

3.1

3.6

80.36

93.35

ng/l

1.34

573

Dislocation of lens

366

1.58

2.57

5.2

3.4

148.68

90.71

ng/l

1.97

315

Drug-induced neutropenia

233

1903

1.24

2.55

3.9

3.8

104.11

87.35

ng/l

1.18

210

1638

Vertigo of central origin

416

1.55

2.54

2.8

3.6

62.79

84.15

ng/l

2.06

360

Drug-induced polyneuropathy

227

1.77

2.54

3.9

5.1

95.72

72.84

ng/l

0.49

200

Contact with other hot metals

303

1.64

2.54

3.4

4.7

73.47

80.20

ng/l

0.23

273

Benign neoplasm: Skin of ear and external auricular canal

132

1008

1.34

2.53

4.6

3.8

110.04

94.37

ng/l

0.69

112

877

Pseudomembranous colitis

174

1.87

2.53

6.5

3.5

108.88

78.41

ng/l

0.90

153

Moderate mental retardation

138

1.99

2.53

6.0

5.5

63.69

65.60

ng/l

0.06

131

Benign neoplasm: Skin of upper limb, including shoulder

465

1.51

2.52

5.0

3.5

148.78

81.42

ng/l

1.64

416

Other degenerative diseases of the basal ganglia

450

1.52

2.52

1.9

4.1

73.41

94.50

ng/l

1.26

394

Granuloma annulare

328

1.61

2.51

3.9

3.6

84.76

74.83

ng/l

0.38

293

L02BA Anti-estrogens

593

5237

1.14

2.50

2.6

3.2

77.38

81.58

ng/l

0.77

513

4440

Foreign body in respiratory tract

156

1219

1.30

2.50

3.7

4.3

74.41

83.71

ng/l

0.72

133

1082

Precocious puberty

2.29

2.50

10.9

7.1

62.83

47.87

ng/l

0.85

Disorders of brain, other and unspecified

197

1.80

2.49

8.9

3.9

103.89

85.41

ng/l

0.47

174

Pleural plaque with presence of asbestos

227

1854

1.24

2.49

3.4

4.4

92.36

109.84

ng/l

2.20

187

1602

Acute epiglottitis

265

1.67

2.49

3.7

4.2

93.69

83.51

ng/l

0.26

246

Rheumatic valve diseases

532

1.47

2.49

5.6

3.6

142.04

92.73

ng/l

1.37

455

Sixth [abducent] nerve palsy

111

829

1.37

2.49

4.1

3.8

98.24

90.30

ng/l

0.29

716

Other disorders affecting eyelid function

213

1.77

2.48

3.6

3.7

77.64

79.42

ng/l

0.04

185

Tuberculosis of other organs

542

1.47

2.47

5.2

3.4

108.76

88.11

ng/l

0.90

463

Primary open-angle glaucoma

1230

10917

1.10

2.47

3.5

3.6

96.41

94.83

ng/l

0.20

985

9126

Pleural plaque without asbestos

126

961

1.34

2.46

5.0

3.9

115.21

102.59

ng/l

0.59

102

814

Myocardial infarction, unclassifiable

783

6272

1.12

2.46

5.4

3.7

132.99

100.88

ng/l

9.76

665

5192

Bursitis of shoulder

550

1.45

2.45

2.8

3.6

73.93

85.28

ng/l

0.77

482

Optic atrophy

436

1.52

2.43

5.2

4.4

86.51

79.75

ng/l

0.22

399

Exposure to other and unspecified animate mechanical forces

609

1.42

2.43

4.5

4.7

90.73

75.97

ng/l

0.65

556

Postpartum haemorrhage due to retained placenta

179

2237

0.79

2.42

2.3

3.1

57.62

72.54

ng/l

4.95

161

2033

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

417

3603

1.17

2.42

3.5

3.8

82.48

90.46

ng/l

1.27

356

3131

Conductive hearing loss, unspecified

252

2086

1.22

2.41

4.2

82.54

87.89

ng/l

0.41

224

1823

Unspecified abortion

144

1119

1.31

2.41

3.6

3.4

81.34

75.13

ng/l

0.49

122

995

Other specified and unspecified disorders of eyelid

340

1.59

2.41

3.4

75.80

82.30

ng/l

0.20

303

Benign neoplasm of brain and other parts of central nervous system

202

1636

1.25

2.41

4.0

3.9

83.73

87.50

ng/l

0.25

180

1420

Burn and corrosion confined to eye and adnexa

403

1.52

2.40

3.3

4.3

75.75

84.54

ng/l

0.42

368

Benign neoplasm: Skin of scalp and neck

595

1.43

2.40

4.7

4.2

103.74

83.94

ng/l

0.66

527

Lichen planus

440

3822

1.16

2.40

3.4

3.7

91.28

89.98

ng/l

0.10

376

3249

Carcinoma in situ of oral cavity, oesophagus and stomach

134

1.99

2.39

2.9

3.7

82.90

84.31

ng/l

0.04

116

Helminthiases

108

807

1.36

2.39

4.8

4.5

86.41

76.69

ng/l

0.55

733

Malignant neoplasm of tonsil, including Hilmo

340

1.58

2.39

3.0

4.3

103.64

93.66

ng/l

0.22

302

FESS (DNB20)

350

2985

1.18

2.39

2.9

4.0

68.86

89.83

ng/l

7.94

300

2630

Other specified and unspecified disorders of lens

263

1.69

2.39

2.6

3.1

133.07

82.77

ng/l

0.68

223

Endovascular or surgical operations to intracerebral aneurysms

195

1576

1.26

2.38

5.5

3.7

94.55

89.48

ng/l

0.29

182

1373

Ulcerative rectosigmoiditis

217

1772

1.24

2.37

4.0

4.1

91.32

88.59

ng/l

0.13

194

1580

Malignant neoplasm of other connective and soft tissue

572

1.44

2.36

3.5

3.9

92.44

90.38

ng/l

0.08

493

Von Willebrand disease

270

1.65

2.35

3.4

79.55

69.44

ng/l

0.35

245

HSIL lesion of the vulva

432

1.51

2.35

5.5

3.0

109.00

77.58

ng/l

1.63

384

Ethmoidectomy

364

3120

1.18

2.34

2.9

4.0

72.34

89.68

ng/l

3.48

314

2751

Nonpyogenic thrombosis of intracranial venous system

186

1.79

2.34

4.8

4.3

66.15

69.61

ng/l

0.12

168

Benign neoplasm: Skin of lip

319

1.59

2.33

3.6

3.5

94.97

83.10

ng/l

0.26

287

Malignant neoplasm of vulva

281

1.65

2.32

3.1

2.9

84.90

77.78

ng/l

0.27

242

Abscess of external ear

255

1.66

2.32

6.5

3.9

114.82

79.31

ng/l

1.22

232

Other, unspecified and serous retinal detachments

101

753

1.37

2.31

6.6

3.8

112.12

89.74

ng/l

1.20

650

Other congenital malformations of skin

225

1851

1.23

2.30

3.2

4.2

76.05

79.55

ng/l

0.34

202

1637

Classical phenylketonuria

5.27

2.30

4.7

3.6

69.92

58.19

ng/l

—

Meningitis

145

1136

1.30

2.30

4.2

3.9

78.85

83.36

ng/l

0.35

127

1005

Other congenital malformations of circulatory system

592

1.42

2.29

3.1

4.0

79.71

82.62

ng/l

0.11

531

Localized skin eruption due to drugs and medicaments

249

1.67

2.28

3.4

3.6

75.91

72.58

ng/l

0.13

225

Benign leiomyoma with endometriosis

582

5172

1.14

2.28

3.2

3.1

81.79

81.49

ng/l

0.04

481

4354

Psoriasis (vulgaris), strict definition

668

1.39

2.28

3.5

4.1

76.05

84.08

ng/l

0.38

599

Hand

122

2.00

2.27

5.8

3.0

69.59

72.95

ng/l

0.07

112

Stenosis and insufficiency of lacrimal passages

319

2717

1.19

2.27

3.7

88.95

89.72

ng/l

0.05

277

2294

Allergic contact dermatitis due to drugs in contact with skin

535

1.44

2.26

3.9

3.5

128.14

77.20

ng/l

1.14

482

Cerebral amyloid angiopathy

116

2.04

2.24

4.3

4.0

88.47

81.38

ng/l

0.15

102

Acute appendicitis, with complications

594

5286

1.13

2.23

4.4

4.1

97.03

93.11

ng/l

0.37

520

4602

Other papulosquamous disorders

235

1.68

2.23

4.0

3.4

158.37

74.88

ng/l

1.43

217

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

314

1.58

2.23

3.8

3.7

83.16

85.20

ng/l

0.07

282

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

569

1.42

2.22

5.2

3.4

91.62

76.23

ng/l

0.51

504

Assault by other specified means

144

1.86

2.21

4.8

4.0

90.77

76.53

ng/l

0.29

134

Other and unspecified trigeminal disorders

347

1.55

2.21

3.3

3.2

73.19

76.35

ng/l

0.14

311

Achalasia of cardia

396

1.51

2.20

3.0

3.9

73.48

90.61

ng/l

1.46

337

Aortic arch syndrome [Takayasu]

2.84

2.20

4.5

4.1

80.27

69.66

ng/l

0.16

Other benign neoplasms of uterus

217

1796

1.23

2.19

2.8

3.0

83.63

84.62

ng/l

0.05

159

1472

Injury of muscle and tendon at shoulder and upper arm level

1137

10472

1.09

2.17

3.8

4.2

87.44

97.18

ng/l

3.24

1003

9083

Malignant neoplasm of colon

480

4227

1.15

2.16

3.7

103.79

97.06

ng/l

0.77

425

3534

Exposure to smoke, fire and flames

490

1.44

2.12

3.0

4.2

81.85

87.40

ng/l

0.25

443

Tuberculosis, IBD comorbidity

232

1934

1.22

2.12

4.2

3.5

95.79

95.28

ng/l

0.03

200

1626

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

335

1.55

2.12

5.7

3.3

110.78

87.82

ng/l

1.03

289

Foreign body entering into or through eye or natural orifice

212

1753

1.22

2.09

4.0

4.6

88.05

91.78

ng/l

0.24

188

1569

Foreign body in ear

384

1.50

2.08

4.9

4.8

92.76

74.51

ng/l

0.77

354

Other hyperalimentation

2.31

2.08

3.9

3.7

65.60

79.01

ng/l

—

Maternal care for known or suspected abnormality of pelvic organs

505

3888

0.88

2.08

2.9

3.6

69.39

77.86

ng/l

1.29

450

3486

Blood alcohol or alcohol intoxication level

408

1.47

2.08

4.8

4.7

81.22

85.80

ng/l

0.16

367

Congenital malformations of spine and bony thorax

133

1.89

2.08

6.8

6.1

47.42

60.23

ng/l

0.94

125

Erythema multiforme

527

1.42

2.07

4.8

4.0

90.13

81.94

ng/l

0.42

473

Vascular dementia (other)

179

1.77

2.06

2.7

3.9

78.57

97.22

ng/l

0.91

159

Use of levodopa decarboxylase inhibitor

472

4170

1.14

2.06

2.8

3.8

80.90

99.43

ng/l

4.74

379

3506

Essential (haemorrhagic) thrombocythaemia

121

943

1.31

2.06

3.2

3.6

90.69

88.63

ng/l

0.09

105

811

CR(E)ST syndrome

403

1.49

2.06

3.8

3.2

75.62

76.62

ng/l

0.04

359

Sequelae of injuries of head

140

1109

1.28

2.06

3.9

4.3

90.91

91.48

ng/l

0.02

114

1000

Benign neoplasm of ovary

628

5643

1.12

2.06

3.6

3.2

90.66

80.99

ng/l

0.81

535

4767

Primary open-angle glaucoma, strict

993

9101

1.10

2.06

3.5

3.6

96.45

94.80

ng/l

0.19

790

7609

Other operation for atrial fibrillation

105

2.02

2.05

4.2

4.7

191.43

95.65

ng/l

1.20

Phlebitis and thrombophlebitis of femoral vein, drug-induced

5.47

2.05

1.6

5.4

174.20

96.27

ng/l

—

All dysplastic lesions of the vagina

639

1.38

2.05

4.9

3.2

118.56

75.47

ng/l

2.26

568

Heberden's nodes [with arthropathy]

227

1.66

2.02

3.5

3.1

74.88

77.37

ng/l

0.08

196

Autism spe

378

1.48

2.00

3.1

6.3

53.40

68.53

ng/l

2.15

357

Peroneal tendinitis

314

1.54

1.99

4.8

3.6

89.72

78.28

ng/l

0.32

286

Other congenital malformations of skin

116

903

1.31

1.99

3.5

4.4

79.77

76.29

ng/l

0.19

104

812

Tuberculosis of other organs, strict

626

1.38

1.99

5.5

3.5

110.98

91.20

ng/l

0.89

533

Alzheimer’s disease (Atypical or mixed)

375

3249

1.16

1.98

2.6

3.3

95.78

101.41

ng/l

0.51

265

2648

Injury of muscle and tendon at hip and thigh level

268

2278

1.19

1.98

4.5

4.1

91.22

90.57

ng/l

0.04

248

2013

Patent foramen ovale

515

1.41

1.98

6.2

5.9

66.93

72.52

ng/l

0.40

474

Hordeolum and other deep inflammation of eyelid

164

1331

1.25

1.97

4.3

4.2

92.84

83.80

ng/l

0.52

143

1179

Embolic stroke

149

1197

1.26

1.96

5.0

3.5

117.42

97.82

ng/l

1.60

133

1009

Benign lipomatous neoplasm of other sites/unspecified

290

2486

1.18

1.96

3.6

3.8

87.62

92.11

ng/l

0.39

242

2110

Mental and behavioural disorders of puerperium, not classified elsewhere

196

1.68

1.96

2.6

3.6

68.36

74.06

ng/l

0.19

180

Malignant neoplasm of stomach

153

1234

1.26

1.95

3.8

3.6

92.01

95.63

ng/l

0.19

135

1033

ILD medications: acetylcysteine

158

1.77

1.95

3.3

4.0

96.65

92.24

ng/l

0.07

137

Herpesviral keratitis and keratoconjunctivitis

135

1075

1.28

1.95

4.7

3.7

102.27

88.30

ng/l

0.91

119

939

Postinfectious hypothyroidism

107

1.96

1.94

8.7

3.0

149.71

77.52

ng/l

0.86

Myeloid leukaemia

637

1.37

1.94

3.9

4.2

82.03

92.27

ng/l

0.72

560

Benign neoplasm: other/unspecified salivary gland

672

1.36

1.93

4.6

3.7

98.03

88.60

ng/l

0.43

588

Congenital malformations of ovaries, fallopian tubes and broad ligaments

140

1119

1.27

1.93

3.4

3.2

82.23

72.32

ng/l

0.46

128

999

Use of other anti-dementia drugs

1053

8055

1.09

1.92

2.2

3.6

81.45

100.65

ng/l

13.85

801

6633

Use of memantine

1053

8055

1.09

1.92

2.2

3.6

81.45

100.65

ng/l

13.85

801

6633

N06DA Anticholinesterases

1336

9812

1.08

1.92

2.6

3.6

83.55

99.63

ng/l

12.11

1051

8107

Use of anticholinesterases

1336

9812

1.08

1.92

2.6

3.6

83.55

99.63

ng/l

12.11

1051

8107

Polycystic ovarian syndrome, broad definition

208

1731

1.21

1.92

3.0

3.3

85.92

71.61

ng/l

0.39

182

1576

Superficial injury of ankle and foot, unspecified

2.07

1.91

2.3

3.9

86.29

72.46

ng/l

0.17

Injury of nerves at wrist and hand level

741

1.33

1.91

3.8

4.2

102.65

88.09

ng/l

0.51

664

Marginal zone B-cell lymphoma, including Hilmo

376

1.48

1.91

5.1

3.7

94.37

86.57

ng/l

0.26

332

Motor neuron disease

350

1.49

1.91

2.6

3.7

74.04

95.50

ng/l

1.21

315

Impaction of intestines

137

1.83

1.91

5.2

4.1

123.90

89.62

ng/l

0.61

119

Malignant neoplasm of oral cavity, including Hilmo

133

1060

1.27

1.90

3.0

3.7

70.63

94.47

ng/l

4.59

116

913

Parkinson's disease, including avohilmo

533

4771

1.13

1.90

2.8

3.8

85.40

99.44

ng/l

1.83

431

4013

Atrial septal defect, secundum type

715

1.34

1.90

6.2

6.0

80.16

65.39

ng/l

1.59

670

L01XX Other antineoplastic agents

192

1594

1.22

1.90

3.0

3.7

85.74

92.71

ng/l

0.66

169

1357

Apocrine sweat disorders, other sweat gland disorders

2.04

1.90

3.0

2.9

91.66

73.09

ng/l

0.34

Benign neoplasm: Vulva

572

1.38

1.89

3.1

109.07

78.59

ng/l

1.31

498

Vitiligo

222

1.63

1.88

6.5

3.1

114.12

69.09

ng/l

1.46

202

Cluster headache, strict, including avohilmo

121

954

1.29

1.88

3.2

3.8

69.19

79.06

ng/l

0.98

109

864

167

2032

0.81

1.87

3.3

4.2

97.92

104.71

ng/l

0.34

142

1773

Pedal cyclist injured in noncollision transport accidents

311

2688

1.17

1.87

3.9

4.2

83.51

87.72

ng/l

0.37

289

2385

Malignant neoplasm of oropharynx

311

1.52

1.87

2.7

4.2

99.95

93.43

ng/l

0.12

275

Spermatocele

185

1529

1.22

1.87

4.6

4.8

99.79

107.03

ng/l

0.51

164

1331

Other bursal cyst

361

1.48

1.87

4.6

3.8

88.38

86.84

ng/l

0.05

327

Struck by thrown, projected or falling objec

128

1017

1.28

1.87

4.2

4.7

76.69

86.52

ng/l

0.74

114

908

Other bullous disorders

685

1.34

1.86

5.0

3.9

123.33

82.25

ng/l

1.41

608

Glaucoma secondary to drugs

2.32

1.86

3.4

4.1

72.31

77.67

ng/l

0.07

Perioral dermatitis

453

1.42

1.85

5.8

3.4

87.00

73.15

ng/l

0.59

405

Injury of muscle and tendon at wrist and hand level

370

3241

1.15

1.85

4.3

92.82

95.31

ng/l

0.19

330

2869

Galactorrhea

184

1.68

1.85

2.7

3.8

60.32

77.35

ng/l

1.28

165

Syndrome of inappropriate secretion of antidiuretic hormone

102

1.96

1.84

2.8

3.0

63.75

78.52

ng/l

0.35

Histrionic personality disorder

117

1.90

1.84

1.9

3.2

56.06

70.61

ng/l

0.86

102

Female infertility

804

4451

1.10

1.83

2.9

3.4

73.72

78.05

ng/l

0.42

716

3915

Dermatitis herpetiformis

413

1.44

1.82

3.8

3.9

119.77

83.77

ng/l

0.86

369

Nonspecific lymphadenitis

162

1326

1.24

1.82

3.8

3.6

83.76

80.20

ng/l

0.27

135

1171

Left ventricular outflow tract obstruction, narrow definition

135

1084

1.26

1.82

5.9

5.4

84.51

79.60

ng/l

0.30

126

998

Benign neoplasm: Brain, unspecified

117

1.88

1.81

3.7

3.4

79.00

74.10

ng/l

0.19

106

Respiratory conditions due to other external agents

533

1.39

1.81

3.8

3.5

89.60

83.73

ng/l

0.27

460

Congenital malformations of spine and bony thorax

125

1.84

1.80

7.3

6.4

47.91

61.24

ng/l

0.92

117

Disorders of urea cycle metabolism

4.43

1.79

7.2

1.8

163.80

58.38

ng/l

—

Occlusion and stenosis of arteries, not leading to stroke

306

1.51

1.79

4.7

3.6

117.97

93.44

ng/l

0.61

269

Mental and behavioural disorders associated with the puerperium

202

1.63

1.77

2.6

3.9

68.36

70.67

ng/l

0.07

189

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

164

1.72

1.76

3.3

3.6

81.27

78.69

ng/l

0.06

149

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

597

1.35

1.74

3.6

3.7

106.76

82.87

ng/l

0.51

530

Aphakia

291

1.51

1.74

6.9

3.7

128.50

86.04

ng/l

0.96

249

Other abortion

172

1.69

1.73

2.9

3.6

74.57

68.91

ng/l

0.24

152

Injury of nerves at forearm level

235

1.57

1.73

3.0

3.8

88.13

76.28

ng/l

0.47

214

Dementia in other diseases classified elsewhere

148

1210

1.24

1.73

3.4

4.0

91.56

99.50

ng/l

0.32

105

1054

All dysplastic lesions of the cervix uteri, vagina or vulva

761

6862

1.10

1.73

3.9

3.3

84.20

75.54

ng/l

1.59

687

6063

Dyshidrosis [pompholyx]

317

1.49

1.72

3.6

3.7

68.03

74.15

ng/l

0.24

280

Dislocation, sprain and strain of joints and ligaments of elbow

169

1399

1.22

1.72

4.1

4.3

80.43

77.60

ng/l

0.21

148

1248

Sequelae of poliomyelitis

181

1.67

1.71

4.2

3.2

119.06

82.79

ng/l

0.79

159

Other specified disorders of external ear

106

836

1.29

1.70

3.7

4.4

87.23

101.01

ng/l

1.07

749

Cluster headache, wide,, including avohilmo

128

1031

1.26

1.69

3.1

3.7

68.18

79.13

ng/l

1.22

115

927

Tibial collateral bursitis [Pellegrini-Stieda]

237

1.57

1.69

3.1

2.9

97.25

75.09

ng/l

0.89

211

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

2.79

1.68

10.3

1.6

114.65

64.43

ng/l

—

Parapsoriasis

377

1.44

1.68

3.7

4.0

81.25

77.82

ng/l

0.13

341

Eustachian salpingitis and obstruction

176

1465

1.21

1.68

5.0

4.2

105.31

83.15

ng/l

1.10

159

1334

Foreign body in alimentary tract

155

1277

1.23

1.67

3.0

4.3

78.05

90.96

ng/l

1.31

135

1126

Normotensive glaucoma

312

2730

1.16

1.67

3.8

3.5

100.25

92.89

ng/l

0.55

258

2275

Benign neoplasm: Peripheral nerves and autonomic nervous system

370

1.44

1.67

2.1

3.6

70.84

79.36

ng/l

0.51

327

Acanthosis nigricans

2.26

1.67

4.8

2.6

94.42

66.83

ng/l

0.75

Injury of muscle and tendon at lower leg level

405

3599

1.13

1.66

4.8

4.3

100.66

96.83

ng/l

0.28

363

3166

Narcolepsy and cataplexy

113

1.83

1.65

4.5

3.4

83.14

70.43

ng/l

0.32

102

Non-small cell lung cancer, squamous, helper endpoint

1175

0.77

1.65

2.7

4.0

67.45

102.82

ng/l

5.30

993

Other diseases of appendix

272

1.52

1.63

5.0

3.6

77.17

82.12

ng/l

0.18

244

Procedures for purposes other than remedying health state

551

1.35

1.63

3.8

2.5

79.67

70.27

ng/l

0.48

491

Other and unspecified injuries of wrist and hand

105

832

1.28

1.62

4.7

4.3

98.06

79.81

ng/l

1.12

752

Injury of blood vessels of thorax

2.09

1.61

1.7

3.1

82.08

69.64

ng/l

0.30

Other benign neoplasm of uterus: Other parts/unspecified

171

1435

1.22

1.60

2.3

2.8

80.46

84.69

ng/l

0.31

120

1162

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

264

2289

1.17

1.59

5.6

3.0

102.29

74.55

ng/l

4.43

242

1959

Dysplasia of cervi uteri

651

4295

1.10

1.59

3.8

3.4

82.01

79.09

ng/l

0.33

587

3761

conjunctival degenerations and deposits

528

1.36

1.59

4.3

3.5

106.70

83.05

ng/l

0.51

466

Malignant neoplasm of mesothelium and soft tissue

119

961

1.26

1.58

3.6

3.8

88.85

90.58

ng/l

0.08

829

Malignant neoplasm of oral cavity

756

1.29

1.57

2.7

3.8

66.58

92.55

ng/l

4.08

660

Malignant neoplasm of gum, including Hilmo

226

1.56

1.8

3.7

53.21

83.05

ng/l

3.57

203

Whooping cough

108

1.82

1.56

12.8

3.7

179.11

66.25

ng/l

1.25

False labour

601

4120

0.91

1.56

2.7

3.7

62.33

77.01

ng/l

9.37

541

3745

Malignant neoplasm of tonsil

283

1.49

1.55

2.8

4.2

106.92

92.94

ng/l

0.26

247

Atypical virus infections of central nervous system

202

1.59

1.55

3.7

3.5

92.83

75.26

ng/l

0.40

180

Glaucoma-related operations

204

1742

1.19

1.54

3.4

3.5

92.11

93.31

ng/l

0.07

175

1461

Tuberculosis, wide

237

2046

1.17

1.53

4.4

3.6

97.41

96.11

ng/l

0.08

205

1722

Bacterial meningitis

777

1.28

1.53

3.7

3.9

76.32

85.44

ng/l

0.72

688

Laparoscopic right hemicolectomy

197

1679

1.19

1.53

3.3

3.8

101.54

94.83

ng/l

0.46

175

1425

Viral meningitis

715

1.29

1.52

2.9

3.8

70.01

80.56

ng/l

0.72

652

Pregnancy, childbirth and the puerperium

1035

5802

0.93

1.52

2.9

3.3

80.71

84.69

ng/l

0.79

867

4832

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

120

976

1.25

1.51

4.3

3.9

92.20

90.72

ng/l

0.06

106

858

Female infertility, tubal origin

119

965

1.25

1.51

3.4

3.5

74.14

76.54

ng/l

0.19

108

886

Mantle cell lymphoma, including Hilmo

302

1.46

1.50

4.0

103.40

92.64

ng/l

0.22

266

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

371

1.42

1.50

7.3

10.0

51.95

48.30

ng/l

0.38

365

Other noninflammatory disorders of cervix uteri

163

1368

1.21

1.50

3.0

3.3

79.69

82.17

ng/l

0.16

132

1170

Dementia due to Parkinsons disease, excluding more controls

446

1.37

1.49

2.5

3.7

77.16

98.35

ng/l

1.27

375

LSIL lesion of the cervix uteri

268

2337

1.15

1.49

3.5

3.2

72.47

73.14

ng/l

0.05

247

2079

Malignant cancer of tonsil and base of tongue, including Hilmo

490

1.35

1.49

2.7

4.1

100.68

94.36

ng/l

0.16

440

Foreign body or object entering through skin

156

1305

1.21

1.47

3.5

4.4

82.71

86.41

ng/l

0.21

135

1170

Multiple gestation

151

1804

0.83

1.46

3.0

3.7

63.20

79.33

ng/l

3.37

140

1630

Contraceptive management

1143

7503

1.07

1.45

4.1

4.2

78.10

87.75

ng/l

3.22

1032

6693

Haemorrhage in early pregnancy

773

6956

1.09

1.45

3.1

3.4

74.82

76.42

ng/l

0.20

693

6099

Arthropathy in Crohn disease

197

1.57

1.45

2.1

3.4

80.65

76.38

ng/l

0.08

179

Drug-induced myopathy

2.20

1.44

3.4

2.8

195.45

70.99

ng/l

1.04

Other diseases of spinal cord

668

1.29

1.44

3.7

3.8

80.71

84.52

ng/l

0.16

589

Burn and corrosion of shoulder and upper limb, except wrist and hand

432

1.37

1.44

4.1

4.6

103.65

80.56

ng/l

0.70

390

Mixed disorders of conduct and emotions

337

1.41

1.44

7.1

6.3

93.62

61.30

ng/l

0.83

313

Transitory endocrine and metabolic disorders specific to fetus and newborn

382

1.40

1.44

7.2

9.9

52.95

48.86

ng/l

0.43

376

Lichen planus, including avohilmo

622

5709

1.10

1.43

3.2

3.6

86.21

89.45

ng/l

0.42

528

4859

Adult-onset Still disease

2.03

1.43

2.9

3.5

62.66

74.27

ng/l

0.28

Early lumbar disc prolapse, operated

184

1564

1.18

1.43

4.0

4.6

84.20

88.99

ng/l

0.22

173

1448

Anti-inflammatory and antirheumatic products, non-steroids

1044

4895

1.08

1.42

3.8

6.0

86.90

112.09

ng/l

10.60

921

4304

Dementia in Alzheimer disease

538

4979

0.91

1.42

2.6

3.6

89.73

103.12

ng/l

2.48

357

4107

Gonococcal infection

750

1.27

1.42

3.3

3.4

81.56

76.59

ng/l

0.26

670

Lichen ruber planus, wide definition including periferal and oral lichen planus

729

6739

1.09

1.41

3.1

3.6

84.79

88.83

ng/l

0.62

618

5765

Idiopathic pulmonary fibrosis

251

2193

1.16

1.41

3.8

3.7

91.25

99.14

ng/l

0.84

223

1838

Certain zoonotic bacterial diseases

706

1.28

1.41

3.5

4.0

101.86

81.20

ng/l

0.95

626

Golimumab

652

1.29

1.41

2.4

4.0

68.77

79.44

ng/l

0.54

595

Malignant cancer of tonsil and base of tongue

391

1.38

1.41

2.5

4.2

100.19

96.21

ng/l

0.08

351

Kaposi sarcoma, including Hilmo

2.78

1.40

3.2

4.0

71.50

81.67

ng/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

635

1.29

1.40

3.2

4.6

94.34

76.06

ng/l

0.67

580

Localized scleroderma [morphea]

358

1.40

5.2

2.8

98.85

71.14

ng/l

1.36

319

Other specific arthropathies, wide

452

1.35

1.39

2.4

3.8

80.62

88.50

ng/l

0.36

393

Cutis laxa senilis

192

1.57

1.39

1.9

2.7

68.71

75.32

ng/l

0.29

167

Benign neoplasm: Tonsil

266

1.47

1.38

4.3

3.1

72.16

75.12

ng/l

0.16

237

Demyelinating diseases of the central nervous system

211

1822

1.17

1.38

3.6

74.73

79.31

ng/l

0.35

183

1626

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

188

1611

1.18

1.37

4.2

4.0

85.05

92.90

ng/l

0.70

160

1418

Ankylosing spondylitis, strict definition

102

824

1.25

1.37

2.9

4.2

69.15

82.39

ng/l

0.90

742

Malignant neoplasm of gum

106

1.79

1.36

1.5

3.7

53.23

80.38

ng/l

1.67

Postpartum care and examination

230

1678

0.86

1.36

3.7

3.5

73.82

73.41

ng/l

0.02

203

1510

Transient synovitis

152

1.62

1.36

5.8

4.9

63.56

70.64

ng/l

0.30

142

Personality and behavioural disorders due to brain disease, damage and dysfunction

317

1.42

1.35

2.6

4.1

75.03

83.99

ng/l

0.69

293

Gonococcal infection

782

1.26

1.35

3.5

84.78

77.21

ng/l

0.42

700

Sequelae of poliomyelitis

218

1.52

1.34

4.0

3.2

109.46

84.34

ng/l

0.55

191

Labyrinthitis

1.99

1.34

5.8

3.1

91.42

77.70

ng/l

0.23

Colorectal cancer

740

6709

1.08

1.34

3.5

3.8

100.11

96.80

ng/l

0.40

641

5608

Other and unspecified disease of Bartholin gland

776

1.26

1.33

3.1

3.2

89.64

79.55

ng/l

0.64

663

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

226

1.49

1.32

2.3

4.3

79.88

77.14

ng/l

0.07

207

Mental and behavioural disorders due to cannabinoids

377

1.37

1.32

1.9

5.0

67.64

85.25

ng/l

0.96

354

Endometroid carcinoma of ovary

160

0.48

1.30

3.3

3.1

103.25

74.04

ng/l

—

140

Hypertrophy of tongue papillae

286

1.43

1.30

6.1

3.4

98.97

75.88

ng/l

0.67

255

Malignant neoplasm of rectosigmoid junction, including Hilmo

697

1.27

1.30

2.9

3.6

88.82

93.14

ng/l

0.25

600

Malignant neoplasm of ovary

117

1407

0.82

1.29

2.5

3.2

72.31

83.20

ng/l

1.22

101

1170

L02BX Other hormone antagonists and related agents

149

1261

1.20

1.29

2.4

4.7

119.32

112.57

ng/l

0.21

128

1092

Pneumoconiosis due to asbestos and other mineral fibres

476

1.33

1.29

4.0

4.6

99.28

116.31

ng/l

0.76

408

Oral lichen planus

699

1.27

1.28

3.5

99.39

81.57

ng/l

0.50

609

Degenerative myopia

155

1.60

1.28

4.6

3.4

80.18

80.76

ng/l

0.02

136

Femoral hernia

138

1161

1.20

1.28

4.3

3.7

95.76

92.66

ng/l

0.12

116

996

Alzheimer disease

1229

8490

1.06

1.28

2.7

3.6

90.18

99.69

ng/l

3.43

973

6980

Other and unspecified bullous disorders

237

1.48

1.28

7.5

3.5

147.32

75.21

ng/l

1.20

209

Mandibular retrognathia AND surgery (BSSO)

481

0.70

1.27

2.3

3.8

68.10

76.92

ng/l

0.50

442

Loose body in joint

459

1.33

1.27

3.0

4.1

78.08

90.81

ng/l

1.07

400

Peripheral retinal degeneration

735

1.26

1.27

3.6

3.4

85.81

81.46

ng/l

0.29

643

Unspecified dementia

379

3074

1.12

1.27

3.1

3.5

95.61

103.03

ng/l

0.72

291

2545

Gastrointestinal stromal tumor and sarcoma

263

1.45

1.26

4.4

4.2

98.00

92.87

ng/l

0.09

232

Female infertility, cervical, vaginal, other or unspecified origin

724

4363

1.08

1.26

2.8

3.4

74.37

78.17

ng/l

0.32

648

3842

Parkinson's disease

501

4588

1.10

1.26

2.9

3.8

86.31

98.62

ng/l

1.37

403

3864

Infections of genitourinary tract in pregnancy

253

2231

1.14

1.25

3.3

88.63

75.52

ng/l

1.28

217

1931

Certain zoonotic bacterial diseases

400

1.35

1.25

3.6

3.7

87.34

79.68

ng/l

0.27

356

Divergent concomitant strabismus

201

1746

1.16

1.25

3.7

3.8

87.83

80.74

ng/l

0.47

180

1535

Burn and corrosion of wrist and hand

745

1.25

1.24

3.6

4.7

89.57

80.73

ng/l

0.44

679

Twin gestation

148

1741

0.84

1.24

3.0

3.8

63.64

79.30

ng/l

3.16

138

1575

Preterm labour and delivery

749

6972

1.08

1.23

3.5

82.72

79.28

ng/l

0.46

649

6101

Benign neoplasm: Conjunctiva

792

1.24

1.23

4.2

3.8

86.76

84.86

ng/l

0.09

694

Benign neoplasm: Larynx

702

1.26

1.23

3.0

3.9

83.58

93.73

ng/l

0.58

616

Acute alcohol intoxication ICD-9

711

1.25

1.22

3.6

4.6

90.48

100.95

ng/l

0.45

633

Schizotypal disorder

410

1.34

1.21

2.7

4.0

71.03

79.90

ng/l

0.38

371

Serous carcinoma of ovary, including Hilmo

1002

0.79

1.21

2.6

3.2

73.47

82.54

ng/l

0.72

836

Benign lipomatous neoplasm of intrathoracic organs

0.00

1.21

0.0

3.6

—

78.05

—

Disorders of optic chiasm

2.80

1.20

2.8

3.7

92.20

87.65

ng/l

—

Simple and mucopurulent chronic bronchitis

122

1022

1.21

1.19

4.9

4.1

91.17

90.35

ng/l

0.03

103

880

Benign neoplasm: Nasopharynx

199

1.50

1.19

2.3

3.4

72.75

82.07

ng/l

0.42

178

Bilateral sagittal split ramus osteotomy operation

601

0.74

1.19

2.3

3.8

71.79

77.77

ng/l

0.34

545

Small cell lung cancer, helper endpoint

554

0.73

1.19

3.3

3.8

99.69

98.28

ng/l

0.02

476

Frostbite

207

1.48

1.19

4.4

3.9

128.25

82.16

ng/l

1.18

192

Benign neoplasm: Tongue

679

1.26

1.18

4.4

3.7

96.44

84.77

ng/l

0.27

600

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

2.68

1.18

8.2

2.6

106.40

60.84

ng/l

—

Symptoms and signs involving appearance and behaviour

150

1.57

1.18

3.3

3.4

99.50

73.63

ng/l

0.57

135

Other/unspecified mastoiditis and related conditions

103

1.72

1.17

4.4

3.7

96.73

82.76

ng/l

0.25

Malignant neoplasm of testis, including Hilmo

275

1.40

1.16

6.9

4.6

125.73

97.33

ng/l

0.93

247

Vestibular neuronitis

265

2362

1.13

1.15

4.0

3.9

92.59

92.37

ng/l

0.01

219

2043

Operations for atrial fibrillation

337

1.37

1.14

4.1

4.0

136.41

92.35

ng/l

1.38

295

Frontotemporal dementia

136

1.61

1.14

3.1

3.3

83.29

82.36

ng/l

0.02

122

Congenital malformations of uterus and cervix

345

1.35

1.13

4.0

3.5

66.08

72.60

ng/l

0.37

315

Propionic acid derivatives

1034

4894

1.07

1.13

3.4

6.0

85.34

112.07

ng/l

12.06

909

4303

MS-disease / Multiple Sclerosis

174

1509

1.16

1.13

2.7

3.7

64.74

79.17

ng/l

2.80

149

1352

Other congenital malformations of face and neck

557

1.27

1.12

3.6

4.3

83.19

78.59

ng/l

0.14

505

Assault by blunt object

243

1.42

1.12

4.0

4.8

90.08

85.68

ng/l

0.10

225

Myasthenia gravis

408

1.33

1.12

3.9

4.1

98.04

85.78

ng/l

0.30

365

Injury of muscle and tendon at ankle and foot level

469

1.30

1.12

3.0

4.0

69.79

80.39

ng/l

0.80

421

Malignant neoplasm of testis

235

1.43

1.11

7.1

4.4

132.85

92.01

ng/l

1.39

213

Inflammatory disease of cervix uteri

208

1833

1.15

1.10

3.2

81.99

80.86

ng/l

0.08

172

1542

Colon adenocarcinoma

360

3271

1.11

1.10

3.7

105.66

97.70

ng/l

0.81

319

2713

Exposure to excessive natural cold

211

1.45

1.09

5.2

4.2

116.13

89.74

ng/l

0.62

187

Other deformities of toe(s)

105

877

1.21

1.09

3.6

3.5

94.34

88.40

ng/l

0.29

744

Benign neoplasm: Respiratory system, unspecified

2.13

1.09

4.8

3.9

113.00

73.93

ng/l

—

Benign neoplasm: Brain, supratentorial

331

1.36

1.09

4.7

3.9

87.74

76.64

ng/l

0.30

297

Melanoma in situ of trunk

376

1.33

1.08

3.5

4.1

105.75

90.71

ng/l

0.44

334

Bus occupant injured in other and unspecified transport accidents

138

1.57

1.07

6.4

2.9

156.53

72.30

ng/l

1.20

123

Pedestrian injured in collision with car, pick-up truck or van

553

1.27

1.07

4.9

3.9

117.07

84.40

ng/l

0.91

493

Cerebral atherosclerosis

297

1.37

1.06

4.4

3.8

92.65

89.57

ng/l

0.08

260

Carcinoma in situ of breast, intraductal

289

2605

1.12

1.06

3.0

3.2

79.86

80.20

ng/l

0.02

241

2201

Other demyelinating diseases of the central nervous system

697

1.23

1.06

4.7

3.7

87.94

78.42

ng/l

0.37

630

Gestational [pregnancy-induced] hypertension

633

5886

1.08

1.05

4.0

3.2

81.02

75.15

ng/l

0.95

574

5194

Other corneal oedema

214

1.45

1.05

3.2

3.5

111.21

81.04

ng/l

0.80

188

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.83

1.04

2.4

3.8

153.14

67.77

ng/l

0.61

Congenital mitral valve regurgitation

1.97

1.04

6.8

7.6

57.11

52.02

ng/l

—

Polyhydramnios

817

1.21

1.03

4.5

3.8

79.37

76.73

ng/l

0.10

739

Sequelae of tuberculosis

449

1.29

1.03

3.0

3.7

92.90

96.20

ng/l

0.11

379

Other sexually transmitted chlamydial diseases

105

882

1.20

1.01

4.4

4.2

71.39

73.89

ng/l

0.12

811

Acute myeloid leukaemia and myelodysplastic syndromes

459

1.28

1.01

2.8

3.8

66.55

93.84

ng/l

3.61

394

Malignant neoplasm of lip, including Hilmo

232

1.41

1.01

5.1

4.0

126.59

101.43

ng/l

0.64

200

Dysplastic lesion of the vagina of unknown severity

0.00

1.00

0.0

3.8

—

84.61

—

LSIL lesion of the vagina

354

1.33

1.00

5.0

3.0

94.72

73.97

ng/l

0.56

318

Oral leukoplakia, including avohilmo

677

1.23

0.99

4.1

3.9

74.02

85.66

ng/l

1.13

601

Carcinoma in situ of other and unspecified genital organs

488

1.27

0.99

4.2

3.0

92.25

76.59

ng/l

0.92

424

Benign neoplasm of other and unspecified female genital organs

143

1240

1.17

0.99

3.2

95.64

78.00

ng/l

1.13

118

1047

Subarachnoid haemorrhage

317

2882

1.11

0.99

4.7

3.6

99.46

90.65

ng/l

0.85

279

2442

Left hemicolectomy

596

1.25

0.99

4.6

3.7

105.46

90.93

ng/l

0.44

525

Frontotemporal dementia, wide, incl. Pick's disease

158

1.50

0.98

3.0

3.5

81.80

85.74

ng/l

0.12

140

Other and unspecified disorders of psychological development

263

1.37

0.97

4.6

7.3

54.92

51.85

ng/l

0.24

257

LeFortI or BSSO operation

724

0.79

0.96

2.7

3.9

70.16

79.29

ng/l

0.69

658

Benign neoplasm: Floor of mouth

1.79

0.96

4.0

4.9

128.33

83.82

ng/l

0.56

Glaucoma, exfoliation

389

3579

1.09

0.95

3.1

3.3

90.56

95.11

ng/l

0.36

320

2937

Other disorders of peripheral nervous system

134

1.54

0.95

2.2

3.8

73.83

80.23

ng/l

0.18

114

Malignant neoplasm of brain

689

0.79

0.95

2.4

4.4

82.44

90.08

ng/l

0.20

614

Complications following abortion and ectopic and molar pregnancy

112

957

1.19

0.95

2.5

3.2

88.24

76.86

ng/l

0.38

817

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

194

1721

1.13

0.94

3.4

3.0

72.75

71.78

ng/l

0.07

172

1531

Other sexually transmitted chlamydial diseases

157

1372

1.15

0.94

4.6

4.0

69.92

72.51

ng/l

0.16

135

1265

Tooth agenesis EXCLUDE clefts and syndromes

707

1.21

0.94

8.7

5.2

82.13

64.65

ng/l

0.78

664

Sequelae of transport accidents

1.68

0.94

3.4

3.1

84.19

73.03

ng/l

0.56

Dissocial personality disorder

235

1.38

0.93

2.8

5.1

74.82

92.61

ng/l

0.58

218

Other meningitis

340

1.32

0.93

5.5

3.7

87.33

77.24

ng/l

0.42

303

Benign neoplasm: Other and unspecified parts of mouth

820

1.20

0.93

4.2

3.7

99.19

85.14

ng/l

1.08

723

Injury of blood vessels at wrist and hand level

135

1.52

0.92

7.0

3.5

152.65

80.77

ng/l

0.97

127

Endometroid carcinoma of ovary, including Hilmo

253

0.65

0.92

3.1

85.29

75.82

ng/l

0.32

220

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

738

1.21

0.92

3.0

3.7

86.76

94.88

ng/l

0.59

630

Benign neoplasm: Connective and other soft tissue of pelvis

1.99

0.91

5.3

6.6

85.50

68.28

ng/l

—

Other acquired deformities of musculoskeletal system and connective tissue

123

1062

1.17

0.91

3.4

3.8

89.20

86.44

ng/l

0.12

104

931

Crushing injury of head

2.13

0.90

1.2

3.7

80.50

71.86

ng/l

—

Chronic myeloproliferative disease

343

1.31

0.90

2.2

3.7

79.29

82.42

ng/l

0.10

300

Injury of nerves and spinal cord at neck level

486

1.25

0.89

3.2

3.9

66.63

87.57

ng/l

1.55

429

Chylothorax

1.86

0.88

3.2

5.5

67.25

88.16

ng/l

—

Macular hole

190

1696

1.13

0.88

4.1

3.6

90.27

90.32

ng/l

0.00

155

1430

Diseases caused by chlamydiae

213

1.39

0.87

4.1

3.5

84.83

71.92

ng/l

0.20

192

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

2.03

0.87

5.8

5.2

78.82

110.60

ng/l

—

Benign neoplasm of male genital organs

416

1.27

0.86

4.8

5.1

108.08

112.96

ng/l

0.10

366

Poor fetal growth

225

2027

1.11

0.85

4.7

3.3

78.16

74.06

ng/l

0.28

204

1832

Fall on and from ladder

200

1793

1.12

0.85

3.8

4.4

89.11

100.33

ng/l

0.97

181

1590

Intussusception

507

1.24

0.85

3.8

3.7

71.88

77.84

ng/l

0.30

442

Maternal care for known or suspected malpresentation of fetus

325

2567

0.91

0.85

2.9

3.7

66.45

77.10

ng/l

1.45

298

2342

Congenital malformations of eyelid, lacrimal apparatus and orbit

180

1.42

0.84

5.7

7.4

70.93

61.98

ng/l

0.21

169

Endometriosis ASRM stages 3,4

709

6700

1.06

0.84

3.4

3.2

77.52

79.69

ng/l

0.33

594

5723

Abnormal reflex

1.59

0.84

4.3

3.8

119.80

77.86

ng/l

—

Secondary malignant neoplasm of respiratory and digestive organs

409

0.74

0.84

1.6

3.5

103.95

91.87

ng/l

0.15

355

Suppurative otitis media, unspecified

507

1.24

0.84

6.3

3.7

101.23

77.79

ng/l

0.65

455

Other disorders of breast and lactation associated with childbirth

249

1.34

0.83

3.3

3.7

58.68

69.41

ng/l

1.05

226

Intestinal helminthiases, other/unspecified

1.67

0.83

4.3

3.2

78.23

74.78

ng/l

0.11

Other and unspecified hydrocephalus

455

1.25

0.82

3.2

3.8

89.63

82.15

ng/l

0.25

408

Drowning and submersion while in natural water

0.51

0.81

2.2

4.3

45.60

93.90

ng/l

—

Normal-pressure hydrocephalus

127

1445

0.87

0.80

2.5

3.6

74.18

98.32

ng/l

4.02

107

1207

Contact with and exposure to communicable diseases

718

6766

1.06

0.80

4.1

4.2

75.53

79.66

ng/l

0.63

606

6139

Chondromalacia

621

1.21

0.79

3.3

4.1

61.42

85.01

ng/l

3.23

564

Blepharospasm

235

1.35

0.79

3.7

3.0

75.71

75.30

ng/l

0.02

214

Adenocarcinoma and papillary adenocarcinoma of stomach

603

1.21

0.79

3.9

3.4

103.19

93.32

ng/l

0.32

514

Cyst of Bartholin Gland

101

871

1.17

0.79

3.1

3.3

80.61

74.51

ng/l

0.26

765

Other protozoal intestinal diseases

412

1.25

0.79

3.5

84.93

72.64

ng/l

0.46

373

Congenital varicose veins

1.59

0.78

6.5

4.7

117.48

69.15

ng/l

0.96

Antepartum haemorrhage, not elsewhere classified

175

1567

1.12

0.77

2.9

3.8

65.76

78.98

ng/l

1.69

164

1428

Spinal enthesopathy

686

1.19

0.77

4.0

3.3

118.71

100.57

ng/l

0.39

540

Aggressive periodontitis

505

1.23

0.77

5.7

3.9

104.61

87.51

ng/l

0.64

453

Lichen sclerosus et atrophicus

331

3062

1.09

0.76

3.0

3.1

80.23

80.68

ng/l

0.04

287

2556

Benign neoplasm: Vagina

352

1.28

0.76

3.7

2.9

76.92

74.66

ng/l

0.07

309

Retinoschisis and retinal cysts

597

1.21

0.76

4.1

3.7

96.93

86.94

ng/l

0.44

522

Other congenital malformations of digestive system

1.71

0.76

5.0

4.1

69.11

71.52

ng/l

—

All dysplastic lesions of the cervix uteri

605

5662

1.06

0.76

3.6

3.4

78.87

75.41

ng/l

0.40

552

5030

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

2.17

0.76

2.0

1.7

29.40

66.47

ng/l

—

Conditions involving the integument and temperature regulation of fetus and newborn

2.13

0.75

9.4

8.1

63.60

44.48

ng/l

—

Complications predominantly related to the puerperium

676

6405

1.06

0.75

2.7

3.4

72.02

76.12

ng/l

0.73

590

5654

Toxic effect of contact with venomous animals

111

970

1.15

0.74

3.6

4.1

77.25

84.67

ng/l

0.57

101

863

Respiratory tuberculosis, confirmed

398

1.25

0.74

4.6

4.0

95.10

90.69

ng/l

0.12

350

Benign neoplasm: Thymus

1.62

0.72

8.9

3.3

64.00

86.32

ng/l

—

Parkinson's disease, strict definition

457

4289

1.07

0.72

2.9

3.8

82.22

99.37

ng/l

4.10

368

3621

Folliculitis decalvans

1.78

0.72

4.6

3.5

81.43

76.76

ng/l

—

Other puerperal infections

142

1262

1.13

0.72

2.6

3.3

62.35

71.25

ng/l

1.26

133

1139

Other/unspecified postprocedural disorders of ear and mastoid process

1.63

0.72

3.3

3.6

76.16

86.80

ng/l

0.30

Superficial injury of neck

345

1.26

0.72

3.4

4.7

77.14

80.75

ng/l

0.09

324

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

124

1095

1.14

0.72

4.0

3.7

94.59

83.37

ng/l

0.64

111

957

HSIL lesion of the cervix uteri, vagina or vulva

468

4394

1.07

0.72

3.9

3.3

86.05

75.65

ng/l

1.46

426

3893

Retained placenta and membranes, without haemorrhage

295

3191

0.92

0.71

2.9

3.4

80.21

77.50

ng/l

0.24

253

2775

Superficial frostbite

118

1.47

0.71

5.1

4.1

143.91

87.04

ng/l

0.77

107

Unspecified multiple injuries

1.65

0.71

3.0

4.4

83.64

84.79

ng/l

0.03

Degeneration of the brain due to alcohol

464

1.22

0.71

2.9

4.4

114.13

101.89

ng/l

0.23

414

Transient global amnesia

296

2738

1.09

0.71

3.1

3.8

85.88

94.65

ng/l

0.86

250

2316

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

130

1151

1.14

0.71

2.7

3.0

72.31

70.97

ng/l

0.08

120

1036

Cerebral oedema

1.73

0.70

9.3

6.0

77.00

77.74

ng/l

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

560

5294

1.06

0.70

3.2

3.8

92.51

94.56

ng/l

0.17

480

4480

Tuberculosis

187

1694

1.11

0.70

3.5

3.6

90.56

97.50

ng/l

0.59

154

1408

Acute drug-induced interstitial lung disorder

179

1.37

0.69

5.8

3.8

123.37

84.90

ng/l

1.09

156

Maxillary prognathism

1.53

0.69

5.2

6.6

70.50

68.58

ng/l

0.04

Degeneration of nervous system due to alcohol

466

1.22

0.68

2.9

4.3

114.13

102.04

ng/l

0.23

413

Malignant neoplasm of ovary, including Hilmo

171

1889

0.90

0.68

3.1

78.74

82.01

ng/l

0.21

149

1573

Other diseases caused by chlamydiae

241

1.31

0.68

3.9

3.5

82.92

69.86

ng/l

0.23

215

Guttate psoriasis

277

1.28

0.67

5.2

3.5

123.73

75.69

ng/l

1.04

249

Congenital ovarian cysts

819

1.16

0.67

3.6

3.2

94.08

71.74

ng/l

0.85

736

Respiratory tuberculosis, bacteriologically and histologically confirmed

413

1.23

0.66

4.5

3.9

95.10

90.93

ng/l

0.11

362

Non-allergic asthma

248

2283

1.09

0.66

4.2

4.3

95.48

87.79

ng/l

0.62

216

1991

Adhesive middle ear disease

305

1.26

0.65

3.6

4.0

109.81

75.78

ng/l

0.65

277

Shigellosis

129

1.42

0.65

6.9

3.3

121.37

70.51

ng/l

0.68

115

Benign neoplasm: Other parts of oropharynx

199

1.33

0.64

3.8

4.0

75.35

83.95

ng/l

0.29

180

Contact with blunt object, undetermined intent

121

1.44

0.64

6.8

4.0

86.53

78.11

ng/l

0.15

111

Distal bite

827

1.15

0.63

10.0

5.8

63.55

61.53

ng/l

0.16

786

Abscess of Bartholin gland

544

1.19

0.63

4.5

3.4

75.16

75.34

ng/l

0.01

485

Occupant of railway train or railway vehicle injured in transport accident

0.00

0.63

0.0

3.2

—

58.09

—

Infectious mononucleosis

152

1371

1.11

0.63

4.1

4.2

67.93

71.07

ng/l

0.29

141

1259

Carcinoma in situ of uteri, other/unspecified

140

0.63

0.62

2.3

3.2

48.78

71.95

ng/l

—

125

Other obstetric trauma

942

0.87

0.62

2.9

3.4

73.09

72.27

ng/l

0.03

854

Unspecified chronic bronchitis

825

1.15

0.62

5.3

3.7

108.61

95.54

ng/l

0.66

707

Use of rasagiline

659

1.17

0.61

2.3

3.9

72.89

92.08

ng/l

1.90

571

Carcinoma in situ of other and unspecified sites

100

884

1.14

0.61

4.5

4.3

104.87

102.06

ng/l

0.10

773

Injury of heart

1.56

0.60

5.8

3.7

121.00

78.15

ng/l

—

Contact with other hot fluids

631

1.17

0.60

4.7

4.8

85.13

76.74

ng/l

0.38

569

Generalized epilepsy, strict definition

446

1.20

0.59

3.1

4.8

86.86

72.00

ng/l

0.42

410

Small cell lung cancer

497

0.82

0.59

3.3

3.4

99.69

93.16

ng/l

0.13

420

Small cell lung cancer, including Hilmo

497

0.82

0.59

3.3

3.4

99.69

93.16

ng/l

0.13

420

Other acute disseminated demyelination

175

1.33

0.59

6.7

3.3

89.24

70.73

ng/l

0.38

161

Alcohol abuse counselling and surveillance

265

0.75

0.59

3.9

5.0

109.60

89.90

ng/l

0.22

242

Non-small cell lung cancer, including Hilmo

448

3990

1.06

0.59

2.9

3.9

82.60

98.76

ng/l

4.36

393

3347

Outcome of delivery

317

2098

0.93

0.58

2.6

3.6

58.97

75.97

ng/l

6.86

297

1893

Chronic mastoiditis

624

1.17

0.58

3.8

92.77

89.15

ng/l

0.16

545

Diseases caused by chlamydiae

265

1.26

0.58

3.8

4.0

80.44

69.98

ng/l

0.18

242

Calcaneal spur

293

1.25

0.57

2.3

3.4

65.11

82.30

ng/l

1.54

264

Use of ropinirole

104

927

1.13

0.57

2.4

3.9

88.08

93.20

ng/l

0.22

809

Congenital ichthyosis

1.57

0.56

10.4

3.9

226.89

77.94

ng/l

—

Habit and impulse disorders

257

1.26

0.56

1.7

5.0

79.20

79.13

ng/l

0.00

241

Congenital hypothyroidism without goiter

125

1.40

0.56

7.5

5.0

125.76

69.36

ng/l

0.91

115

Use of rivastigmine

536

5093

1.05

0.55

2.5

3.4

79.54

97.92

ng/l

7.27

435

4135

Hypertrophy of bone

1.51

0.55

2.4

4.4

58.78

79.35

ng/l

—

Other osteochondropathies

162

1480

1.10

0.55

4.1

4.3

93.83

85.82

ng/l

0.65

142

1332

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

169

1.33

0.55

3.2

3.9

90.44

82.13

ng/l

0.27

148

Malignant neoplasm of palate

1.58

0.55

4.6

4.2

70.10

84.89

ng/l

—

Syndactyly

1.51

0.55

6.0

3.9

86.44

76.10

ng/l

—

Malignant neoplasm, without specification of site, including Hilmo

131

1184

1.11

0.55

3.4

3.3

76.29

92.99

ng/l

1.94

115

989

Bullous keratopathy

214

1.29

0.54

2.8

3.8

71.68

84.50

ng/l

0.61

188

Alzheimer’s disease (Early onset), excluding more controls

866

0.88

0.54

2.8

3.5

89.33

97.39

ng/l

0.27

723

Other appendicitis

216

2002

1.08

0.53

5.2

3.9

101.58

87.70

ng/l

0.99

195

1766

Carcinoma in situ of cervix uteri, exocervix

134

0.66

0.53

2.9

3.5

61.00

74.65

ng/l

—

129

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

197

1.29

0.53

2.9

4.0

65.85

85.19

ng/l

1.09

175

Follicular lymphoma, hilmo

125

1134

1.11

0.51

3.1

3.8

74.80

90.51

ng/l

1.16

980

Malignant neoplasm of pancreas

165

1794

0.91

0.51

3.6

3.5

78.04

95.93

ng/l

2.24

138

1501

Noise effects on inner ear

801

1.13

0.51

4.1

5.1

101.36

104.37

ng/l

0.08

712

Exposure to excessive natural heat

1.61

0.50

6.3

4.4

119.29

79.94

ng/l

—

Burn and corrosion of head and neck

390

1.19

0.50

2.4

4.5

69.10

82.32

ng/l

0.69

355

Transient acantholytic dermatosis [Grover]

1.55

0.49

1.7

5.0

95.71

90.60

ng/l

—

Respiratory tuberculosis

152

1395

1.10

0.49

3.7

3.6

89.91

96.54

ng/l

0.48

129

1175

Respiratory tuberculosis, confirmed and not-confirmed

152

1396

1.10

0.49

3.7

3.6

89.91

96.62

ng/l

0.49

129

1176

Other diseases caused by chlamydiae

290

1.22

0.49

3.7

3.9

79.03

69.55

ng/l

0.18

261

Varicose veins of other sites

163

1502

1.09

0.48

3.1

4.1

72.33

91.88

ng/l

2.94

138

1314

Pedal cyclist injured in collision with motor vehicle

645

0.86

0.48

1.8

4.1

84.77

81.80

ng/l

0.09

578

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

147

1.32

0.47

2.0

3.9

53.93

89.88

ng/l

3.86

130

Non-small cell lung cancer, squamous

1024

0.89

0.47

2.7

3.6

67.45

98.68

ng/l

4.57

860

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

789

1.12

0.46

4.1

4.5

77.80

79.27

ng/l

0.07

711

Malignant neoplasm of bronchus and lung

506

4388

0.95

0.46

2.9

3.9

82.22

99.40

ng/l

5.24

437

3680

Other fibroblastic disorders

1.48

0.45

6.3

2.6

109.90

70.53

ng/l

—

Inflammation of lacrimal passages (acute and unspecified)

432

1.17

0.45

4.8

3.5

116.58

80.13

ng/l

1.49

382

Malignant neoplasm of brain, including Hilmo

1073

0.90

0.45

2.9

4.1

86.35

89.50

ng/l

0.11

945

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

238

2533

0.94

0.45

3.1

3.9

94.05

97.55

ng/l

0.21

197

2142

Dermatitis due to ingested food

703

1.12

0.45

7.0

6.9

58.11

56.40

ng/l

0.10

671

Traumatic amputation of hip and thigh

1.68

0.44

30.2

2.7

150.40

70.38

ng/l

—

Neuromyelitis optica

1.46

0.44

6.6

3.4

59.56

73.31

ng/l

—

Enterobiasis

340

1.19

0.44

3.4

5.3

72.32

64.91

ng/l

0.28

315

Abnormal pulmonary venous return

1.48

0.44

10.3

5.7

72.80

58.18

ng/l

—

Benign neoplasm: Lip

509

1.15

0.43

3.2

4.0

76.91

87.88

ng/l

0.72

455

Marfan's syndrome

105

1.36

0.42

3.9

4.2

106.29

83.62

ng/l

0.61

Fibrosarcoma

172

0.74

0.42

4.2

3.9

100.83

81.73

ng/l

0.43

156

Other bursitis of knee

277

1.20

0.42

4.5

4.2

79.56

88.82

ng/l

0.37

248

Leprosy [Hansen's disease]

0.00

0.41

0.0

2.8

—

63.19

—

Burn and corrosion of hip and lower limb, except ankle and foot

464

1.15

0.41

3.2

4.3

84.68

81.27

ng/l

0.08

418

Evidence of alcohol involvement determined by level of intoxication

168

1.26

0.41

6.5

4.4

82.55

77.02

ng/l

0.10

155

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

194

1816

1.07

0.41

3.4

3.3

72.75

73.94

ng/l

0.08

172

1607

Operations 1 for CAVS

1.34

0.40

4.3

7.0

48.88

65.34

ng/l

—

Perforation of oesophagus

1.37

0.40

3.0

3.6

99.31

85.10

ng/l

0.22

Colorectal neuroendocrine tumor and carcinoma

297

1.19

0.40

4.3

3.6

101.46

77.31

ng/l

0.65

266

Congenital aortic valve stenosis

106

1.35

0.40

4.1

7.2

47.55

59.79

ng/l

0.68

101

Malignant neoplasm of other and unspecified parts of tongue

316

1.18

0.40

3.1

3.4

64.56

83.57

ng/l

0.94

280

Adenocarcinoma and papilloma adenocarcinoma of rectum

229

2427

0.94

0.40

3.1

3.8

95.19

97.96

ng/l

0.15

189

2043

Endometriosis of rectovaginal septum and vagina

220

2072

1.07

0.39

2.9

3.2

77.78

82.39

ng/l

0.34

168

1778

Other acantholytic disorders

1.36

0.39

1.8

4.2

95.56

88.51

ng/l

—

Other disorders of amniotic fluid and membranes

240

2479

0.94

0.38

2.8

3.7

66.29

78.36

ng/l

2.06

203

2248

Cholesteatoma of middle ear

143

1329

1.08

0.38

3.9

3.8

96.38

92.30

ng/l

0.22

120

1142

Oral lichen planus, including avohilmo , including avohilmo

193

1814

1.07

0.38

3.0

3.6

86.65

84.23

ng/l

0.10

160

1554

Malignant neoplasm of heart, mediastinum and pleura

267

0.82

0.37

2.4

4.1

93.07

102.07

ng/l

0.11

231

Use of riluzole

0.62

0.36

1.4

3.8

66.40

73.79

ng/l

—

Alzheimer’s disease (Late onset)

848

6935

1.03

0.36

2.7

3.5

88.23

100.17

ng/l

3.92

682

5679

Malignant neoplasm of tongue, including Hilmo

584

1.12

0.36

2.8

3.6

68.13

88.62

ng/l

1.88

518

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

480

1.13

0.36

3.1

3.3

64.93

86.60

ng/l

1.82

426

Other and unspecified degenerative diseases of nervous system

661

1.11

0.35

3.4

3.6

94.97

95.30

ng/l

0.01

572

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

181

1.23

0.35

2.6

3.5

75.07

82.57

ng/l

0.24

166

Colorectal adenocarcinoma

586

5654

1.04

0.35

3.4

3.8

101.50

97.60

ng/l

0.42

507

4741

Use of amantadine

386

1.15

0.35

3.4

3.3

69.20

77.83

ng/l

0.67

339

Deep endometriosis

248

2609

0.95

0.35

2.9

3.1

75.68

79.15

ng/l

0.28

192

2194

Optic neuritis

853

1.10

0.35

3.8

3.7

79.81

78.90

ng/l

0.04

764

Cyst of spleen

1.36

0.35

7.7

4.4

62.17

75.35

ng/l

—

Malignant neoplasm of corpus uteri, including Hilmo

323

3092

1.05

0.34

3.4

3.1

92.56

84.30

ng/l

1.02

258

2539

Use of galantamine

265

2525

1.05

0.34

2.7

3.3

83.26

98.27

ng/l

1.87

211

2054

Malignant neoplasm of tongue

425

1.14

0.34

2.8

3.6

66.95

87.26

ng/l

1.33

379

Ectopic pregnancy

467

4504

1.04

0.34

3.0

3.4

73.82

78.22

ng/l

0.80

408

3954

Anisometropia and aniseikonia

740

1.10

0.33

4.8

3.9

104.08

78.99

ng/l

0.50

658

Congenital malformations of breast

275

1.17

0.33

2.3

3.5

67.33

68.85

ng/l

0.07

250

Other mosquito-borne viral fevers

132

0.75

0.33

1.9

3.3

53.82

76.64

ng/l

—

117

HSIL lesion of the cervix uteri

392

3773

1.04

0.32

3.7

3.3

79.97

74.57

ng/l

0.51

359

3380

Labour and delivery complicated by umbilical cord complications

110

1021

1.08

0.32

2.4

3.3

66.82

73.56

ng/l

0.50

910

Undefined dementia

383

3397

1.04

0.32

3.1

3.2

96.28

99.17

ng/l

0.22

292

2765

Puerperal sepsis

375

3610

1.04

0.31

2.6

3.3

77.55

78.00

ng/l

0.03

312

3150

Occupant of pick-up truck or van injured in other and unspecified transport accidents

100

0.69

0.31

5.4

4.5

94.46

79.12

ng/l

—

Migraine without aura, drug-induced

218

0.82

0.31

4.8

3.4

131.88

73.40

ng/l

0.79

194

Fibrosarcoma, including Hilmo

196

0.81

0.31

3.9

89.42

79.15

ng/l

0.24

176

Congenital musculoskeletal deformities of head, face, spine and chest

231

1.18

0.30

8.6

5.6

68.11

69.42

ng/l

0.05

221

Carcinoma in situ, bladder

813

1.09

0.30

4.5

4.2

109.62

101.69

ng/l

0.29

709

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

401

1.13

0.30

3.8

3.5

81.89

92.00

ng/l

0.47

349

Malignant neoplasm of cervix uteri, including Hilmo

592

1.11

0.30

6.0

3.1

107.42

77.83

ng/l

1.25

522

Malignant neoplasm of uterus, part unspecified, including Hilmo

130

1.25

0.30

4.6

2.6

138.50

84.77

ng/l

—

108

Surgical ablation of atrial fibrillation

110

0.72

0.29

4.5

4.2

109.41

85.42

ng/l

—

100

malignant neoplasm of female genital organs

511

4927

1.03

0.29

3.3

3.1

85.73

83.86

ng/l

0.21

422

4054

Malignant neoplasm of lip

158

1.22

0.29

5.9

4.1

121.36

97.44

ng/l

0.70

137

Malignant neoplasm of rectum

234

2447

0.95

0.28

3.3

3.8

96.95

97.82

ng/l

0.04

191

2063

Maternal care for other known or suspected fetal problems

451

2951

0.97

0.28

3.3

3.7

70.34

75.70

ng/l

0.60

406

2691

Other menopausal disorders

888

4888

1.03

0.28

2.6

3.3

73.64

81.61

ng/l

2.70

767

4247

Congenital hydrocephalus

1.26

0.28

3.9

29.88

65.10

ng/l

—

Contact with sharp object, undetermined intent

413

1.12

0.27

3.0

4.9

116.53

85.99

ng/l

0.63

373

Malignant neoplasm, without specification of site

788

1.08

0.27

3.0

3.4

72.51

97.08

ng/l

2.96

660

Foreign body on external eye

327

3151

1.04

0.27

4.3

4.8

91.94

99.56

ng/l

0.69

294

2843

Gestational diabetes (for exclusion)

760

5416

0.97

0.27

3.5

73.26

73.46

ng/l

0.02

685

4923

Other specified/unspecified disorders of tympanic membrane

1.30

0.27

10.7

4.0

111.18

80.41

ng/l

0.25

Erysipeloid

1.30

0.27

3.5

2.7

135.17

66.29

ng/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

410

1.12

0.26

11.6

9.7

59.30

50.11

ng/l

0.51

405

Abnormal findings on antenatal screening of mother

127

1197

1.06

0.26

2.5

3.5

66.31

72.48

ng/l

0.42

114

1092

Otosclerosis

216

2068

1.05

0.26

3.7

3.9

93.80

90.95

ng/l

0.14

182

1776

Other maternal disorders predominantly related to pregnancy

1727

10665

1.02

0.25

3.5

3.4

79.65

76.85

ng/l

0.66

1517

9296

Congenital malformations of eyelid, lacrimal apparatus and orbit

217

1.16

0.25

5.7

6.9

70.93

61.30

ng/l

0.23

206

Contact with other sharp object(s)

136

1288

1.06

0.25

4.8

4.6

76.33

83.56

ng/l

0.59

119

1168

Purulent endophthalmitis

152

1.20

0.24

7.4

3.4

149.30

84.58

ng/l

0.72

133

Pregnancy examination and test

323

1938

1.04

0.24

2.8

3.6

67.30

74.54

ng/l

1.01

294

1741

Endometriosis diagnosis and infertility diagnosis occurring together

214

2229

0.96

0.23

2.5

3.3

65.21

74.67

ng/l

1.71

194

1983

Malignant neoplasm of eye, brain and central nervous system

929

0.93

0.23

3.2

4.2

87.21

90.48

ng/l

0.11

817

Communicating hydrocephalus

544

1.09

0.23

4.2

3.8

85.54

84.55

ng/l

0.04

477

Use of levodopa decarbox-comt-inhibitor

835

0.93

0.23

2.6

4.0

82.08

98.91

ng/l

1.51

718

Contact with machinery

246

2370

1.04

0.23

4.7

98.68

104.79

ng/l

0.43

218

2113

Perichondritis of external ear

429

1.10

0.23

3.8

96.63

85.51

ng/l

0.34

378

Use of selegiline

113

1193

0.94

0.22

2.6

3.8

70.71

96.24

ng/l

4.62

1022

Carcinoma in situ of other/unspecified female genital organs

0.00

0.22

0.0

1.5

—

66.20

—

Crushing injury of thorax and traumatic amputation of part of thorax

0.00

0.22

0.0

7.9

—

94.45

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

1.20

0.22

2.0

6.3

65.20

89.55

ng/l

—

Contact with nonpowered hand tool

827

1.07

0.21

5.0

4.6

83.98

91.12

ng/l

0.33

749

Pectus excavatum

103

0.77

0.21

5.5

6.7

76.96

62.13

ng/l

—

Myiasis

0.00

0.21

0.0

2.8

—

70.62

—

Malignant neoplasm of palate, including Hilmo

145

1.19

0.21

3.9

3.3

65.53

77.28

ng/l

0.60

129

Systemic atrophies primarily affecting the central nervous system

110

1043

1.06

0.21

4.5

4.2

94.42

93.97

ng/l

0.02

908

146

1390

1.05

0.21

4.0

3.3

90.93

93.71

ng/l

0.14

125

1126

Labyrinthine dysfunction

0.00

0.20

0.0

4.0

—

87.41

—

Complications of the puerperium, not elsewhere classified

717

0.93

0.20

3.3

70.99

70.33

ng/l

0.03

652

Inhalation of gastric contents

1.19

0.20

4.8

5.2

74.00

99.39

ng/l

—

Congenital malformations of breast

289

1.11

0.19

2.3

3.7

67.33

70.94

ng/l

0.17

263

Benign neoplasm: Rectum/anal canal icd-9

213

1.14

0.19

5.1

3.4

138.41

88.34

ng/l

1.02

178

Congenital malformations of oesophagus

128

1.19

0.19

4.4

81.47

66.54

ng/l

0.52

114

Non-small cell lung cancer, adenocarcinoma

164

1577

1.04

0.19

2.6

3.7

83.27

95.40

ng/l

1.41

149

1320

Respiratory tuberculosis, not confirmed

109

1038

1.05

0.18

3.2

3.7

85.46

98.14

ng/l

1.15

876

Pedal cyclist injured in collision with pedestrian or animal

128

1.18

0.18

5.4

3.4

109.23

69.14

ng/l

0.94

120

Mumps

541

1.08

0.18

3.4

4.0

79.17

80.47

ng/l

0.04

488

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1776

14214

0.99

0.18

3.6

3.7

83.31

84.77

ng/l

0.25

1569

12384

Maternal care for known or suspected fetal abnormality and damage

286

2530

0.97

0.18

2.9

3.7

64.48

78.45

ng/l

4.36

269

2310

Hydrocephalus

222

2152

1.03

0.17

3.3

3.7

76.69

92.37

ng/l

2.73

193

1798

Maxillary hypoplasia

0.72

0.17

1.2

4.9

65.40

60.80

ng/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

253

1.11

0.17

8.3

5.4

67.63

67.97

ng/l

0.01

241

Oher contracture of tendon (sheath)

1.19

0.17

6.4

4.5

95.50

90.21

ng/l

—

Acute myringitis

139

1.16

0.16

9.4

4.3

92.44

74.11

ng/l

0.56

127

Intrahepatic Cholestasis of Pregnancy (ICP)

130

1248

1.04

0.16

2.7

3.2

72.31

71.35

ng/l

0.05

120

1125

Ill-defined and unknown causes of mortality

229

2358

0.97

0.16

4.2

3.8

121.07

100.20

ng/l

1.51

176

1989

Dementia due to Parkinson's disease

637

0.94

0.16

2.5

3.9

77.16

100.49

ng/l

1.54

541

Mandibular retrognathia

139

1334

1.04

0.16

5.8

4.8

70.99

73.82

ng/l

0.20

122

1224

Unspecified maternal hypertension

193

0.88

0.16

2.3

3.2

64.74

64.88

ng/l

0.01

180

Esophageal diverticulum (pouch)

1.17

0.16

2.6

3.6

95.33

75.25

ng/l

—

Other disorders following mastoidectomy

102

1.19

0.15

3.5

3.6

85.83

91.43

ng/l

0.12

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

1.15

0.15

8.1

4.6

128.18

88.24

ng/l

—

Universal erythroderma, KELA reimbursement

274

1.10

0.15

4.6

3.8

79.26

83.68

ng/l

0.15

243

Prolapse and hernia of ovary and fallopian tube

130

1239

1.04

0.15

3.1

2.7

82.83

86.82

ng/l

0.26

104

979

Arteriovenous malformation of cerebral vessels

226

1.11

0.15

3.1

3.8

63.96

76.57

ng/l

0.73

203

Arthropod-borne viral fevers and viral haemorrhagic fevers

235

2286

1.03

0.15

3.7

4.1

92.69

92.39

ng/l

0.01

211

2016

Benign neoplasm: Lower jaw bone

0.80

0.15

4.4

4.0

109.57

73.82

ng/l

—

Pectus excavatum

0.82

0.15

6.0

80.14

63.31

ng/l

—

Abnormalities of forces of labour

231

2251

1.03

0.14

3.3

3.6

71.50

78.63

ng/l

1.02

208

2033

Non-small cell lung cancer, adenocarcinoma, helper endpoint

164

1691

0.97

0.14

2.6

3.9

83.27

95.70

ng/l

1.42

149

1451

Vascular dementia (multiple infarctions)

266

1.09

0.13

2.9

3.9

102.24

105.13

ng/l

0.05

231

Major anomalies of jaw size

561

0.94

0.13

2.9

4.6

73.99

76.08

ng/l

0.07

512

Malignant neoplasm of corpus uteri

274

2680

1.02

0.13

3.2

3.0

89.60

84.81

ng/l

0.44

219

2200

Maternal care for known or suspected disproportion

814

1.05

0.13

2.8

3.5

75.59

75.55

ng/l

0.00

738

Other congenital malformations of ear

190

1.11

0.13

4.8

6.0

58.62

64.37

ng/l

0.26

175

Polypectomy (DHB20)

149

1535

0.97

0.12

4.2

4.4

97.67

97.85

ng/l

0.01

137

1360

Postprocedural disorders of ear and mastoid process, not elsewhere classified

210

1.10

0.12

3.3

3.5

94.78

85.88

ng/l

0.24

187

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

162

1.12

0.12

3.6

4.0

57.38

74.99

ng/l

0.86

145

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

827

1.04

0.12

3.6

3.0

78.73

82.92

ng/l

0.27

692

Fall involving playground equipment

201

1.10

0.12

9.1

8.1

51.27

53.97

ng/l

0.09

194

Malignant neoplasm of rectum, including Hilmo

318

3239

0.98

0.12

3.2

3.9

92.25

97.48

ng/l

0.45

266

2727

Acquired stenosis of external ear canal

201

1.10

0.11

4.8

4.2

126.64

84.84

ng/l

0.65

185

Occupational exposure to risk-factors

729

1.05

0.11

3.6

4.4

81.78

95.29

ng/l

0.88

653

Other spirochaetal diseases

940

9305

1.01

0.11

3.0

3.9

73.21

89.85

ng/l

11.96

801

8059

Malignant neoplasm of respiratory system and intrathoracic organs

595

5015

0.99

0.11

3.0

4.0

80.96

98.88

ng/l

6.35

512

4215

Pterygium

720

0.96

0.11

2.7

3.9

95.10

96.02

ng/l

0.02

630

Lesion of sciatic nerve

123

1193

1.03

0.11

3.4

3.5

100.69

97.66

ng/l

0.08

109

997

Radiodermatitis

1.12

0.10

4.4

2.8

70.60

76.44

ng/l

—

Upper arm

1.04

0.09

6.6

4.5

76.40

82.53

ng/l

—

Other spirochaetal diseases

928

9200

1.01

0.09

2.9

3.9

72.70

89.75

ng/l

12.64

790

7962

Esophageal diverticulum (pouch)

1.14

0.09

2.7

3.0

76.50

72.44

ng/l

—

Desensitization to allergens

949

0.97

0.09

2.9

4.7

62.57

72.48

ng/l

1.13

870

Use of donepezil

714

6769

1.01

0.09

2.6

3.4

86.54

98.46

ng/l

4.39

544

5548

Mechanical strabismus

1.06

0.09

1.3

2.9

35.33

71.86

ng/l

—

Congenital malformations of oesophagus

107

1.13

0.08

4.9

4.6

68.58

66.56

ng/l

0.07

Obstructed labour due to maternal pelvic abnormality

434

4392

0.99

0.08

3.4

74.41

79.56

ng/l

0.94

390

3813

Other parasitologically confirmed or unspecified malaria

1.10

0.08

4.4

122.86

80.25

ng/l

—

Hypertrophy of (infrapatellar) fat pad

195

1.08

0.08

2.8

4.2

78.37

78.35

ng/l

0.00

180

Malignant neoplasm of oesophagus, including Hilmo

784

0.97

0.08

4.2

4.0

109.30

98.22

ng/l

0.41

685

Injury of blood vessels at forearm level

0.85

0.08

7.2

4.5

211.00

85.21

ng/l

—

Exposure to ignition of highly flammable material

0.84

0.08

1.8

4.1

119.17

77.05

ng/l

—

Benign neoplasm: Testis

0.82

0.08

7.5

5.2

62.48

92.20

ng/l

—

Injury of blood vessels at hip and thigh level

0.84

0.07

2.7

4.0

90.66

83.52

ng/l

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

1.09

0.07

2.2

3.7

68.11

69.24

ng/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

181

1841

0.98

0.07

3.6

4.1

90.03

91.81

ng/l

0.06

160

1629

Use of interferon beta-1a

413

1.04

0.06

4.1

3.8

77.39

78.39

ng/l

0.03

385

Secondary malignant neoplasm of other and unspecified sites

427

0.96

0.06

2.3

3.5

118.00

88.85

ng/l

0.37

372

Postpartum haemorrhage due to anatomy

146

1487

0.98

0.06

3.2

3.0

60.07

70.34

ng/l

1.55

135

1361

Other obstructed labour

182

1792

1.02

0.06

2.9

3.4

78.21

75.89

ng/l

0.13

159

1579

Malignant neoplasm of bronchus and lung, including Hilmo

632

5249

1.01

0.06

3.3

4.0

85.31

99.11

ng/l

3.97

542

4406

Spontaneous abortion

1363

9232

0.99

0.06

3.4

76.35

78.31

ng/l

0.36

1195

8019

Prominent ears

129

1.09

0.05

5.6

5.8

57.07

64.75

ng/l

0.24

122

Rubella [German measles]

534

1.03

0.05

5.5

4.6

112.88

96.16

ng/l

0.54

499

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1440

10922

1.00

0.05

3.5

3.3

78.54

77.58

ng/l

0.15

1314

9494

Erosion and ectropion of cervix uteri

773

1.02

0.05

3.4

78.75

83.15

ng/l

0.23

659

Beningn neoplasm: Meninges, unspecified

417

1.03

0.04

3.3

3.2

78.78

78.71

ng/l

0.00

368

Laparoscopic left hemicolectomy

423

0.97

0.04

1.9

3.9

106.28

86.36

ng/l

0.54

377

Lyme disease

908

9118

1.00

0.04

2.9

3.9

72.10

90.01

ng/l

13.67

773

7888

Other ill-defined and unspecified causes of mortality

210

2121

0.99

0.04

4.3

3.8

123.36

100.02

ng/l

1.68

165

1792

Motorcycle rider injured in other and unspecified transport accidents

954

1.02

0.04

4.7

5.2

85.78

85.56

ng/l

0.01

870

Spirochaetal infections, other/unspecified

915

9184

1.00

0.03

2.9

3.9

72.63

89.83

ng/l

12.48

780

7950

Malignant neoplasm of pancreas, including Hilmo

224

2259

0.99

0.03

3.6

80.93

97.75

ng/l

2.56

189

1878

Carcinoma in situ of breast, other/unspecified

421

0.97

0.03

2.2

3.0

63.76

77.40

ng/l

0.80

369

Malaria

102

1.08

0.03

3.5

4.1

100.36

82.58

ng/l

0.16

Mucinous and mucinous cystic tumor

112

1.08

0.03

1.8

2.5

66.83

68.69

ng/l

0.07

Medical treatment for female infertility

397

3926

1.01

0.02

3.1

3.4

75.49

73.00

ng/l

0.11

362

3577

Supervision of high-risk pregnancy

453

2738

1.00

0.02

3.1

3.6

64.72

76.86

ng/l

4.39

423

2472

Alzheimer’s disease, strict definition

893

7376

1.00

0.02

2.7

3.5

88.87

99.64

ng/l

3.29

717

6054

Carcinoma in situ of cervix uteri

186

1846

1.01

0.02

3.6

3.2

83.82

73.79

ng/l

0.67

167

1623

Left side

113

1.07

0.02

3.1

3.9

99.00

82.10

ng/l

—

Disorders of acoustic nerve

681

1.01

0.01

4.0

3.6

88.01

87.19

ng/l

0.02

600

Early lumbar disc prolapse operation

188

1870

1.01

0.01

3.9

4.1

83.96

83.48

ng/l

0.02

176

1704

Other abnormal products of conception

714

4735

1.00

0.01

3.3

3.6

71.35

75.23

ng/l

0.68

649

4286

Biological medicines for asthma

367

0.98

0.01

2.6

3.9

79.40

78.90

ng/l

0.01

336

Benign neoplasm: Cranial nerves

733

1.01

0.01

4.2

3.5

89.03

84.31

ng/l

0.15

645

Squamous cell neoplasms and carcinoma of cervix

114

1.06

0.01

10.2

2.6

107.33

74.13

ng/l

0.45

Use of dimethyl fumarate

126

0.95

0.00

3.4

3.6

72.00

74.24

ng/l

0.05

118

Benign neoplasm: Connective and other soft tissue, unspecified

264

1.02

0.00

3.1

3.6

84.41

77.07

ng/l

0.26

237

Non-small cell lung cancer

266

2634

1.00

0.00

2.6

3.8

77.74

102.51

ng/l

6.82

230

2199

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

374

0.99

0.00

2.2

3.7

79.95

95.10

ng/l

0.45

327

Osteochondrosis of ankle, juvenile

102

0.98

0.00

2.5

4.6

52.70

66.24

ng/l

—

Malignant neoplasm of oesophagus

544

0.99

0.00

3.3

4.0

76.73

97.32

ng/l

1.55

479

Arteriovenous malformation of peripheral vessels

111

0.99

0.00

5.8

4.3

68.85

70.97

ng/l

0.05

105

Morphin

432

1.00

0.00

2.5

3.4

86.15

94.94

ng/l

0.16

377

Maternal care for cervical incompetence

962

1.00

0.00

2.7

3.3

87.10

78.14

ng/l

0.28

833

L02BB Anti-androgens

228

2281

1.00

0.00

3.2

4.5

108.67

110.85

ng/l

0.11

201

1960

Failed induction of labour

917

1.00

0.00

2.9

3.6

61.65

75.65

ng/l

1.30

830

Traumatic amputation of wrist and hand

893

1.00

0.00

3.5

4.9

88.12

100.92

ng/l

0.46

800

Unattended death

195

0.97

0.00

1.8

3.9

58.00

89.03

ng/l

0.96

174

Total (external) ophthalmoplegia

0.00

0.0

1.6

—

47.50

—

Idiopathic peripheral autonomic neuropathy

0.95

0.00

4.9

4.2

130.75

85.59

ng/l

—

Malignant neoplasm of other and ill-defined sites

0.91

0.00

4.6

2.7

84.00

87.77

ng/l

—

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

0.00

0.0

1.4

—

46.74

—

Anthrax

0.00

0.0

4.6

—

117.40

—

Unspecified effects of radiation

0.00

0.0

1.8

—

58.40

—

Hereditary angioödema type 2

0.00

-0.00

0.0

1.1

—

105.53

—

Malignant neoplasm of placenta

0.00

-0.00

0.0

1.7

—

82.50

—

Malignant neoplasm of penis

0.98

-0.00

8.7

5.0

166.00

87.06

ng/l

—

Rheumatic fever without mention of heart involvement

0.98

-0.00

2.7

5.0

98.08

79.60

ng/l

—

Congenital malformation of vitreous humour

0.00

-0.00

0.0

3.5

—

63.33

—

Gangrene and necrosis of lung

0.00

-0.00

0.0

7.8

—

106.33

—

Infantile papular acrodermatitis [Gianotti-Crosti]

0.00

-0.00

0.0

4.6

—

36.00

—

Carcinoma in situ of other/unspecified digestive organs

0.00

-0.00

0.0

2.8

—

55.88

—

Deficiency of vitamin E

0.00

-0.00

0.0

3.4

—

69.71

—

Other transitory neonatal endocrine disorders

0.00

-0.00

0.0

8.7

—

36.71

—

Contact urticaria

0.88

-0.00

2.5

2.6

61.33

64.68

ng/l

—

Fetus and newborn affected by maternal use of alcohol

0.00

-0.00

0.0

7.4

—

32.41

—

Alcohol-induced pseudo-Cushing syndrome

0.00

-0.00

0.0

4.6

—

93.80

—

Crushing injury of shoulder and upper arm

0.00

-0.00

0.0

5.6

—

72.29

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

14.0

—

40.60

—

Vascular dementia (sudden onset)

0.96

-0.00

2.7

3.2

81.75

93.80

ng/l

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

2.6

—

54.80

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

3.7

—

82.83

—

Toxic effect of soaps and detergents

0.00

-0.00

0.0

4.0

—

45.62

—

Diving or jumping into water causing injury other than drowning or submersion

0.93

-0.00

2.4

5.0

71.50

79.83

ng/l

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.92

-0.00

5.7

3.8

135.00

84.30

ng/l

—

Benign neoplasm: Lymph nodes

1.02

-0.00

3.5

2.8

124.83

76.84

ng/l

—

Carcinoma in situ of other and unspecified parts of intestine

0.00

-0.00

0.0

3.0

—

60.94

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Parathyrin.intact [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS